id	sid	tid	token	lemma	pos
ajlm-297	1	1	article	article	PROPN
ajlm-297	1	2	information	information	NOUN
ajlm-297	1	3	authors	authors	PROPN
ajlm-297	1	4	:	:	PUNCT
ajlm-297	1	5	caroline	caroline	PROPN
ajlm-297	1	6	 	 	SPACE
ajlm-297	1	7	mangare1	mangare1	PROPN
ajlm-297	1	8	amos	amos	PROPN
ajlm-297	1	9	 	 	SPACE
ajlm-297	1	10	mbugua1	mbugua1	PROPN
ajlm-297	1	11	peter	peter	PROPN
ajlm-297	1	12	 	 	SPACE
ajlm-297	1	13	maturi2	maturi2	PROPN
ajlm-297	1	14	jamila	jamila	PROPN
ajlm-297	1	15	 	 	SPACE
ajlm-297	1	16	rajab2	rajab2	PROPN
ajlm-297	1	17	rainer	rainer	PROPN
ajlm-297	1	18	 	 	SPACE
ajlm-297	1	19	blasczyk3	blasczyk3	PROPN
ajlm-297	1	20	hans	hans	PROPN
ajlm-297	1	21	-	-	PUNCT
ajlm-297	1	22	gert	gert	NOUN
ajlm-297	1	23	 	 	SPACE
ajlm-297	1	24	heuft3	heuft3	NOUN
ajlm-297	1	25	affiliations	affiliation	NOUN
ajlm-297	1	26	:	:	PUNCT
ajlm-297	1	27	1jomo	1jomo	NUM
ajlm-297	1	28	kenyatta	kenyatta	PROPN
ajlm-297	1	29	university	university	PROPN
ajlm-297	1	30	of	of	ADP
ajlm-297	1	31	agriculture	agriculture	NOUN
ajlm-297	1	32	and	and	CCONJ
ajlm-297	1	33	technology	technology	NOUN
ajlm-297	1	34	,	,	PUNCT
ajlm-297	1	35	nairobi	nairobi	PROPN
ajlm-297	1	36	,	,	PUNCT
ajlm-297	1	37	kenya	kenya	PROPN
ajlm-297	1	38	2kenyatta	2kenyatta	NUM
ajlm-297	1	39	national	national	ADJ
ajlm-297	1	40	hospital	hospital	NOUN
ajlm-297	1	41	/	/	SYM
ajlm-297	1	42	university	university	PROPN
ajlm-297	1	43	of	of	ADP
ajlm-297	1	44	nairobi	nairobi	PROPN
ajlm-297	1	45	,	,	PUNCT
ajlm-297	1	46	department	department	NOUN
ajlm-297	1	47	of	of	ADP
ajlm-297	1	48	hematology	hematology	NOUN
ajlm-297	1	49	and	and	CCONJ
ajlm-297	1	50	blood	blood	NOUN
ajlm-297	1	51	transfusion	transfusion	NOUN
ajlm-297	1	52	,	,	PUNCT
ajlm-297	1	53	nairobi	nairobi	PROPN
ajlm-297	1	54	,	,	PUNCT
ajlm-297	1	55	kenya	kenya	PROPN
ajlm-297	1	56	3institute	3institute	NUM
ajlm-297	1	57	for	for	ADP
ajlm-297	1	58	transfusion	transfusion	NOUN
ajlm-297	1	59	medicine	medicine	NOUN
ajlm-297	1	60	,	,	PUNCT
ajlm-297	1	61	hannover	hannover	PROPN
ajlm-297	1	62	medical	medical	PROPN
ajlm-297	1	63	school	school	PROPN
ajlm-297	1	64	,	,	PUNCT
ajlm-297	1	65	hannover	hannover	PROPN
ajlm-297	1	66	,	,	PUNCT
ajlm-297	1	67	germany	germany	PROPN
ajlm-297	1	68	correspondence	correspondence	NOUN
ajlm-297	1	69	to	to	ADP
ajlm-297	1	70	:	:	PUNCT
ajlm-297	1	71	caroline	caroline	PROPN
ajlm-297	1	72	mangare	mangare	PROPN
ajlm-297	1	73	email	email	NOUN
ajlm-297	1	74	:	:	PUNCT
ajlm-297	1	75	caroleunice2000@gmail.com	caroleunice2000@gmail.com	X
ajlm-297	1	76	postal	postal	ADJ
ajlm-297	1	77	address	address	PROPN
ajlm-297	1	78	:	:	PUNCT
ajlm-297	1	79	54128	54128	NUM
ajlm-297	1	80	00200	00200	NUM
ajlm-297	1	81	nairobi	nairobi	PROPN
ajlm-297	1	82	,	,	PUNCT
ajlm-297	1	83	kenya	kenya	PROPN
ajlm-297	1	84	dates	date	NOUN
ajlm-297	1	85	:	:	PUNCT
ajlm-297	1	86	received	receive	VERB
ajlm-297	1	87	:	:	PUNCT
ajlm-297	1	88	 	 	SPACE
ajlm-297	1	89	28	28	NUM
ajlm-297	1	90	 	 	SPACE
ajlm-297	1	91	jan	jan	PROPN
ajlm-297	1	92	.	.	PROPN
ajlm-297	1	93	 	 	SPACE
ajlm-297	1	94	2015	2015	NUM
ajlm-297	1	95	accepted	accept	VERB
ajlm-297	1	96	:	:	PUNCT
ajlm-297	1	97	 	 	SPACE
ajlm-297	1	98	15	15	NUM
ajlm-297	1	99	 	 	SPACE
ajlm-297	1	100	aug	aug	PROPN
ajlm-297	1	101	.	.	PROPN
ajlm-297	1	102	 	 	SPACE
ajlm-297	1	103	2015	2015	NUM
ajlm-297	1	104	published	publish	VERB
ajlm-297	1	105	:	:	PUNCT
ajlm-297	1	106	 	 	SPACE
ajlm-297	1	107	25	25	NUM
ajlm-297	1	108	 	 	SPACE
ajlm-297	1	109	sept	sept	PROPN
ajlm-297	1	110	.	.	PROPN
ajlm-297	1	111	 	 	SPACE
ajlm-297	1	112	2015	2015	NUM
ajlm-297	1	113	how	how	SCONJ
ajlm-297	1	114	to	to	PART
ajlm-297	1	115	cite	cite	VERB
ajlm-297	1	116	this	this	DET
ajlm-297	1	117	article	article	NOUN
ajlm-297	1	118	:	:	PUNCT
ajlm-297	1	119	mangare	mangare	PROPN
ajlm-297	1	120	c	c	X
ajlm-297	1	121	,	,	PUNCT
ajlm-297	1	122	mbugua	mbugua	PROPN
ajlm-297	1	123	a	a	NOUN
ajlm-297	1	124	,	,	PUNCT
ajlm-297	1	125	maturi	maturi	PROPN
ajlm-297	1	126	p	p	PROPN
ajlm-297	1	127	,	,	PUNCT
ajlm-297	1	128	et	et	PROPN
ajlm-297	1	129	al	al	PROPN
ajlm-297	1	130	.	.	PROPN
ajlm-297	1	131	red	red	PROPN
ajlm-297	1	132	cell	cell	PROPN
ajlm-297	1	133	alloand	alloand	PROPN
ajlm-297	1	134	autoimmunisation	autoimmunisation	NOUN
ajlm-297	1	135	in	in	ADP
ajlm-297	1	136	transfused	transfused	ADJ
ajlm-297	1	137	sickle	sickle	NOUN
ajlm-297	1	138	cell	cell	NOUN
ajlm-297	1	139	and	and	CCONJ
ajlm-297	1	140	cancer	cancer	NOUN
ajlm-297	1	141	patients	patient	NOUN
ajlm-297	1	142	in	in	ADP
ajlm-297	1	143	kenyatta	kenyatta	PROPN
ajlm-297	1	144	national	national	PROPN
ajlm-297	1	145	hospital	hospital	PROPN
ajlm-297	1	146	,	,	PUNCT
ajlm-297	1	147	nairobi	nairobi	PROPN
ajlm-297	1	148	,	,	PUNCT
ajlm-297	1	149	kenya	kenya	PROPN
ajlm-297	1	150	.	.	PUNCT
ajlm-297	2	1	afr	afr	PROPN
ajlm-297	2	2	j	j	PROPN
ajlm-297	2	3	lab	lab	PROPN
ajlm-297	2	4	med	med	PROPN
ajlm-297	2	5	.	.	PUNCT
ajlm-297	2	6	2015;4(1	2015;4(1	NOUN
ajlm-297	2	7	)	)	PUNCT
ajlm-297	2	8	,	,	PUNCT
ajlm-297	2	9	art	art	NOUN
ajlm-297	2	10	.	.	PUNCT
ajlm-297	3	1	#	#	SYM
ajlm-297	3	2	297	297	NUM
ajlm-297	3	3	,	,	PUNCT
ajlm-297	3	4	7	7	NUM
ajlm-297	3	5	pages	page	NOUN
ajlm-297	3	6	.	.	PUNCT
ajlm-297	4	1	http://dx.doi.org/10.4102/ajlm.v4i1.297	http://dx.doi.org/10.4102/ajlm.v4i1.297	PROPN
ajlm-297	4	2	copyright	copyright	NOUN
ajlm-297	4	3	notice	notice	NOUN
ajlm-297	4	4	:	:	PUNCT
ajlm-297	4	5	©	©	PROPN
ajlm-297	4	6	2015	2015	NUM
ajlm-297	4	7	.	.	PUNCT
ajlm-297	5	1	the	the	DET
ajlm-297	5	2	authors	author	NOUN
ajlm-297	5	3	.	.	PUNCT
ajlm-297	6	1	licensee	licensee	NOUN
ajlm-297	6	2	:	:	PUNCT
ajlm-297	6	3	aosis	aosis	NOUN
ajlm-297	6	4	openjournals	openjournal	NOUN
ajlm-297	6	5	.	.	PUNCT
ajlm-297	7	1	this	this	PRON
ajlm-297	7	2	is	be	AUX
ajlm-297	7	3	an	an	DET
ajlm-297	7	4	open	open	ADJ
ajlm-297	7	5	access	access	NOUN
ajlm-297	7	6	article	article	NOUN
ajlm-297	7	7	distributed	distribute	VERB
ajlm-297	7	8	under	under	ADP
ajlm-297	7	9	the	the	DET
ajlm-297	7	10	terms	term	NOUN
ajlm-297	7	11	of	of	ADP
ajlm-297	7	12	the	the	DET
ajlm-297	7	13	creative	creative	ADJ
ajlm-297	7	14	commons	common	NOUN
ajlm-297	7	15	attribution	attribution	NOUN
ajlm-297	7	16	license	license	NOUN
ajlm-297	7	17	,	,	PUNCT
ajlm-297	7	18	which	which	PRON
ajlm-297	7	19	permits	permit	VERB
ajlm-297	7	20	unrestricted	unrestricted	ADJ
ajlm-297	7	21	use	use	NOUN
ajlm-297	7	22	,	,	PUNCT
ajlm-297	7	23	distribution	distribution	NOUN
ajlm-297	7	24	,	,	PUNCT
ajlm-297	7	25	and	and	CCONJ
ajlm-297	7	26	reproduction	reproduction	NOUN
ajlm-297	7	27	in	in	ADP
ajlm-297	7	28	any	any	DET
ajlm-297	7	29	medium	medium	NOUN
ajlm-297	7	30	,	,	PUNCT
ajlm-297	7	31	provided	provide	VERB
ajlm-297	7	32	the	the	DET
ajlm-297	7	33	original	original	ADJ
ajlm-297	7	34	work	work	NOUN
ajlm-297	7	35	is	be	AUX
ajlm-297	7	36	properly	properly	ADV
ajlm-297	7	37	cited	cite	VERB
ajlm-297	7	38	.	.	PUNCT
ajlm-297	8	1	red	red	ADJ
ajlm-297	8	2	cell	cell	PROPN
ajlm-297	8	3	alloand	alloand	PROPN
ajlm-297	8	4	autoimmunisation	autoimmunisation	NOUN
ajlm-297	8	5	in	in	ADP
ajlm-297	8	6	transfused	transfused	ADJ
ajlm-297	8	7	sickle	sickle	NOUN
ajlm-297	8	8	cell	cell	NOUN
ajlm-297	8	9	and	and	CCONJ
ajlm-297	8	10	cancer	cancer	NOUN
ajlm-297	8	11	patients	patient	NOUN
ajlm-297	8	12	in	in	ADP
ajlm-297	8	13	kenyatta	kenyatta	PROPN
ajlm-297	8	14	national	national	PROPN
ajlm-297	8	15	hospital	hospital	PROPN
ajlm-297	8	16	,	,	PUNCT
ajlm-297	8	17	nairobi	nairobi	PROPN
ajlm-297	8	18	,	,	PUNCT
ajlm-297	8	19	kenya	kenya	PROPN
ajlm-297	8	20	in	in	ADP
ajlm-297	8	21	this	this	DET
ajlm-297	8	22	original	original	ADJ
ajlm-297	8	23	research	research	NOUN
ajlm-297	8	24	...	...	PUNCT
ajlm-297	8	25	open	open	ADJ
ajlm-297	8	26	access	access	NOUN
ajlm-297	8	27	•	•	ADP
ajlm-297	8	28	abstract	abstract	ADJ
ajlm-297	8	29	•	•	NUM
ajlm-297	8	30	introduction	introduction	NOUN
ajlm-297	8	31	•	•	NOUN
ajlm-297	8	32	methods	method	NOUN
ajlm-297	8	33	   	   	SPACE
ajlm-297	8	34	•	•	NOUN
ajlm-297	8	35	setting	set	VERB
ajlm-297	8	36	and	and	CCONJ
ajlm-297	8	37	design	design	NOUN
ajlm-297	8	38	   	   	SPACE
ajlm-297	8	39	•	•	NOUN
ajlm-297	8	40	data	datum	NOUN
ajlm-297	8	41	and	and	CCONJ
ajlm-297	8	42	sample	sample	NOUN
ajlm-297	8	43	collection	collection	NOUN
ajlm-297	8	44	   	   	SPACE
ajlm-297	8	45	•	•	NOUN
ajlm-297	8	46	laboratory	laboratory	NOUN
ajlm-297	8	47	investigations	investigation	NOUN
ajlm-297	8	48	   	   	SPACE
ajlm-297	8	49	•	•	NUM
ajlm-297	8	50	immunohaematological	immunohaematological	ADJ
ajlm-297	8	51	testing	testing	NOUN
ajlm-297	8	52	   	   	SPACE
ajlm-297	8	53	•	•	NUM
ajlm-297	8	54	statistical	statistical	ADJ
ajlm-297	8	55	analyses	analysis	NOUN
ajlm-297	8	56	   	   	SPACE
ajlm-297	8	57	•	•	NUM
ajlm-297	8	58	ethical	ethical	ADJ
ajlm-297	8	59	considerations	consideration	NOUN
ajlm-297	8	60	•	•	ADP
ajlm-297	8	61	results	result	NOUN
ajlm-297	8	62	   	   	SPACE
ajlm-297	8	63	•	•	NUM
ajlm-297	8	64	patient	patient	NOUN
ajlm-297	8	65	data	datum	NOUN
ajlm-297	8	66	   	   	SPACE
ajlm-297	8	67	•	•	NUM
ajlm-297	8	68	serological	serological	ADJ
ajlm-297	8	69	results	result	NOUN
ajlm-297	8	70	   	   	SPACE
ajlm-297	8	71	•	•	NUM
ajlm-297	8	72	rbc	rbc	PROPN
ajlm-297	8	73	alloantibody	alloantibody	ADJ
ajlm-297	8	74	identification	identification	NOUN
ajlm-297	8	75	   	   	SPACE
ajlm-297	8	76	•	•	NOUN
ajlm-297	8	77	red	red	ADJ
ajlm-297	8	78	cell	cell	NOUN
ajlm-297	8	79	autoimmunisation	autoimmunisation	NOUN
ajlm-297	8	80	   	   	SPACE
ajlm-297	8	81	•	•	NUM
ajlm-297	8	82	comparison	comparison	NOUN
ajlm-297	8	83	of	of	ADP
ajlm-297	8	84	combined	combined	ADJ
ajlm-297	8	85	rbc	rbc	PROPN
ajlm-297	8	86	alloand	alloand	PROPN
ajlm-297	8	87	autoimmunisation	autoimmunisation	NOUN
ajlm-297	8	88	in	in	ADP
ajlm-297	8	89	sickle	sickle	PROPN
ajlm-297	8	90	cell	cell	NOUN
ajlm-297	8	91	versus	versus	ADP
ajlm-297	8	92	cancer	cancer	NOUN
ajlm-297	8	93	patients	patient	NOUN
ajlm-297	8	94	   	   	SPACE
ajlm-297	8	95	•	•	NUM
ajlm-297	8	96	healthy	healthy	ADJ
ajlm-297	8	97	donor	donor	NOUN
ajlm-297	8	98	phenotypes	phenotype	NOUN
ajlm-297	9	1	•	•	NOUN
ajlm-297	9	2	discussion	discussion	NOUN
ajlm-297	9	3	   	   	SPACE
ajlm-297	9	4	•	•	NUM
ajlm-297	9	5	limitations	limitation	NOUN
ajlm-297	9	6	   	   	SPACE
ajlm-297	9	7	•	•	NUM
ajlm-297	9	8	conclusion	conclusion	NOUN
ajlm-297	9	9	•	•	NOUN
ajlm-297	9	10	trustworthiness	trustworthiness	NOUN
ajlm-297	9	11	   	   	SPACE
ajlm-297	9	12	•	•	NUM
ajlm-297	9	13	reliability	reliability	NOUN
ajlm-297	9	14	and	and	CCONJ
ajlm-297	9	15	validity	validity	NOUN
ajlm-297	9	16	•	•	NUM
ajlm-297	9	17	acknowledgements	acknowledgement	NOUN
ajlm-297	9	18	   	   	SPACE
ajlm-297	9	19	•	•	NOUN
ajlm-297	9	20	competing	compete	VERB
ajlm-297	9	21	interests	interest	NOUN
ajlm-297	9	22	   	   	SPACE
ajlm-297	9	23	•	•	NUM
ajlm-297	9	24	authors	author	NOUN
ajlm-297	9	25	’	'	PUNCT
ajlm-297	9	26	contributions	contribution	NOUN
ajlm-297	9	27	•	•	NUM
ajlm-297	9	28	references	reference	NOUN
ajlm-297	9	29	abstract	abstract	ADJ
ajlm-297	9	30	top	top	PROPN
ajlm-297	9	31	↑	↑	PROPN
ajlm-297	9	32	background	background	NOUN
ajlm-297	9	33	:	:	PUNCT
ajlm-297	9	34	currently	currently	ADV
ajlm-297	9	35	,	,	PUNCT
ajlm-297	9	36	no	no	DET
ajlm-297	9	37	data	datum	NOUN
ajlm-297	9	38	are	be	AUX
ajlm-297	9	39	available	available	ADJ
ajlm-297	9	40	on	on	ADP
ajlm-297	9	41	the	the	DET
ajlm-297	9	42	prevalence	prevalence	NOUN
ajlm-297	9	43	of	of	ADP
ajlm-297	9	44	red	red	ADJ
ajlm-297	9	45	blood	blood	NOUN
ajlm-297	9	46	cell	cell	NOUN
ajlm-297	9	47	(	(	PUNCT
ajlm-297	9	48	rbc	rbc	PROPN
ajlm-297	9	49	)	)	PUNCT
ajlm-297	9	50	antibody	antibody	NOUN
ajlm-297	9	51	formation	formation	NOUN
ajlm-297	9	52	amongst	amongst	ADP
ajlm-297	9	53	kenyan	kenyan	ADJ
ajlm-297	9	54	patients	patient	NOUN
ajlm-297	9	55	with	with	ADP
ajlm-297	9	56	multiple	multiple	ADJ
ajlm-297	9	57	transfusion	transfusion	NOUN
ajlm-297	9	58	needs	need	NOUN
ajlm-297	9	59	,	,	PUNCT
ajlm-297	9	60	such	such	ADJ
ajlm-297	9	61	as	as	ADP
ajlm-297	9	62	patients	patient	NOUN
ajlm-297	9	63	with	with	ADP
ajlm-297	9	64	sickle	sickle	NOUN
ajlm-297	9	65	cell	cell	NOUN
ajlm-297	9	66	disease	disease	NOUN
ajlm-297	9	67	(	(	PUNCT
ajlm-297	9	68	scd	scd	NOUN
ajlm-297	9	69	)	)	PUNCT
ajlm-297	9	70	or	or	CCONJ
ajlm-297	9	71	haematological	haematological	ADJ
ajlm-297	9	72	malignancies	malignancy	NOUN
ajlm-297	9	73	(	(	PUNCT
ajlm-297	9	74	hm	hm	INTJ
ajlm-297	9	75	)	)	PUNCT
ajlm-297	9	76	and	and	CCONJ
ajlm-297	9	77	solid	solid	ADJ
ajlm-297	9	78	(	(	PUNCT
ajlm-297	9	79	sm	sm	NOUN
ajlm-297	9	80	)	)	PUNCT
ajlm-297	9	81	malignancies	malignancy	NOUN
ajlm-297	9	82	.	.	PUNCT
ajlm-297	10	1	objectives	objective	NOUN
ajlm-297	10	2	:	:	PUNCT
ajlm-297	10	3	we	we	PRON
ajlm-297	10	4	determined	determine	VERB
ajlm-297	10	5	the	the	DET
ajlm-297	10	6	prevalence	prevalence	NOUN
ajlm-297	10	7	and	and	CCONJ
ajlm-297	10	8	specificities	specificity	NOUN
ajlm-297	10	9	of	of	ADP
ajlm-297	10	10	rbc	rbc	PROPN
ajlm-297	10	11	alloantibodies	alloantibody	NOUN
ajlm-297	10	12	and	and	CCONJ
ajlm-297	10	13	autoantibodies	autoantibody	NOUN
ajlm-297	10	14	in	in	ADP
ajlm-297	10	15	two	two	NUM
ajlm-297	10	16	patient	patient	ADJ
ajlm-297	10	17	groups	group	NOUN
ajlm-297	10	18	with	with	ADP
ajlm-297	10	19	recurrent	recurrent	ADJ
ajlm-297	10	20	transfusion	transfusion	NOUN
ajlm-297	10	21	demands	demand	NOUN
ajlm-297	10	22	at	at	ADP
ajlm-297	10	23	kenyatta	kenyatta	PROPN
ajlm-297	10	24	national	national	PROPN
ajlm-297	10	25	hospital	hospital	PROPN
ajlm-297	10	26	,	,	PUNCT
ajlm-297	10	27	nairobi	nairobi	PROPN
ajlm-297	10	28	,	,	PUNCT
ajlm-297	10	29	kenya	kenya	PROPN
ajlm-297	10	30	.	.	PUNCT
ajlm-297	11	1	method	method	PROPN
ajlm-297	11	2	:	:	PUNCT
ajlm-297	11	3	between	between	ADP
ajlm-297	11	4	february	february	PROPN
ajlm-297	11	5	and	and	CCONJ
ajlm-297	11	6	august	august	PROPN
ajlm-297	11	7	2014	2014	NUM
ajlm-297	11	8	,	,	PUNCT
ajlm-297	11	9	300	300	NUM
ajlm-297	11	10	samples	sample	NOUN
ajlm-297	11	11	from	from	ADP
ajlm-297	11	12	scd	scd	PROPN
ajlm-297	11	13	,	,	PUNCT
ajlm-297	11	14	hm	hm	INTJ
ajlm-297	11	15	and	and	CCONJ
ajlm-297	11	16	sm	sm	PROPN
ajlm-297	11	17	patients	patient	NOUN
ajlm-297	11	18	were	be	AUX
ajlm-297	11	19	collected	collect	VERB
ajlm-297	11	20	and	and	CCONJ
ajlm-297	11	21	screened	screen	VERB
ajlm-297	11	22	for	for	ADP
ajlm-297	11	23	alloantibodies	alloantibody	NOUN
ajlm-297	11	24	.	.	PUNCT
ajlm-297	12	1	samples	sample	NOUN
ajlm-297	12	2	from	from	ADP
ajlm-297	12	3	51	51	NUM
ajlm-297	12	4	healthy	healthy	ADJ
ajlm-297	12	5	blood	blood	NOUN
ajlm-297	12	6	donors	donor	NOUN
ajlm-297	12	7	were	be	AUX
ajlm-297	12	8	screened	screen	VERB
ajlm-297	12	9	for	for	ADP
ajlm-297	12	10	irregular	irregular	ADJ
ajlm-297	12	11	antibodies	antibody	NOUN
ajlm-297	12	12	and	and	CCONJ
ajlm-297	12	13	phenotyped	phenotype	VERB
ajlm-297	12	14	.	.	PUNCT
ajlm-297	13	1	results	result	NOUN
ajlm-297	13	2	:	:	PUNCT
ajlm-297	13	3	amongst	amongst	ADP
ajlm-297	13	4	the	the	DET
ajlm-297	13	5	228	228	NUM
ajlm-297	13	6	patients	patient	NOUN
ajlm-297	13	7	with	with	ADP
ajlm-297	13	8	viable	viable	ADJ
ajlm-297	13	9	samples	sample	NOUN
ajlm-297	13	10	(	(	PUNCT
ajlm-297	13	11	scd	scd	NOUN
ajlm-297	13	12	,	,	PUNCT
ajlm-297	13	13	n	n	PROPN
ajlm-297	13	14	=	=	SYM
ajlm-297	13	15	137	137	NUM
ajlm-297	13	16	;	;	PUNCT
ajlm-297	13	17	hm	hm	INTJ
ajlm-297	13	18	,	,	PUNCT
ajlm-297	13	19	n	n	PROPN
ajlm-297	13	20	=	=	SYM
ajlm-297	13	21	48	48	NUM
ajlm-297	13	22	;	;	PUNCT
ajlm-297	13	23	sm	sm	NOUN
ajlm-297	13	24	,	,	PUNCT
ajlm-297	13	25	n	n	NOUN
ajlm-297	13	26	=	=	SYM
ajlm-297	13	27	43	43	NUM
ajlm-297	13	28	)	)	PUNCT
ajlm-297	13	29	,	,	PUNCT
ajlm-297	13	30	the	the	DET
ajlm-297	13	31	median	median	ADJ
ajlm-297	13	32	transfusion	transfusion	NOUN
ajlm-297	13	33	frequency	frequency	NOUN
ajlm-297	13	34	was	be	AUX
ajlm-297	13	35	two	two	NUM
ajlm-297	13	36	to	to	PART
ajlm-297	13	37	three	three	NUM
ajlm-297	13	38	events	event	NOUN
ajlm-297	13	39	per	per	ADP
ajlm-297	13	40	group	group	NOUN
ajlm-297	13	41	,	,	PUNCT
ajlm-297	13	42	38	38	NUM
ajlm-297	13	43	(	(	PUNCT
ajlm-297	13	44	16.7	16.7	NUM
ajlm-297	13	45	%	%	NOUN
ajlm-297	13	46	)	)	PUNCT
ajlm-297	13	47	were	be	AUX
ajlm-297	13	48	rbc	rbc	PROPN
ajlm-297	13	49	immunised	immunise	VERB
ajlm-297	13	50	and	and	CCONJ
ajlm-297	13	51	32	32	NUM
ajlm-297	13	52	(	(	PUNCT
ajlm-297	13	53	14.0	14.0	NUM
ajlm-297	13	54	%	%	NOUN
ajlm-297	13	55	)	)	PUNCT
ajlm-297	13	56	had	have	VERB
ajlm-297	13	57	a	a	DET
ajlm-297	13	58	positive	positive	ADJ
ajlm-297	13	59	direct	direct	ADJ
ajlm-297	13	60	antiglobulin	antiglobulin	NOUN
ajlm-297	13	61	test	test	NOUN
ajlm-297	13	62	.	.	PUNCT
ajlm-297	14	1	we	we	PRON
ajlm-297	14	2	identified	identify	VERB
ajlm-297	14	3	specific	specific	ADJ
ajlm-297	14	4	alloantibodies	alloantibody	NOUN
ajlm-297	14	5	in	in	ADP
ajlm-297	14	6	six	six	NUM
ajlm-297	14	7	patients	patient	NOUN
ajlm-297	14	8	(	(	PUNCT
ajlm-297	14	9	2.6	2.6	NUM
ajlm-297	14	10	%	%	NOUN
ajlm-297	14	11	)	)	PUNCT
ajlm-297	14	12	.	.	PUNCT
ajlm-297	15	1	four	four	NUM
ajlm-297	15	2	of	of	ADP
ajlm-297	15	3	these	these	DET
ajlm-297	15	4	six	six	NUM
ajlm-297	15	5	were	be	AUX
ajlm-297	15	6	scd	scd	NOUN
ajlm-297	15	7	patients	patient	NOUN
ajlm-297	15	8	(	(	PUNCT
ajlm-297	15	9	2.9	2.9	NUM
ajlm-297	15	10	%	%	NOUN
ajlm-297	15	11	)	)	PUNCT
ajlm-297	15	12	who	who	PRON
ajlm-297	15	13	had	have	VERB
ajlm-297	15	14	specific	specific	ADJ
ajlm-297	15	15	rbc	rbc	PROPN
ajlm-297	15	16	alloantibodies	alloantibody	NOUN
ajlm-297	15	17	(	(	PUNCT
ajlm-297	15	18	anti	anti	ADJ
ajlm-297	15	19	-	-	ADJ
ajlm-297	15	20	cw	cw	ADJ
ajlm-297	15	21	,	,	PUNCT
ajlm-297	15	22	anti	anti	ADJ
ajlm-297	15	23	-	-	ADJ
ajlm-297	15	24	m	m	ADJ
ajlm-297	15	25	,	,	PUNCT
ajlm-297	15	26	anti	anti	ADJ
ajlm-297	15	27	-	-	ADJ
ajlm-297	15	28	cob	cob	ADJ
ajlm-297	15	29	,	,	PUNCT
ajlm-297	15	30	anti	anti	ADJ
ajlm-297	15	31	-	-	ADJ
ajlm-297	15	32	s	s	NOUN
ajlm-297	15	33	)	)	PUNCT
ajlm-297	15	34	;	;	PUNCT
ajlm-297	15	35	amongst	amongst	ADP
ajlm-297	15	36	hm	hm	INTJ
ajlm-297	15	37	patients	patient	NOUN
ajlm-297	15	38	one	one	NUM
ajlm-297	15	39	had	have	VERB
ajlm-297	15	40	anti	anti	ADJ
ajlm-297	15	41	-	-	ADJ
ajlm-297	15	42	k	k	ADJ
ajlm-297	15	43	and	and	CCONJ
ajlm-297	15	44	one	one	NUM
ajlm-297	15	45	had	have	VERB
ajlm-297	15	46	anti	anti	ADJ
ajlm-297	15	47	-	-	ADJ
ajlm-297	15	48	lea	lea	ADJ
ajlm-297	15	49	.	.	PUNCT
ajlm-297	16	1	rbc	rbc	PROPN
ajlm-297	16	2	autoantibody	autoantibody	PROPN
ajlm-297	16	3	prevalence	prevalence	NOUN
ajlm-297	16	4	was	be	AUX
ajlm-297	16	5	3.1	3.1	NUM
ajlm-297	16	6	%	%	NOUN
ajlm-297	16	7	(	(	PUNCT
ajlm-297	16	8	7/228	7/228	NUM
ajlm-297	16	9	)	)	PUNCT
ajlm-297	16	10	.	.	PUNCT
ajlm-297	17	1	amongst	amongst	ADP
ajlm-297	17	2	the	the	DET
ajlm-297	17	3	healthy	healthy	ADJ
ajlm-297	17	4	blood	blood	NOUN
ajlm-297	17	5	donors	donor	NOUN
ajlm-297	17	6	,	,	PUNCT
ajlm-297	17	7	the	the	DET
ajlm-297	17	8	ror	ror	NOUN
ajlm-297	17	9	,	,	PUNCT
ajlm-297	17	10	ccd.ee	ccd.ee	NOUN
ajlm-297	17	11	and	and	CCONJ
ajlm-297	17	12	r2r	r2r	NOUN
ajlm-297	17	13	,	,	PUNCT
ajlm-297	17	14	ccd.ee	ccd.ee	NOUN
ajlm-297	17	15	phenotypes	phenotype	NOUN
ajlm-297	17	16	accounted	account	VERB
ajlm-297	17	17	for	for	ADP
ajlm-297	17	18	82	82	NUM
ajlm-297	17	19	%	%	NOUN
ajlm-297	17	20	of	of	ADP
ajlm-297	17	21	the	the	DET
ajlm-297	17	22	rhesus	rhesus	NOUN
ajlm-297	17	23	phenotypes	phenotype	NOUN
ajlm-297	17	24	and	and	CCONJ
ajlm-297	17	25	all	all	PRON
ajlm-297	17	26	were	be	AUX
ajlm-297	17	27	kell	kell	PROPN
ajlm-297	17	28	negative	negative	PROPN
ajlm-297	17	29	.	.	PUNCT
ajlm-297	18	1	conclusion	conclusion	NOUN
ajlm-297	18	2	:	:	PUNCT
ajlm-297	18	3	the	the	DET
ajlm-297	18	4	numbers	number	NOUN
ajlm-297	18	5	of	of	ADP
ajlm-297	18	6	transfusions	transfusion	NOUN
ajlm-297	18	7	and	and	CCONJ
ajlm-297	18	8	the	the	DET
ajlm-297	18	9	rates	rate	NOUN
ajlm-297	18	10	of	of	ADP
ajlm-297	18	11	rbc	rbc	PROPN
ajlm-297	18	12	alloantibodies	alloantibody	NOUN
ajlm-297	18	13	are	be	AUX
ajlm-297	18	14	low	low	ADJ
ajlm-297	18	15	and	and	CCONJ
ajlm-297	18	16	the	the	DET
ajlm-297	18	17	most	most	ADV
ajlm-297	18	18	important	important	ADJ
ajlm-297	18	19	rbc	rbc	PROPN
ajlm-297	18	20	alloantibody	alloantibody	ADJ
ajlm-297	18	21	-	-	PUNCT
ajlm-297	18	22	inducing	induce	VERB
ajlm-297	18	23	blood	blood	NOUN
ajlm-297	18	24	group	group	NOUN
ajlm-297	18	25	antigens	antigen	NOUN
ajlm-297	18	26	are	be	AUX
ajlm-297	18	27	relatively	relatively	ADV
ajlm-297	18	28	homogeneously	homogeneously	ADV
ajlm-297	18	29	distributed	distribute	VERB
ajlm-297	18	30	in	in	ADP
ajlm-297	18	31	this	this	DET
ajlm-297	18	32	population	population	NOUN
ajlm-297	18	33	.	.	PUNCT
ajlm-297	19	1	a	a	DET
ajlm-297	19	2	general	general	ADJ
ajlm-297	19	3	change	change	NOUN
ajlm-297	19	4	in	in	ADP
ajlm-297	19	5	the	the	DET
ajlm-297	19	6	kenyatta	kenyatta	PROPN
ajlm-297	19	7	national	national	PROPN
ajlm-297	19	8	hospital	hospital	PROPN
ajlm-297	19	9	pre	pre	ADJ
ajlm-297	19	10	-	-	ADJ
ajlm-297	19	11	transfusion	transfusion	ADJ
ajlm-297	19	12	test	test	NOUN
ajlm-297	19	13	regimen	regiman	NOUN
ajlm-297	19	14	is	be	AUX
ajlm-297	19	15	thus	thus	ADV
ajlm-297	19	16	not	not	PART
ajlm-297	19	17	necessary	necessary	ADJ
ajlm-297	19	18	.	.	PUNCT
ajlm-297	20	1	the	the	DET
ajlm-297	20	2	current	current	ADJ
ajlm-297	20	3	transfusion	transfusion	NOUN
ajlm-297	20	4	practice	practice	NOUN
ajlm-297	20	5	should	should	AUX
ajlm-297	20	6	be	be	AUX
ajlm-297	20	7	reconsidered	reconsider	VERB
ajlm-297	20	8	if	if	SCONJ
ajlm-297	20	9	transfusion	transfusion	NOUN
ajlm-297	20	10	frequencies	frequency	NOUN
ajlm-297	20	11	increase	increase	VERB
ajlm-297	20	12	in	in	ADP
ajlm-297	20	13	the	the	DET
ajlm-297	20	14	future	future	NOUN
ajlm-297	20	15	.	.	PUNCT
ajlm-297	21	1	introduction	introduction	NOUN
ajlm-297	21	2	top	top	PROPN
ajlm-297	21	3	↑	↑	NOUN
ajlm-297	21	4	blood	blood	NOUN
ajlm-297	21	5	transfusion	transfusion	NOUN
ajlm-297	21	6	constitutes	constitute	VERB
ajlm-297	21	7	an	an	DET
ajlm-297	21	8	important	important	ADJ
ajlm-297	21	9	supportive	supportive	ADJ
ajlm-297	21	10	modality	modality	NOUN
ajlm-297	21	11	in	in	ADP
ajlm-297	21	12	the	the	DET
ajlm-297	21	13	management	management	NOUN
ajlm-297	21	14	of	of	ADP
ajlm-297	21	15	patients	patient	NOUN
ajlm-297	21	16	with	with	ADP
ajlm-297	21	17	sickle	sickle	NOUN
ajlm-297	21	18	cell	cell	NOUN
ajlm-297	21	19	disease	disease	NOUN
ajlm-297	21	20	(	(	PUNCT
ajlm-297	21	21	scd	scd	NOUN
ajlm-297	21	22	)	)	PUNCT
ajlm-297	21	23	and	and	CCONJ
ajlm-297	21	24	cancer	cancer	NOUN
ajlm-297	21	25	,	,	PUNCT
ajlm-297	21	26	because	because	SCONJ
ajlm-297	21	27	of	of	ADP
ajlm-297	21	28	longer	long	ADJ
ajlm-297	21	29	periods	period	NOUN
ajlm-297	21	30	of	of	ADP
ajlm-297	21	31	treatment	treatment	NOUN
ajlm-297	21	32	and	and	CCONJ
ajlm-297	21	33	increased	increase	VERB
ajlm-297	21	34	survival	survival	NOUN
ajlm-297	21	35	rates	rate	NOUN
ajlm-297	21	36	.	.	PUNCT
ajlm-297	22	1	scd	scd	PROPN
ajlm-297	22	2	is	be	AUX
ajlm-297	22	3	the	the	DET
ajlm-297	22	4	most	most	ADV
ajlm-297	22	5	prevalent	prevalent	ADJ
ajlm-297	22	6	haematologic	haematologic	ADJ
ajlm-297	22	7	genetic	genetic	ADJ
ajlm-297	22	8	disease	disease	NOUN
ajlm-297	22	9	in	in	ADP
ajlm-297	22	10	kenya1	kenya1	NOUN
ajlm-297	22	11	and	and	CCONJ
ajlm-297	22	12	cancer	cancer	NOUN
ajlm-297	22	13	is	be	AUX
ajlm-297	22	14	an	an	DET
ajlm-297	22	15	increasingly	increasingly	ADV
ajlm-297	22	16	important	important	ADJ
ajlm-297	22	17	challenge	challenge	NOUN
ajlm-297	22	18	for	for	SCONJ
ajlm-297	22	19	the	the	DET
ajlm-297	22	20	kenyan	kenyan	ADJ
ajlm-297	22	21	public	public	ADJ
ajlm-297	22	22	health	health	NOUN
ajlm-297	22	23	system.2	system.2	NOUN
ajlm-297	22	24	red	red	ADJ
ajlm-297	22	25	blood	blood	NOUN
ajlm-297	22	26	cell	cell	NOUN
ajlm-297	22	27	(	(	PUNCT
ajlm-297	22	28	rbc	rbc	PROPN
ajlm-297	22	29	)	)	PUNCT
ajlm-297	22	30	alloand	alloand	PROPN
ajlm-297	22	31	autoimmunisation	autoimmunisation	NOUN
ajlm-297	22	32	often	often	ADV
ajlm-297	22	33	develop	develop	VERB
ajlm-297	22	34	as	as	ADP
ajlm-297	22	35	a	a	DET
ajlm-297	22	36	result	result	NOUN
ajlm-297	22	37	of	of	ADP
ajlm-297	22	38	transfusions	transfusion	NOUN
ajlm-297	22	39	with	with	ADP
ajlm-297	22	40	allogeneic	allogeneic	ADJ
ajlm-297	22	41	blood	blood	NOUN
ajlm-297	22	42	and	and	CCONJ
ajlm-297	22	43	occur	occur	VERB
ajlm-297	22	44	because	because	SCONJ
ajlm-297	22	45	of	of	ADP
ajlm-297	22	46	the	the	DET
ajlm-297	22	47	response	response	NOUN
ajlm-297	22	48	of	of	ADP
ajlm-297	22	49	recipients	recipient	NOUN
ajlm-297	22	50	’	'	PUNCT
ajlm-297	22	51	immune	immune	ADJ
ajlm-297	22	52	systems	system	NOUN
ajlm-297	22	53	to	to	ADP
ajlm-297	22	54	foreign	foreign	ADJ
ajlm-297	22	55	rbc	rbc	PROPN
ajlm-297	22	56	antigens	antigen	NOUN
ajlm-297	22	57	from	from	ADP
ajlm-297	22	58	donors.3	donors.3	PROPN
ajlm-297	22	59	some	some	PRON
ajlm-297	22	60	of	of	ADP
ajlm-297	22	61	the	the	DET
ajlm-297	22	62	facets	facet	NOUN
ajlm-297	22	63	involved	involve	VERB
ajlm-297	22	64	in	in	ADP
ajlm-297	22	65	these	these	DET
ajlm-297	22	66	immunological	immunological	ADJ
ajlm-297	22	67	reactions	reaction	NOUN
ajlm-297	22	68	are	be	AUX
ajlm-297	22	69	:	:	PUNCT
ajlm-297	22	70	recipient	recipient	NOUN
ajlm-297	22	71	age	age	NOUN
ajlm-297	22	72	;	;	PUNCT
ajlm-297	22	73	sex	sex	NOUN
ajlm-297	22	74	;	;	PUNCT
ajlm-297	22	75	history	history	NOUN
ajlm-297	22	76	of	of	ADP
ajlm-297	22	77	pregnancy	pregnancy	NOUN
ajlm-297	22	78	;	;	PUNCT
ajlm-297	22	79	number	number	NOUN
ajlm-297	22	80	of	of	ADP
ajlm-297	22	81	blood	blood	NOUN
ajlm-297	22	82	units	unit	NOUN
ajlm-297	22	83	transfused	transfuse	VERB
ajlm-297	22	84	;	;	PUNCT
ajlm-297	22	85	and	and	CCONJ
ajlm-297	22	86	diagnosisand	diagnosisand	PRON
ajlm-297	22	87	treatment	treatment	NOUN
ajlm-297	22	88	-	-	PUNCT
ajlm-297	22	89	related	relate	VERB
ajlm-297	22	90	impairment	impairment	NOUN
ajlm-297	22	91	to	to	ADP
ajlm-297	22	92	the	the	DET
ajlm-297	22	93	recipient	recipient	NOUN
ajlm-297	22	94	's	's	PART
ajlm-297	22	95	immune	immune	ADJ
ajlm-297	22	96	system.4,5	system.4,5	PROPN
ajlm-297	22	97	rbc	rbc	PROPN
ajlm-297	22	98	alloimmunisation	alloimmunisation	NOUN
ajlm-297	22	99	is	be	AUX
ajlm-297	22	100	associated	associate	VERB
ajlm-297	22	101	with	with	ADP
ajlm-297	22	102	clinical	clinical	ADJ
ajlm-297	22	103	complications	complication	NOUN
ajlm-297	22	104	,	,	PUNCT
ajlm-297	22	105	such	such	ADJ
ajlm-297	22	106	as	as	ADP
ajlm-297	22	107	morbidity	morbidity	NOUN
ajlm-297	22	108	resulting	result	VERB
ajlm-297	22	109	from	from	ADP
ajlm-297	22	110	acute	acute	ADJ
ajlm-297	22	111	and	and	CCONJ
ajlm-297	22	112	delayed	delay	VERB
ajlm-297	22	113	haemolytic	haemolytic	ADJ
ajlm-297	22	114	transfusion	transfusion	NOUN
ajlm-297	22	115	reactions	reaction	NOUN
ajlm-297	22	116	.	.	PUNCT
ajlm-297	23	1	the	the	DET
ajlm-297	23	2	former	former	ADJ
ajlm-297	23	3	can	can	AUX
ajlm-297	23	4	mimic	mimic	VERB
ajlm-297	23	5	a	a	DET
ajlm-297	23	6	sickle	sickle	NOUN
ajlm-297	23	7	cell	cell	NOUN
ajlm-297	23	8	crisis	crisis	NOUN
ajlm-297	23	9	.	.	PUNCT
ajlm-297	24	1	furthermore	furthermore	ADV
ajlm-297	24	2	,	,	PUNCT
ajlm-297	24	3	alloimmunisation	alloimmunisation	NOUN
ajlm-297	24	4	creates	create	VERB
ajlm-297	24	5	difficulties	difficulty	NOUN
ajlm-297	24	6	for	for	ADP
ajlm-297	24	7	laboratories	laboratory	NOUN
ajlm-297	24	8	,	,	PUNCT
ajlm-297	24	9	including	include	VERB
ajlm-297	24	10	expensive	expensive	ADJ
ajlm-297	24	11	and	and	CCONJ
ajlm-297	24	12	time	time	NOUN
ajlm-297	24	13	-	-	PUNCT
ajlm-297	24	14	consuming	consume	VERB
ajlm-297	24	15	laboratory	laboratory	NOUN
ajlm-297	24	16	workups	workup	NOUN
ajlm-297	24	17	to	to	PART
ajlm-297	24	18	determine	determine	VERB
ajlm-297	24	19	compatible	compatible	ADJ
ajlm-297	24	20	blood	blood	NOUN
ajlm-297	24	21	,	,	PUNCT
ajlm-297	24	22	especially	especially	ADV
ajlm-297	24	23	for	for	ADP
ajlm-297	24	24	cases	case	NOUN
ajlm-297	24	25	with	with	ADP
ajlm-297	24	26	multiple	multiple	ADJ
ajlm-297	24	27	alloantibodies	alloantibody	NOUN
ajlm-297	24	28	(	(	PUNCT
ajlm-297	24	29	alloab	alloab	PROPN
ajlm-297	24	30	)	)	PUNCT
ajlm-297	24	31	.	.	PUNCT
ajlm-297	25	1	alloabs	alloab	NOUN
ajlm-297	25	2	can	can	AUX
ajlm-297	25	3	become	become	VERB
ajlm-297	25	4	undetectable	undetectable	ADJ
ajlm-297	25	5	over	over	ADP
ajlm-297	25	6	time	time	NOUN
ajlm-297	25	7	and/or	and/or	CCONJ
ajlm-297	25	8	be	be	AUX
ajlm-297	25	9	boostered	boostere	VERB
ajlm-297	25	10	as	as	ADP
ajlm-297	25	11	an	an	DET
ajlm-297	25	12	anamnestic	anamnestic	ADJ
ajlm-297	25	13	response	response	NOUN
ajlm-297	25	14	after	after	ADP
ajlm-297	25	15	another	another	DET
ajlm-297	25	16	transfusion	transfusion	NOUN
ajlm-297	25	17	.	.	PUNCT
ajlm-297	26	1	rbc	rbc	PROPN
ajlm-297	26	2	alloab	alloab	PROPN
ajlm-297	26	3	against	against	ADP
ajlm-297	26	4	incompatible	incompatible	ADJ
ajlm-297	26	5	rbc	rbc	PROPN
ajlm-297	26	6	in	in	ADP
ajlm-297	26	7	an	an	DET
ajlm-297	26	8	allogeneic	allogeneic	ADJ
ajlm-297	26	9	bone	bone	NOUN
ajlm-297	26	10	marrow	marrow	NOUN
ajlm-297	26	11	transplant	transplant	NOUN
ajlm-297	26	12	may	may	AUX
ajlm-297	26	13	require	require	VERB
ajlm-297	26	14	procedures	procedure	NOUN
ajlm-297	26	15	for	for	ADP
ajlm-297	26	16	rbc	rbc	PROPN
ajlm-297	26	17	reduction.6,7	reduction.6,7	PROPN
ajlm-297	26	18	the	the	DET
ajlm-297	26	19	development	development	NOUN
ajlm-297	26	20	of	of	ADP
ajlm-297	26	21	alloab	alloab	PROPN
ajlm-297	26	22	has	have	AUX
ajlm-297	26	23	been	be	AUX
ajlm-297	26	24	associated	associate	VERB
ajlm-297	26	25	with	with	ADP
ajlm-297	26	26	that	that	PRON
ajlm-297	26	27	of	of	ADP
ajlm-297	26	28	autoantibodies	autoantibody	NOUN
ajlm-297	26	29	(	(	PUNCT
ajlm-297	26	30	autoab),8,9	autoab),8,9	NUM
ajlm-297	26	31	which	which	PRON
ajlm-297	26	32	can	can	AUX
ajlm-297	26	33	shorten	shorten	VERB
ajlm-297	26	34	the	the	DET
ajlm-297	26	35	lifespan	lifespan	NOUN
ajlm-297	26	36	of	of	ADP
ajlm-297	26	37	recipients	recipient	NOUN
ajlm-297	26	38	’	'	PUNCT
ajlm-297	26	39	own	own	ADJ
ajlm-297	26	40	rbcs	rbc	NOUN
ajlm-297	26	41	and/or	and/or	CCONJ
ajlm-297	26	42	transfused	transfused	ADJ
ajlm-297	26	43	rbcs	rbc	NOUN
ajlm-297	26	44	and	and	CCONJ
ajlm-297	26	45	potentially	potentially	ADV
ajlm-297	26	46	cause	cause	VERB
ajlm-297	26	47	haemolysis	haemolysis	NOUN
ajlm-297	26	48	.	.	PUNCT
ajlm-297	27	1	because	because	SCONJ
ajlm-297	27	2	of	of	ADP
ajlm-297	27	3	this	this	PRON
ajlm-297	27	4	,	,	PUNCT
ajlm-297	27	5	these	these	DET
ajlm-297	27	6	patients	patient	NOUN
ajlm-297	27	7	may	may	AUX
ajlm-297	27	8	require	require	VERB
ajlm-297	27	9	several	several	ADJ
ajlm-297	27	10	transfusions	transfusion	NOUN
ajlm-297	27	11	and	and	CCONJ
ajlm-297	27	12	may	may	AUX
ajlm-297	27	13	need	need	VERB
ajlm-297	27	14	interventions	intervention	NOUN
ajlm-297	27	15	,	,	PUNCT
ajlm-297	27	16	such	such	ADJ
ajlm-297	27	17	as	as	ADP
ajlm-297	27	18	drugs	drug	NOUN
ajlm-297	27	19	to	to	PART
ajlm-297	27	20	suppress	suppress	VERB
ajlm-297	27	21	the	the	DET
ajlm-297	27	22	immune	immune	ADJ
ajlm-297	27	23	system	system	NOUN
ajlm-297	27	24	and/or	and/or	CCONJ
ajlm-297	27	25	splenectomy.9	splenectomy.9	ADV
ajlm-297	27	26	these	these	DET
ajlm-297	27	27	challenges	challenge	NOUN
ajlm-297	27	28	need	need	VERB
ajlm-297	27	29	to	to	PART
ajlm-297	27	30	be	be	AUX
ajlm-297	27	31	considered	consider	VERB
ajlm-297	27	32	when	when	SCONJ
ajlm-297	27	33	handling	handle	VERB
ajlm-297	27	34	patients	patient	NOUN
ajlm-297	27	35	who	who	PRON
ajlm-297	27	36	are	be	AUX
ajlm-297	27	37	likely	likely	ADJ
ajlm-297	27	38	to	to	PART
ajlm-297	27	39	be	be	AUX
ajlm-297	27	40	transfusion	transfusion	NOUN
ajlm-297	27	41	-	-	PUNCT
ajlm-297	27	42	dependent	dependent	ADJ
ajlm-297	27	43	,	,	PUNCT
ajlm-297	27	44	as	as	ADV
ajlm-297	27	45	well	well	ADV
ajlm-297	27	46	as	as	ADP
ajlm-297	27	47	those	those	PRON
ajlm-297	27	48	who	who	PRON
ajlm-297	27	49	could	could	AUX
ajlm-297	27	50	benefit	benefit	VERB
ajlm-297	27	51	from	from	ADP
ajlm-297	27	52	haematopoietic	haematopoietic	ADJ
ajlm-297	27	53	stem	stem	NOUN
ajlm-297	27	54	cell	cell	NOUN
ajlm-297	27	55	transplantations	transplantation	NOUN
ajlm-297	27	56	.	.	PUNCT
ajlm-297	28	1	decreasing	decrease	VERB
ajlm-297	28	2	the	the	DET
ajlm-297	28	3	risk	risk	NOUN
ajlm-297	28	4	of	of	ADP
ajlm-297	28	5	rbc	rbc	PROPN
ajlm-297	28	6	alloimmunisation	alloimmunisation	NOUN
ajlm-297	28	7	by	by	ADP
ajlm-297	28	8	implementing	implement	VERB
ajlm-297	28	9	strategies	strategy	NOUN
ajlm-297	28	10	to	to	PART
ajlm-297	28	11	avoid	avoid	VERB
ajlm-297	28	12	allogeneic	allogeneic	ADJ
ajlm-297	28	13	blood	blood	NOUN
ajlm-297	28	14	transfusions	transfusion	NOUN
ajlm-297	28	15	(	(	PUNCT
ajlm-297	28	16	e.g.	e.g.	ADV
ajlm-297	28	17	,	,	PUNCT
ajlm-297	28	18	erythropoietin	erythropoietin	ADJ
ajlm-297	28	19	administration	administration	NOUN
ajlm-297	28	20	in	in	ADP
ajlm-297	28	21	cancer	cancer	NOUN
ajlm-297	28	22	patients	patient	NOUN
ajlm-297	28	23	)	)	PUNCT
ajlm-297	28	24	or	or	CCONJ
ajlm-297	28	25	extensive	extensive	ADJ
ajlm-297	28	26	phenotypic	phenotypic	NOUN
ajlm-297	28	27	matching	matching	NOUN
ajlm-297	28	28	of	of	ADP
ajlm-297	28	29	rbc	rbc	PROPN
ajlm-297	28	30	blood	blood	NOUN
ajlm-297	28	31	group	group	NOUN
ajlm-297	28	32	antigens	antigen	NOUN
ajlm-297	28	33	,	,	PUNCT
ajlm-297	28	34	such	such	ADJ
ajlm-297	28	35	as	as	ADP
ajlm-297	28	36	the	the	DET
ajlm-297	28	37	rhesus	rhesus	NOUN
ajlm-297	28	38	,	,	PUNCT
ajlm-297	28	39	kell	kell	PROPN
ajlm-297	28	40	,	,	PUNCT
ajlm-297	28	41	duffy	duffy	PROPN
ajlm-297	28	42	,	,	PUNCT
ajlm-297	28	43	kidd	kidd	PROPN
ajlm-297	28	44	and	and	CCONJ
ajlm-297	28	45	mns	mns	PROPN
ajlm-297	28	46	blood	blood	NOUN
ajlm-297	28	47	groups	group	NOUN
ajlm-297	28	48	,	,	PUNCT
ajlm-297	28	49	has	have	AUX
ajlm-297	28	50	been	be	AUX
ajlm-297	28	51	advocated	advocate	VERB
ajlm-297	28	52	previously.10,11	previously.10,11	NOUN
ajlm-297	28	53	however	however	ADV
ajlm-297	28	54	,	,	PUNCT
ajlm-297	28	55	this	this	PRON
ajlm-297	28	56	is	be	AUX
ajlm-297	28	57	costly	costly	ADJ
ajlm-297	28	58	and	and	CCONJ
ajlm-297	28	59	impractical	impractical	ADJ
ajlm-297	28	60	in	in	ADP
ajlm-297	28	61	many	many	ADJ
ajlm-297	28	62	health	health	NOUN
ajlm-297	28	63	settings	setting	NOUN
ajlm-297	28	64	,	,	PUNCT
ajlm-297	28	65	particularly	particularly	ADV
ajlm-297	28	66	in	in	ADP
ajlm-297	28	67	developing	develop	VERB
ajlm-297	28	68	countries	country	NOUN
ajlm-297	28	69	.	.	PUNCT
ajlm-297	29	1	studies	study	NOUN
ajlm-297	29	2	conducted	conduct	VERB
ajlm-297	29	3	on	on	ADP
ajlm-297	29	4	the	the	DET
ajlm-297	29	5	frequency	frequency	NOUN
ajlm-297	29	6	of	of	ADP
ajlm-297	29	7	rbc	rbc	PROPN
ajlm-297	29	8	alloimmunisation	alloimmunisation	PROPN
ajlm-297	29	9	in	in	ADP
ajlm-297	29	10	different	different	ADJ
ajlm-297	29	11	patient	patient	NOUN
ajlm-297	29	12	populations	population	NOUN
ajlm-297	29	13	have	have	AUX
ajlm-297	29	14	reported	report	VERB
ajlm-297	29	15	rates	rate	NOUN
ajlm-297	29	16	of	of	ADP
ajlm-297	29	17	1	1	NUM
ajlm-297	29	18	%	%	NOUN
ajlm-297	29	19	to	to	PART
ajlm-297	29	20	6	6	NUM
ajlm-297	29	21	%	%	NOUN
ajlm-297	29	22	in	in	ADP
ajlm-297	29	23	occasionally	occasionally	ADV
ajlm-297	29	24	transfused	transfuse	VERB
ajlm-297	29	25	patients	patient	NOUN
ajlm-297	29	26	and	and	CCONJ
ajlm-297	29	27	up	up	ADP
ajlm-297	29	28	to	to	PART
ajlm-297	29	29	30	30	NUM
ajlm-297	29	30	%	%	NOUN
ajlm-297	29	31	in	in	ADP
ajlm-297	29	32	poly	poly	ADJ
ajlm-297	29	33	-	-	PUNCT
ajlm-297	29	34	transfused	transfuse	VERB
ajlm-297	29	35	patients.12	patients.12	NOUN
ajlm-297	29	36	in	in	ADP
ajlm-297	29	37	europe	europe	PROPN
ajlm-297	29	38	and	and	CCONJ
ajlm-297	29	39	the	the	DET
ajlm-297	29	40	united	united	PROPN
ajlm-297	29	41	states	states	PROPN
ajlm-297	29	42	,	,	PUNCT
ajlm-297	29	43	alloimmunisation	alloimmunisation	NOUN
ajlm-297	29	44	rates	rate	NOUN
ajlm-297	29	45	of	of	ADP
ajlm-297	29	46	5	5	NUM
ajlm-297	29	47	%	%	NOUN
ajlm-297	29	48	to	to	PART
ajlm-297	29	49	36	36	NUM
ajlm-297	29	50	%	%	NOUN
ajlm-297	29	51	have	have	AUX
ajlm-297	29	52	been	be	AUX
ajlm-297	29	53	reported	report	VERB
ajlm-297	29	54	amongst	amongst	ADP
ajlm-297	29	55	transfused	transfused	ADJ
ajlm-297	29	56	scd	scd	PROPN
ajlm-297	29	57	patients.13	patients.13	PROPN
ajlm-297	29	58	currently	currently	ADV
ajlm-297	29	59	,	,	PUNCT
ajlm-297	29	60	there	there	PRON
ajlm-297	29	61	are	be	VERB
ajlm-297	29	62	minimal	minimal	ADJ
ajlm-297	29	63	data	datum	NOUN
ajlm-297	29	64	from	from	ADP
ajlm-297	29	65	africa	africa	PROPN
ajlm-297	29	66	regarding	regard	VERB
ajlm-297	29	67	transfusion	transfusion	NOUN
ajlm-297	29	68	-	-	PUNCT
ajlm-297	29	69	dependent	dependent	ADJ
ajlm-297	29	70	rbc	rbc	PROPN
ajlm-297	29	71	allo-/autoimmunisation	allo-/autoimmunisation	PROPN
ajlm-297	29	72	.	.	PUNCT
ajlm-297	30	1	the	the	DET
ajlm-297	30	2	few	few	ADJ
ajlm-297	30	3	existing	exist	VERB
ajlm-297	30	4	studies	study	NOUN
ajlm-297	30	5	have	have	AUX
ajlm-297	30	6	reported	report	VERB
ajlm-297	30	7	varied	varied	ADJ
ajlm-297	30	8	results	result	NOUN
ajlm-297	30	9	.	.	PUNCT
ajlm-297	31	1	a	a	DET
ajlm-297	31	2	ugandan	ugandan	PROPN
ajlm-297	31	3	study3	study3	NOUN
ajlm-297	31	4	recently	recently	ADV
ajlm-297	31	5	reported	report	VERB
ajlm-297	31	6	an	an	DET
ajlm-297	31	7	rbc	rbc	PROPN
ajlm-297	31	8	alloimmunisation	alloimmunisation	NOUN
ajlm-297	31	9	prevalence	prevalence	NOUN
ajlm-297	31	10	rate	rate	NOUN
ajlm-297	31	11	of	of	ADP
ajlm-297	31	12	6.1	6.1	NUM
ajlm-297	31	13	%	%	NOUN
ajlm-297	31	14	amongst	amongst	ADP
ajlm-297	31	15	428	428	NUM
ajlm-297	31	16	scd	scd	NOUN
ajlm-297	31	17	patients	patient	NOUN
ajlm-297	31	18	.	.	PUNCT
ajlm-297	32	1	an	an	DET
ajlm-297	32	2	investigation	investigation	NOUN
ajlm-297	32	3	conducted	conduct	VERB
ajlm-297	32	4	in	in	ADP
ajlm-297	32	5	egypt	egypt	PROPN
ajlm-297	32	6	amongst	amongst	ADP
ajlm-297	32	7	42	42	NUM
ajlm-297	32	8	scd	scd	NOUN
ajlm-297	32	9	patients	patient	NOUN
ajlm-297	32	10	reported	report	VERB
ajlm-297	32	11	an	an	DET
ajlm-297	32	12	alloimmunisation	alloimmunisation	NOUN
ajlm-297	32	13	rate	rate	NOUN
ajlm-297	32	14	of	of	ADP
ajlm-297	32	15	21.4%,14	21.4%,14	ADV
ajlm-297	32	16	whereas	whereas	SCONJ
ajlm-297	32	17	amongst	amongst	ADP
ajlm-297	32	18	130	130	NUM
ajlm-297	32	19	tunisian	tunisian	ADJ
ajlm-297	32	20	thalassaemia	thalassaemia	NOUN
ajlm-297	32	21	patients	patient	NOUN
ajlm-297	32	22	,	,	PUNCT
ajlm-297	32	23	rbc	rbc	PROPN
ajlm-297	32	24	alloimmunisation	alloimmunisation	NOUN
ajlm-297	32	25	was	be	AUX
ajlm-297	32	26	7.7	7.7	NUM
ajlm-297	32	27	%	%	NOUN
ajlm-297	32	28	and	and	CCONJ
ajlm-297	32	29	40	40	NUM
ajlm-297	32	30	%	%	NOUN
ajlm-297	32	31	of	of	ADP
ajlm-297	32	32	these	these	DET
ajlm-297	32	33	patients	patient	NOUN
ajlm-297	32	34	developed	develop	VERB
ajlm-297	32	35	rbc	rbc	PROPN
ajlm-297	32	36	autoantibodies.15	autoantibodies.15	PROPN
ajlm-297	32	37	in	in	ADP
ajlm-297	32	38	a	a	DET
ajlm-297	32	39	study	study	NOUN
ajlm-297	32	40	of	of	ADP
ajlm-297	32	41	108	108	NUM
ajlm-297	32	42	ugandan	ugandan	ADJ
ajlm-297	32	43	patients	patient	NOUN
ajlm-297	32	44	with	with	ADP
ajlm-297	32	45	malignancies	malignancy	NOUN
ajlm-297	32	46	,	,	PUNCT
ajlm-297	32	47	alloimmunisation	alloimmunisation	NOUN
ajlm-297	32	48	was	be	AUX
ajlm-297	32	49	reported	report	VERB
ajlm-297	32	50	at	at	ADP
ajlm-297	32	51	a	a	DET
ajlm-297	32	52	frequency	frequency	NOUN
ajlm-297	32	53	of	of	ADP
ajlm-297	32	54	8.3%.16	8.3%.16	NUM
ajlm-297	32	55	there	there	PRON
ajlm-297	32	56	are	be	VERB
ajlm-297	32	57	no	no	DET
ajlm-297	32	58	data	datum	NOUN
ajlm-297	32	59	on	on	ADP
ajlm-297	32	60	the	the	DET
ajlm-297	32	61	prevalence	prevalence	NOUN
ajlm-297	32	62	of	of	ADP
ajlm-297	32	63	rbc	rbc	PROPN
ajlm-297	32	64	alloab	alloab	PROPN
ajlm-297	32	65	/	/	SYM
ajlm-297	32	66	autoab	autoab	PROPN
ajlm-297	32	67	formation	formation	NOUN
ajlm-297	32	68	amongst	amongst	ADP
ajlm-297	32	69	kenyan	kenyan	ADJ
ajlm-297	32	70	patients	patient	NOUN
ajlm-297	32	71	,	,	PUNCT
ajlm-297	32	72	where	where	SCONJ
ajlm-297	32	73	pretransfusion	pretransfusion	NOUN
ajlm-297	32	74	testing	testing	NOUN
ajlm-297	32	75	is	be	AUX
ajlm-297	32	76	limited	limit	VERB
ajlm-297	32	77	to	to	ADP
ajlm-297	32	78	abo	abo	NOUN
ajlm-297	32	79	/	/	SYM
ajlm-297	32	80	rhesus	rhesus	NOUN
ajlm-297	32	81	d	d	NOUN
ajlm-297	32	82	group	group	NOUN
ajlm-297	32	83	typing	typing	NOUN
ajlm-297	32	84	and	and	CCONJ
ajlm-297	32	85	crossmatching	crossmatche	VERB
ajlm-297	32	86	only	only	ADV
ajlm-297	32	87	.	.	PUNCT
ajlm-297	33	1	as	as	SCONJ
ajlm-297	33	2	there	there	PRON
ajlm-297	33	3	is	be	VERB
ajlm-297	33	4	no	no	DET
ajlm-297	33	5	routine	routine	ADJ
ajlm-297	33	6	pre	pre	ADJ
ajlm-297	33	7	-	-	ADJ
ajlm-297	33	8	transfusion	transfusion	ADJ
ajlm-297	33	9	rbc	rbc	PROPN
ajlm-297	33	10	antibody	antibody	NOUN
ajlm-297	33	11	screening	screening	NOUN
ajlm-297	33	12	or	or	CCONJ
ajlm-297	33	13	identification	identification	NOUN
ajlm-297	33	14	,	,	PUNCT
ajlm-297	33	15	this	this	DET
ajlm-297	33	16	study	study	NOUN
ajlm-297	33	17	sought	seek	VERB
ajlm-297	33	18	to	to	PART
ajlm-297	33	19	determine	determine	VERB
ajlm-297	33	20	the	the	DET
ajlm-297	33	21	prevalence	prevalence	NOUN
ajlm-297	33	22	and	and	CCONJ
ajlm-297	33	23	specificities	specificity	NOUN
ajlm-297	33	24	of	of	ADP
ajlm-297	33	25	rbc	rbc	PROPN
ajlm-297	33	26	alloabs	alloabs	PROPN
ajlm-297	33	27	and	and	CCONJ
ajlm-297	33	28	autoabs	autoab	NOUN
ajlm-297	33	29	amongst	amongst	ADP
ajlm-297	33	30	two	two	NUM
ajlm-297	33	31	different	different	ADJ
ajlm-297	33	32	groups	group	NOUN
ajlm-297	33	33	of	of	ADP
ajlm-297	33	34	transfusion	transfusion	NOUN
ajlm-297	33	35	recipients	recipient	NOUN
ajlm-297	33	36	at	at	ADP
ajlm-297	33	37	kenyatta	kenyatta	PROPN
ajlm-297	33	38	national	national	PROPN
ajlm-297	33	39	hospital	hospital	PROPN
ajlm-297	33	40	(	(	PUNCT
ajlm-297	33	41	knh	knh	PROPN
ajlm-297	33	42	)	)	PUNCT
ajlm-297	33	43	,	,	PUNCT
ajlm-297	33	44	nairobi	nairobi	PROPN
ajlm-297	33	45	,	,	PUNCT
ajlm-297	33	46	kenya	kenya	PROPN
ajlm-297	33	47	.	.	PUNCT
ajlm-297	34	1	in	in	ADP
ajlm-297	34	2	addition	addition	NOUN
ajlm-297	34	3	,	,	PUNCT
ajlm-297	34	4	we	we	PRON
ajlm-297	34	5	screened	screen	VERB
ajlm-297	34	6	samples	sample	NOUN
ajlm-297	34	7	from	from	ADP
ajlm-297	34	8	blood	blood	NOUN
ajlm-297	34	9	donors	donor	NOUN
ajlm-297	34	10	for	for	ADP
ajlm-297	34	11	irregular	irregular	ADJ
ajlm-297	34	12	antibodies	antibody	NOUN
ajlm-297	34	13	and	and	CCONJ
ajlm-297	34	14	phenotyped	phenotype	VERB
ajlm-297	34	15	them	they	PRON
ajlm-297	34	16	for	for	ADP
ajlm-297	34	17	abo	abo	NOUN
ajlm-297	34	18	,	,	PUNCT
ajlm-297	34	19	rhesus	rhesus	NOUN
ajlm-297	34	20	and	and	CCONJ
ajlm-297	34	21	kell	kell	PROPN
ajlm-297	34	22	antigens	antigen	NOUN
ajlm-297	34	23	in	in	ADP
ajlm-297	34	24	order	order	NOUN
ajlm-297	34	25	to	to	PART
ajlm-297	34	26	determine	determine	VERB
ajlm-297	34	27	whether	whether	SCONJ
ajlm-297	34	28	there	there	PRON
ajlm-297	34	29	is	be	VERB
ajlm-297	34	30	alloimmunisation	alloimmunisation	NOUN
ajlm-297	34	31	in	in	ADP
ajlm-297	34	32	the	the	DET
ajlm-297	34	33	general	general	ADJ
ajlm-297	34	34	population	population	NOUN
ajlm-297	34	35	served	serve	VERB
ajlm-297	34	36	by	by	ADP
ajlm-297	34	37	knh	knh	PROPN
ajlm-297	34	38	.	.	PUNCT
ajlm-297	35	1	methods	method	NOUN
ajlm-297	35	2	top	top	VERB
ajlm-297	35	3	↑	↑	NOUN
ajlm-297	35	4	setting	set	VERB
ajlm-297	35	5	and	and	CCONJ
ajlm-297	35	6	design	design	NOUN
ajlm-297	35	7	using	use	VERB
ajlm-297	35	8	a	a	DET
ajlm-297	35	9	cross	cross	ADJ
ajlm-297	35	10	-	-	ADJ
ajlm-297	35	11	sectional	sectional	ADJ
ajlm-297	35	12	design	design	NOUN
ajlm-297	35	13	,	,	PUNCT
ajlm-297	35	14	scd	scd	NOUN
ajlm-297	35	15	,	,	PUNCT
ajlm-297	35	16	haematological	haematological	ADJ
ajlm-297	35	17	malignancy	malignancy	NOUN
ajlm-297	35	18	(	(	PUNCT
ajlm-297	35	19	hm	hm	INTJ
ajlm-297	35	20	)	)	PUNCT
ajlm-297	35	21	and	and	CCONJ
ajlm-297	35	22	solid	solid	ADJ
ajlm-297	35	23	malignancy	malignancy	NOUN
ajlm-297	35	24	(	(	PUNCT
ajlm-297	35	25	sm	sm	NOUN
ajlm-297	35	26	)	)	PUNCT
ajlm-297	35	27	patients	patient	NOUN
ajlm-297	35	28	attending	attend	VERB
ajlm-297	35	29	haematology	haematology	NOUN
ajlm-297	35	30	and	and	CCONJ
ajlm-297	35	31	oncology	oncology	NOUN
ajlm-297	35	32	clinics	clinic	NOUN
ajlm-297	35	33	at	at	ADP
ajlm-297	35	34	knh	knh	PROPN
ajlm-297	35	35	were	be	AUX
ajlm-297	35	36	approached	approach	VERB
ajlm-297	35	37	between	between	ADP
ajlm-297	35	38	february	february	PROPN
ajlm-297	35	39	and	and	CCONJ
ajlm-297	35	40	august	august	PROPN
ajlm-297	35	41	2014	2014	NUM
ajlm-297	35	42	and	and	CCONJ
ajlm-297	35	43	invited	invite	VERB
ajlm-297	35	44	to	to	PART
ajlm-297	35	45	participate	participate	VERB
ajlm-297	35	46	in	in	ADP
ajlm-297	35	47	the	the	DET
ajlm-297	35	48	study	study	NOUN
ajlm-297	35	49	.	.	PUNCT
ajlm-297	36	1	to	to	PART
ajlm-297	36	2	be	be	AUX
ajlm-297	36	3	eligible	eligible	ADJ
ajlm-297	36	4	for	for	ADP
ajlm-297	36	5	the	the	DET
ajlm-297	36	6	study	study	NOUN
ajlm-297	36	7	,	,	PUNCT
ajlm-297	36	8	participants	participant	NOUN
ajlm-297	36	9	had	have	VERB
ajlm-297	36	10	to	to	PART
ajlm-297	36	11	be	be	AUX
ajlm-297	36	12	knh	knh	PROPN
ajlm-297	36	13	patients	patient	NOUN
ajlm-297	36	14	with	with	ADP
ajlm-297	36	15	scd	scd	PROPN
ajlm-297	36	16	,	,	PUNCT
ajlm-297	36	17	hm	hm	INTJ
ajlm-297	36	18	or	or	CCONJ
ajlm-297	36	19	sm	sm	PROPN
ajlm-297	36	20	who	who	PRON
ajlm-297	36	21	had	have	AUX
ajlm-297	36	22	received	receive	VERB
ajlm-297	36	23	at	at	ADP
ajlm-297	36	24	least	least	ADV
ajlm-297	36	25	one	one	NUM
ajlm-297	36	26	allogeneic	allogeneic	ADJ
ajlm-297	36	27	blood	blood	NOUN
ajlm-297	36	28	transfusion	transfusion	NOUN
ajlm-297	36	29	;	;	PUNCT
ajlm-297	36	30	300	300	NUM
ajlm-297	36	31	patients	patient	NOUN
ajlm-297	36	32	met	meet	VERB
ajlm-297	36	33	the	the	DET
ajlm-297	36	34	inclusion	inclusion	NOUN
ajlm-297	36	35	criteria	criterion	NOUN
ajlm-297	36	36	.	.	PUNCT
ajlm-297	37	1	samples	sample	NOUN
ajlm-297	37	2	from	from	ADP
ajlm-297	37	3	51	51	NUM
ajlm-297	37	4	healthy	healthy	ADJ
ajlm-297	37	5	blood	blood	NOUN
ajlm-297	37	6	donors	donor	NOUN
ajlm-297	37	7	of	of	ADP
ajlm-297	37	8	african	african	ADJ
ajlm-297	37	9	ancestry	ancestry	NOUN
ajlm-297	37	10	from	from	ADP
ajlm-297	37	11	knh	knh	PROPN
ajlm-297	37	12	's	's	PART
ajlm-297	37	13	blood	blood	NOUN
ajlm-297	37	14	bank	bank	NOUN
ajlm-297	37	15	were	be	AUX
ajlm-297	37	16	obtained	obtain	VERB
ajlm-297	37	17	for	for	ADP
ajlm-297	37	18	limited	limited	ADJ
ajlm-297	37	19	rbc	rbc	PROPN
ajlm-297	37	20	antigen	antigen	PROPN
ajlm-297	37	21	phenotyping	phenotyping	NOUN
ajlm-297	37	22	.	.	PUNCT
ajlm-297	38	1	the	the	DET
ajlm-297	38	2	kenya	kenya	PROPN
ajlm-297	38	3	national	national	PROPN
ajlm-297	38	4	blood	blood	NOUN
ajlm-297	38	5	transfusion	transfusion	NOUN
ajlm-297	38	6	policy	policy	NOUN
ajlm-297	38	7	defines	define	VERB
ajlm-297	38	8	the	the	DET
ajlm-297	38	9	criteria	criterion	NOUN
ajlm-297	38	10	for	for	ADP
ajlm-297	38	11	healthy	healthy	ADJ
ajlm-297	38	12	donors	donor	NOUN
ajlm-297	38	13	as	as	ADP
ajlm-297	38	14	those	those	PRON
ajlm-297	38	15	who	who	PRON
ajlm-297	38	16	are	be	AUX
ajlm-297	38	17	aged	age	VERB
ajlm-297	38	18	18–65	18–65	NUM
ajlm-297	38	19	years	year	NOUN
ajlm-297	38	20	;	;	PUNCT
ajlm-297	38	21	weigh	weigh	VERB
ajlm-297	38	22	more	more	ADJ
ajlm-297	38	23	than	than	ADP
ajlm-297	38	24	50	50	NUM
ajlm-297	38	25	kg	kg	NOUN
ajlm-297	38	26	;	;	PUNCT
ajlm-297	38	27	have	have	VERB
ajlm-297	38	28	a	a	DET
ajlm-297	38	29	minimum	minimum	ADJ
ajlm-297	38	30	haemoglobin	haemoglobin	NOUN
ajlm-297	38	31	of	of	ADP
ajlm-297	38	32	12	12	NUM
ajlm-297	38	33	g	g	NOUN
ajlm-297	38	34	/	/	SYM
ajlm-297	38	35	dl	dl	PROPN
ajlm-297	38	36	;	;	PUNCT
ajlm-297	38	37	have	have	VERB
ajlm-297	38	38	normal	normal	ADJ
ajlm-297	38	39	blood	blood	NOUN
ajlm-297	38	40	pressure	pressure	NOUN
ajlm-297	38	41	(	(	PUNCT
ajlm-297	38	42	systolic	systolic	ADJ
ajlm-297	38	43	120–129	120–129	NUM
ajlm-297	38	44	mmhg	mmhg	NOUN
ajlm-297	38	45	,	,	PUNCT
ajlm-297	38	46	diastolic	diastolic	ADJ
ajlm-297	38	47	80–89	80–89	NUM
ajlm-297	38	48	mmhg	mmhg	NOUN
ajlm-297	38	49	)	)	PUNCT
ajlm-297	38	50	and	and	CCONJ
ajlm-297	38	51	a	a	DET
ajlm-297	38	52	pulse	pulse	NOUN
ajlm-297	38	53	rate	rate	NOUN
ajlm-297	38	54	of	of	ADP
ajlm-297	38	55	60–100	60–100	NUM
ajlm-297	38	56	beats	beat	NOUN
ajlm-297	38	57	per	per	ADP
ajlm-297	38	58	minute.17	minute.17	PROPN
ajlm-297	38	59	data	datum	NOUN
ajlm-297	38	60	and	and	CCONJ
ajlm-297	38	61	sample	sample	NOUN
ajlm-297	38	62	collection	collection	NOUN
ajlm-297	38	63	after	after	ADP
ajlm-297	38	64	obtaining	obtain	VERB
ajlm-297	38	65	informed	informed	ADJ
ajlm-297	38	66	consent	consent	NOUN
ajlm-297	38	67	,	,	PUNCT
ajlm-297	38	68	2–4	2–4	PROPN
ajlm-297	38	69	ml	ml	NOUN
ajlm-297	38	70	of	of	ADP
ajlm-297	38	71	blood	blood	NOUN
ajlm-297	38	72	was	be	AUX
ajlm-297	38	73	drawn	draw	VERB
ajlm-297	38	74	from	from	ADP
ajlm-297	38	75	patients	patient	NOUN
ajlm-297	38	76	into	into	ADP
ajlm-297	38	77	ethylenediaminetetraacetic	ethylenediaminetetraacetic	ADJ
ajlm-297	38	78	acid	acid	NOUN
ajlm-297	38	79	tubes	tube	NOUN
ajlm-297	38	80	for	for	ADP
ajlm-297	38	81	laboratory	laboratory	NOUN
ajlm-297	38	82	investigations	investigation	NOUN
ajlm-297	38	83	.	.	PUNCT
ajlm-297	39	1	patients	patient	NOUN
ajlm-297	39	2	’	'	PUNCT
ajlm-297	39	3	notes	note	NOUN
ajlm-297	39	4	were	be	AUX
ajlm-297	39	5	reviewed	review	VERB
ajlm-297	39	6	for	for	ADP
ajlm-297	39	7	:	:	PUNCT
ajlm-297	39	8	demographic	demographic	ADJ
ajlm-297	39	9	characteristics	characteristic	NOUN
ajlm-297	39	10	;	;	PUNCT
ajlm-297	39	11	recipient	recipient	NOUN
ajlm-297	39	12	age	age	NOUN
ajlm-297	39	13	;	;	PUNCT
ajlm-297	39	14	sex	sex	NOUN
ajlm-297	39	15	;	;	PUNCT
ajlm-297	39	16	diagnosis	diagnosis	NOUN
ajlm-297	39	17	;	;	PUNCT
ajlm-297	39	18	history	history	NOUN
ajlm-297	39	19	of	of	ADP
ajlm-297	39	20	pregnancy	pregnancy	NOUN
ajlm-297	39	21	;	;	PUNCT
ajlm-297	39	22	and	and	CCONJ
ajlm-297	39	23	transfusion	transfusion	NOUN
ajlm-297	39	24	history	history	NOUN
ajlm-297	39	25	and	and	CCONJ
ajlm-297	39	26	indications	indication	NOUN
ajlm-297	39	27	.	.	PUNCT
ajlm-297	40	1	the	the	DET
ajlm-297	40	2	number	number	NOUN
ajlm-297	40	3	of	of	ADP
ajlm-297	40	4	blood	blood	NOUN
ajlm-297	40	5	components	component	NOUN
ajlm-297	40	6	,	,	PUNCT
ajlm-297	40	7	units	unit	NOUN
ajlm-297	40	8	transfused	transfuse	VERB
ajlm-297	40	9	and	and	CCONJ
ajlm-297	40	10	transfusion	transfusion	NOUN
ajlm-297	40	11	episodes	episode	NOUN
ajlm-297	40	12	were	be	AUX
ajlm-297	40	13	recorded	record	VERB
ajlm-297	40	14	.	.	PUNCT
ajlm-297	41	1	healthy	healthy	ADJ
ajlm-297	41	2	blood	blood	NOUN
ajlm-297	41	3	donor	donor	NOUN
ajlm-297	41	4	samples	sample	NOUN
ajlm-297	41	5	were	be	AUX
ajlm-297	41	6	collected	collect	VERB
ajlm-297	41	7	from	from	ADP
ajlm-297	41	8	donors	donor	NOUN
ajlm-297	41	9	who	who	PRON
ajlm-297	41	10	gave	give	VERB
ajlm-297	41	11	consent	consent	NOUN
ajlm-297	41	12	and	and	CCONJ
ajlm-297	41	13	met	meet	VERB
ajlm-297	41	14	the	the	DET
ajlm-297	41	15	healthy	healthy	ADJ
ajlm-297	41	16	donor	donor	NOUN
ajlm-297	41	17	criteria	criterion	NOUN
ajlm-297	41	18	.	.	PUNCT
ajlm-297	42	1	documentation	documentation	NOUN
ajlm-297	42	2	of	of	ADP
ajlm-297	42	3	patient	patient	ADJ
ajlm-297	42	4	ethnicity	ethnicity	NOUN
ajlm-297	42	5	is	be	AUX
ajlm-297	42	6	a	a	DET
ajlm-297	42	7	routine	routine	ADJ
ajlm-297	42	8	requirement	requirement	NOUN
ajlm-297	42	9	in	in	ADP
ajlm-297	42	10	kenyan	kenyan	ADJ
ajlm-297	42	11	medical	medical	ADJ
ajlm-297	42	12	records	record	NOUN
ajlm-297	42	13	or	or	CCONJ
ajlm-297	42	14	clinical	clinical	ADJ
ajlm-297	42	15	data	datum	NOUN
ajlm-297	42	16	.	.	PUNCT
ajlm-297	43	1	laboratory	laboratory	NOUN
ajlm-297	43	2	investigations	investigation	NOUN
ajlm-297	43	3	plasma	plasma	NOUN
ajlm-297	43	4	and	and	CCONJ
ajlm-297	43	5	rbcs	rbc	NOUN
ajlm-297	43	6	were	be	AUX
ajlm-297	43	7	separated	separate	VERB
ajlm-297	43	8	within	within	ADP
ajlm-297	43	9	two	two	NUM
ajlm-297	43	10	hours	hour	NOUN
ajlm-297	43	11	after	after	ADP
ajlm-297	43	12	collection	collection	NOUN
ajlm-297	43	13	and	and	CCONJ
ajlm-297	43	14	the	the	DET
ajlm-297	43	15	plasma	plasma	NOUN
ajlm-297	43	16	was	be	AUX
ajlm-297	43	17	frozen	freeze	VERB
ajlm-297	43	18	whilst	whilst	SCONJ
ajlm-297	43	19	the	the	DET
ajlm-297	43	20	red	red	ADJ
ajlm-297	43	21	cells	cell	NOUN
ajlm-297	43	22	were	be	AUX
ajlm-297	43	23	stored	store	VERB
ajlm-297	43	24	at	at	ADP
ajlm-297	43	25	2	2	NUM
ajlm-297	43	26	°	°	ADP
ajlm-297	43	27	c	c	NOUN
ajlm-297	43	28	–	–	PUNCT
ajlm-297	43	29	6	6	NUM
ajlm-297	43	30	°	°	ADP
ajlm-297	43	31	c	c	NOUN
ajlm-297	43	32	.	.	PUNCT
ajlm-297	44	1	rbcs	rbc	NOUN
ajlm-297	44	2	were	be	AUX
ajlm-297	44	3	preserved	preserve	VERB
ajlm-297	44	4	by	by	ADP
ajlm-297	44	5	adding	add	VERB
ajlm-297	44	6	a	a	DET
ajlm-297	44	7	drop	drop	NOUN
ajlm-297	44	8	of	of	ADP
ajlm-297	44	9	citrate	citrate	NOUN
ajlm-297	44	10	phosphate	phosphate	NOUN
ajlm-297	44	11	dextrose	dextrose	NOUN
ajlm-297	44	12	anticoagulant	anticoagulant	NOUN
ajlm-297	44	13	.	.	PUNCT
ajlm-297	45	1	the	the	DET
ajlm-297	45	2	samples	sample	NOUN
ajlm-297	45	3	were	be	AUX
ajlm-297	45	4	then	then	ADV
ajlm-297	45	5	shipped	ship	VERB
ajlm-297	45	6	on	on	ADP
ajlm-297	45	7	dry	dry	ADJ
ajlm-297	45	8	ice	ice	NOUN
ajlm-297	45	9	at	at	ADP
ajlm-297	45	10	a	a	DET
ajlm-297	45	11	controlled	control	VERB
ajlm-297	45	12	temperature	temperature	NOUN
ajlm-297	45	13	to	to	ADP
ajlm-297	45	14	the	the	DET
ajlm-297	45	15	institute	institute	NOUN
ajlm-297	45	16	for	for	ADP
ajlm-297	45	17	transfusion	transfusion	NOUN
ajlm-297	45	18	medicine	medicine	NOUN
ajlm-297	45	19	at	at	ADP
ajlm-297	45	20	hannover	hannover	PROPN
ajlm-297	45	21	medical	medical	PROPN
ajlm-297	45	22	school	school	PROPN
ajlm-297	45	23	,	,	PUNCT
ajlm-297	45	24	hannover	hannover	PROPN
ajlm-297	45	25	,	,	PUNCT
ajlm-297	45	26	germany	germany	PROPN
ajlm-297	45	27	for	for	ADP
ajlm-297	45	28	immunohaematological	immunohaematological	ADJ
ajlm-297	45	29	analysis	analysis	NOUN
ajlm-297	45	30	.	.	PUNCT
ajlm-297	46	1	immunohaematological	immunohaematological	ADJ
ajlm-297	46	2	testing	testing	NOUN
ajlm-297	46	3	the	the	DET
ajlm-297	46	4	bio	bio	NOUN
ajlm-297	46	5	-	-	PROPN
ajlm-297	46	6	rad	rad	ADJ
ajlm-297	46	7	i	i	PROPN
ajlm-297	46	8	d	d	PROPN
ajlm-297	46	9	gel	gel	NOUN
ajlm-297	46	10	card	card	NOUN
ajlm-297	46	11	system	system	NOUN
ajlm-297	46	12	(	(	PUNCT
ajlm-297	46	13	diamed	diame	VERB
ajlm-297	46	14	-	-	PUNCT
ajlm-297	46	15	id	id	NOUN
ajlm-297	46	16	®	®	NOUN
ajlm-297	46	17	;	;	PUNCT
ajlm-297	46	18	bio	bio	PROPN
ajlm-297	46	19	-	-	ADJ
ajlm-297	46	20	rad	rad	PROPN
ajlm-297	46	21	laboratories	laboratory	NOUN
ajlm-297	46	22	,	,	PUNCT
ajlm-297	46	23	diamed	diame	VERB
ajlm-297	46	24	gmbh	gmbh	PROPN
ajlm-297	46	25	,	,	PUNCT
ajlm-297	46	26	cressier	cressier	PROPN
ajlm-297	46	27	,	,	PUNCT
ajlm-297	46	28	switzerland	switzerland	PROPN
ajlm-297	46	29	)	)	PUNCT
ajlm-297	46	30	was	be	AUX
ajlm-297	46	31	used	use	VERB
ajlm-297	46	32	with	with	ADP
ajlm-297	46	33	both	both	CCONJ
ajlm-297	46	34	untreated	untreated	ADJ
ajlm-297	46	35	and	and	CCONJ
ajlm-297	46	36	papain	papain	NOUN
ajlm-297	46	37	-	-	PUNCT
ajlm-297	46	38	treated	treat	VERB
ajlm-297	46	39	rbc	rbc	PROPN
ajlm-297	46	40	reagents	reagent	NOUN
ajlm-297	46	41	.	.	PUNCT
ajlm-297	47	1	plasma	plasma	NOUN
ajlm-297	47	2	samples	sample	NOUN
ajlm-297	47	3	were	be	AUX
ajlm-297	47	4	screened	screen	VERB
ajlm-297	47	5	for	for	ADP
ajlm-297	47	6	the	the	DET
ajlm-297	47	7	presence	presence	NOUN
ajlm-297	47	8	of	of	ADP
ajlm-297	47	9	rbc	rbc	PROPN
ajlm-297	47	10	alloab	alloab	VERB
ajlm-297	47	11	by	by	ADP
ajlm-297	47	12	use	use	NOUN
ajlm-297	47	13	of	of	ADP
ajlm-297	47	14	a	a	DET
ajlm-297	47	15	standard	standard	ADJ
ajlm-297	47	16	three	three	NUM
ajlm-297	47	17	-	-	PUNCT
ajlm-297	47	18	cell	cell	NOUN
ajlm-297	47	19	panel	panel	NOUN
ajlm-297	47	20	of	of	ADP
ajlm-297	47	21	reagent	reagent	ADJ
ajlm-297	47	22	group	group	NOUN
ajlm-297	47	23	o	o	NOUN
ajlm-297	47	24	rbcs	rbc	NOUN
ajlm-297	47	25	using	use	VERB
ajlm-297	47	26	nacl	nacl	ADJ
ajlm-297	47	27	gel	gel	NOUN
ajlm-297	47	28	cards	card	NOUN
ajlm-297	47	29	at	at	ADP
ajlm-297	47	30	room	room	NOUN
ajlm-297	47	31	temperature	temperature	NOUN
ajlm-297	47	32	for	for	ADP
ajlm-297	47	33	alloabs	alloab	NOUN
ajlm-297	47	34	with	with	ADP
ajlm-297	47	35	low	low	ADJ
ajlm-297	47	36	thermal	thermal	ADJ
ajlm-297	47	37	range	range	NOUN
ajlm-297	47	38	and	and	CCONJ
ajlm-297	47	39	low	low	ADJ
ajlm-297	47	40	ionic	ionic	ADJ
ajlm-297	47	41	strength	strength	NOUN
ajlm-297	47	42	saline	saline	NOUN
ajlm-297	47	43	(	(	PUNCT
ajlm-297	47	44	liss	liss	PROPN
ajlm-297	47	45	)	)	PUNCT
ajlm-297	47	46	gel	gel	NOUN
ajlm-297	47	47	cards	card	NOUN
ajlm-297	47	48	(	(	PUNCT
ajlm-297	47	49	liss	liss	PROPN
ajlm-297	47	50	/	/	SYM
ajlm-297	47	51	coombs	coombs	PROPN
ajlm-297	47	52	)	)	PUNCT
ajlm-297	47	53	at	at	ADP
ajlm-297	47	54	37	37	NUM
ajlm-297	47	55	°	°	NOUN
ajlm-297	47	56	c	c	NOUN
ajlm-297	47	57	for	for	ADP
ajlm-297	47	58	warm	warm	ADJ
ajlm-297	47	59	-	-	PUNCT
ajlm-297	47	60	reacting	react	VERB
ajlm-297	47	61	alloabs	alloab	NOUN
ajlm-297	47	62	.	.	PUNCT
ajlm-297	48	1	for	for	ADP
ajlm-297	48	2	samples	sample	NOUN
ajlm-297	48	3	that	that	PRON
ajlm-297	48	4	showed	show	VERB
ajlm-297	48	5	agglutination	agglutination	NOUN
ajlm-297	48	6	,	,	PUNCT
ajlm-297	48	7	subsequent	subsequent	ADJ
ajlm-297	48	8	antibody	antibody	NOUN
ajlm-297	48	9	identification	identification	NOUN
ajlm-297	48	10	was	be	AUX
ajlm-297	48	11	carried	carry	VERB
ajlm-297	48	12	out	out	ADP
ajlm-297	48	13	with	with	ADP
ajlm-297	48	14	at	at	ADV
ajlm-297	48	15	least	least	ADV
ajlm-297	48	16	one	one	NUM
ajlm-297	48	17	11	11	NUM
ajlm-297	48	18	-	-	PUNCT
ajlm-297	48	19	cell	cell	NOUN
ajlm-297	48	20	group	group	NOUN
ajlm-297	48	21	o	o	PROPN
ajlm-297	48	22	rbc	rbc	PROPN
ajlm-297	48	23	panel	panel	NOUN
ajlm-297	48	24	(	(	PUNCT
ajlm-297	48	25	usually	usually	ADV
ajlm-297	48	26	bio	bio	PROPN
ajlm-297	48	27	-	-	PROPN
ajlm-297	48	28	rad	rad	PROPN
ajlm-297	48	29	,	,	PUNCT
ajlm-297	48	30	switzerland	switzerland	PROPN
ajlm-297	48	31	)	)	PUNCT
ajlm-297	48	32	.	.	PUNCT
ajlm-297	49	1	in	in	ADP
ajlm-297	49	2	instances	instance	NOUN
ajlm-297	49	3	without	without	ADP
ajlm-297	49	4	immediate	immediate	ADJ
ajlm-297	49	5	determination	determination	NOUN
ajlm-297	49	6	of	of	ADP
ajlm-297	49	7	alloab	alloab	PROPN
ajlm-297	49	8	specificity	specificity	NOUN
ajlm-297	49	9	,	,	PUNCT
ajlm-297	49	10	additional	additional	ADJ
ajlm-297	49	11	cell	cell	NOUN
ajlm-297	49	12	panels	panel	NOUN
ajlm-297	49	13	(	(	PUNCT
ajlm-297	49	14	e.g.	e.g.	ADV
ajlm-297	49	15	,	,	PUNCT
ajlm-297	49	16	an	an	DET
ajlm-297	49	17	11	11	NUM
ajlm-297	49	18	-	-	PUNCT
ajlm-297	49	19	cell	cell	NOUN
ajlm-297	49	20	[	[	X
ajlm-297	49	21	grifols	grifol	NOUN
ajlm-297	49	22	inc	inc	PROPN
ajlm-297	49	23	.	.	PROPN
ajlm-297	49	24	,	,	PUNCT
ajlm-297	49	25	los	los	PROPN
ajlm-297	49	26	angeles	angeles	PROPN
ajlm-297	49	27	,	,	PUNCT
ajlm-297	49	28	california	california	PROPN
ajlm-297	49	29	,	,	PUNCT
ajlm-297	49	30	united	united	PROPN
ajlm-297	49	31	states	states	PROPN
ajlm-297	49	32	]	]	PUNCT
ajlm-297	49	33	and/or	and/or	CCONJ
ajlm-297	49	34	a	a	DET
ajlm-297	49	35	16	16	NUM
ajlm-297	49	36	-	-	PUNCT
ajlm-297	49	37	cell	cell	NOUN
ajlm-297	49	38	panel	panel	NOUN
ajlm-297	49	39	[	[	X
ajlm-297	49	40	sanquin	sanquin	NOUN
ajlm-297	49	41	,	,	PUNCT
ajlm-297	49	42	plesmanlaan	plesmanlaan	NOUN
ajlm-297	49	43	,	,	PUNCT
ajlm-297	49	44	amsterdam	amsterdam	PROPN
ajlm-297	49	45	,	,	PUNCT
ajlm-297	49	46	netherlands	netherlands	PROPN
ajlm-297	49	47	]	]	PUNCT
ajlm-297	49	48	)	)	PUNCT
ajlm-297	49	49	were	be	AUX
ajlm-297	49	50	used	use	VERB
ajlm-297	49	51	.	.	PUNCT
ajlm-297	50	1	if	if	SCONJ
ajlm-297	50	2	a	a	DET
ajlm-297	50	3	patient	patient	NOUN
ajlm-297	50	4	's	's	PART
ajlm-297	50	5	plasma	plasma	NOUN
ajlm-297	50	6	sample	sample	NOUN
ajlm-297	50	7	showed	show	VERB
ajlm-297	50	8	agglutination	agglutination	NOUN
ajlm-297	50	9	of	of	ADP
ajlm-297	50	10	reagent	reagent	ADJ
ajlm-297	50	11	screening	screening	NOUN
ajlm-297	50	12	cells	cell	NOUN
ajlm-297	50	13	,	,	PUNCT
ajlm-297	50	14	an	an	DET
ajlm-297	50	15	autocontrol	autocontrol	NOUN
ajlm-297	50	16	was	be	AUX
ajlm-297	50	17	also	also	ADV
ajlm-297	50	18	performed	perform	VERB
ajlm-297	50	19	by	by	ADP
ajlm-297	50	20	reacting	react	VERB
ajlm-297	50	21	the	the	DET
ajlm-297	50	22	patient	patient	NOUN
ajlm-297	50	23	's	's	PART
ajlm-297	50	24	rbcs	rbc	NOUN
ajlm-297	50	25	with	with	ADP
ajlm-297	50	26	his	his	PRON
ajlm-297	50	27	or	or	CCONJ
ajlm-297	50	28	her	her	PRON
ajlm-297	50	29	own	own	ADJ
ajlm-297	50	30	plasma	plasma	NOUN
ajlm-297	50	31	.	.	PUNCT
ajlm-297	51	1	positive	positive	ADJ
ajlm-297	51	2	autocontrols	autocontrol	NOUN
ajlm-297	51	3	were	be	AUX
ajlm-297	51	4	further	far	ADV
ajlm-297	51	5	evaluated	evaluate	VERB
ajlm-297	51	6	by	by	ADP
ajlm-297	51	7	means	mean	NOUN
ajlm-297	51	8	of	of	ADP
ajlm-297	51	9	a	a	DET
ajlm-297	51	10	poly-/monospecific	poly-/monospecific	CCONJ
ajlm-297	51	11	direct	direct	ADJ
ajlm-297	51	12	antiglobulin	antiglobulin	NOUN
ajlm-297	51	13	test	test	NOUN
ajlm-297	51	14	(	(	PUNCT
ajlm-297	51	15	dat	dat	PROPN
ajlm-297	51	16	)	)	PUNCT
ajlm-297	51	17	.	.	PUNCT
ajlm-297	52	1	dat	dat	PROPN
ajlm-297	52	2	was	be	AUX
ajlm-297	52	3	performed	perform	VERB
ajlm-297	52	4	using	use	VERB
ajlm-297	52	5	monoclonal	monoclonal	NOUN
ajlm-297	52	6	gel	gel	NOUN
ajlm-297	52	7	cards	card	NOUN
ajlm-297	52	8	consisting	consist	VERB
ajlm-297	52	9	of	of	ADP
ajlm-297	52	10	anti	anti	ADJ
ajlm-297	52	11	-	-	ADJ
ajlm-297	52	12	igg	igg	ADJ
ajlm-297	52	13	,	,	PUNCT
ajlm-297	52	14	anti	anti	ADJ
ajlm-297	52	15	-	-	ADJ
ajlm-297	52	16	iga	iga	ADJ
ajlm-297	52	17	,	,	PUNCT
ajlm-297	52	18	anti	anti	ADJ
ajlm-297	52	19	-	-	ADJ
ajlm-297	52	20	igm	igm	ADJ
ajlm-297	52	21	,	,	PUNCT
ajlm-297	52	22	anti	anti	ADJ
ajlm-297	52	23	-	-	ADJ
ajlm-297	52	24	c3c	c3c	ADJ
ajlm-297	52	25	and	and	CCONJ
ajlm-297	52	26	anti	anti	NOUN
ajlm-297	52	27	-	-	ADJ
ajlm-297	52	28	c3d	c3d	NOUN
ajlm-297	52	29	.	.	PUNCT
ajlm-297	53	1	from	from	ADP
ajlm-297	53	2	samples	sample	NOUN
ajlm-297	53	3	that	that	PRON
ajlm-297	53	4	were	be	AUX
ajlm-297	53	5	positive	positive	ADJ
ajlm-297	53	6	with	with	ADP
ajlm-297	53	7	at	at	ADV
ajlm-297	53	8	least	least	ADJ
ajlm-297	53	9	one	one	NUM
ajlm-297	53	10	of	of	ADP
ajlm-297	53	11	these	these	DET
ajlm-297	53	12	antiglobulins	antiglobulin	NOUN
ajlm-297	53	13	,	,	PUNCT
ajlm-297	53	14	an	an	DET
ajlm-297	53	15	acid	acid	ADJ
ajlm-297	53	16	eluate	eluate	NOUN
ajlm-297	53	17	was	be	AUX
ajlm-297	53	18	prepared	prepare	VERB
ajlm-297	53	19	.	.	PUNCT
ajlm-297	54	1	the	the	DET
ajlm-297	54	2	eluate	eluate	ADJ
ajlm-297	54	3	was	be	AUX
ajlm-297	54	4	screened	screen	VERB
ajlm-297	54	5	using	use	VERB
ajlm-297	54	6	the	the	DET
ajlm-297	54	7	standard	standard	ADJ
ajlm-297	54	8	three	three	NUM
ajlm-297	54	9	-	-	PUNCT
ajlm-297	54	10	cell	cell	NOUN
ajlm-297	54	11	panel	panel	NOUN
ajlm-297	54	12	.	.	PUNCT
ajlm-297	55	1	those	those	PRON
ajlm-297	55	2	that	that	PRON
ajlm-297	55	3	were	be	AUX
ajlm-297	55	4	positive	positive	ADJ
ajlm-297	55	5	were	be	AUX
ajlm-297	55	6	then	then	ADV
ajlm-297	55	7	analysed	analyse	VERB
ajlm-297	55	8	for	for	ADP
ajlm-297	55	9	specificity	specificity	NOUN
ajlm-297	55	10	using	use	VERB
ajlm-297	55	11	11	11	NUM
ajlm-297	55	12	-	-	PUNCT
ajlm-297	55	13	cell	cell	NOUN
ajlm-297	55	14	panels	panel	NOUN
ajlm-297	55	15	containing	contain	VERB
ajlm-297	55	16	these	these	DET
ajlm-297	55	17	antigens	antigen	NOUN
ajlm-297	55	18	:	:	PUNCT
ajlm-297	56	1	d	d	X
ajlm-297	56	2	,	,	PUNCT
ajlm-297	56	3	c	c	X
ajlm-297	56	4	,	,	PUNCT
ajlm-297	56	5	e	e	NOUN
ajlm-297	56	6	,	,	PUNCT
ajlm-297	56	7	c	c	X
ajlm-297	56	8	,	,	PUNCT
ajlm-297	56	9	e	e	NOUN
ajlm-297	56	10	,	,	PUNCT
ajlm-297	56	11	k	k	PROPN
ajlm-297	56	12	,	,	PUNCT
ajlm-297	56	13	k	k	PROPN
ajlm-297	56	14	,	,	PUNCT
ajlm-297	56	15	fya	fya	PROPN
ajlm-297	56	16	,	,	PUNCT
ajlm-297	56	17	fyb	fyb	PROPN
ajlm-297	56	18	,	,	PUNCT
ajlm-297	56	19	jka	jka	PROPN
ajlm-297	56	20	,	,	PUNCT
ajlm-297	56	21	jkb	jkb	NOUN
ajlm-297	56	22	,	,	PUNCT
ajlm-297	56	23	lea	lea	PROPN
ajlm-297	56	24	,	,	PUNCT
ajlm-297	56	25	leb	leb	PROPN
ajlm-297	56	26	,	,	PUNCT
ajlm-297	56	27	p1	p1	PROPN
ajlm-297	56	28	,	,	PUNCT
ajlm-297	56	29	m	m	PROPN
ajlm-297	56	30	,	,	PUNCT
ajlm-297	56	31	n	n	CCONJ
ajlm-297	56	32	,	,	PUNCT
ajlm-297	56	33	s	s	X
ajlm-297	56	34	and	and	CCONJ
ajlm-297	56	35	s.	s.	PROPN
ajlm-297	56	36	in	in	ADP
ajlm-297	56	37	addition	addition	NOUN
ajlm-297	56	38	,	,	PUNCT
ajlm-297	56	39	donor	donor	NOUN
ajlm-297	56	40	blood	blood	NOUN
ajlm-297	56	41	was	be	AUX
ajlm-297	56	42	screened	screen	VERB
ajlm-297	56	43	for	for	ADP
ajlm-297	56	44	irregular	irregular	ADJ
ajlm-297	56	45	antibodies	antibody	NOUN
ajlm-297	56	46	using	use	VERB
ajlm-297	56	47	a	a	DET
ajlm-297	56	48	panel	panel	NOUN
ajlm-297	56	49	of	of	ADP
ajlm-297	56	50	three	three	NUM
ajlm-297	56	51	screening	screen	VERB
ajlm-297	56	52	cells	cell	NOUN
ajlm-297	56	53	and	and	CCONJ
ajlm-297	56	54	then	then	ADV
ajlm-297	56	55	phenotyped	phenotype	VERB
ajlm-297	56	56	for	for	ADP
ajlm-297	56	57	abo	abo	NOUN
ajlm-297	56	58	,	,	PUNCT
ajlm-297	56	59	rhesus	rhesus	NOUN
ajlm-297	56	60	(	(	PUNCT
ajlm-297	56	61	c	c	NOUN
ajlm-297	56	62	,	,	PUNCT
ajlm-297	56	63	c	c	X
ajlm-297	56	64	,	,	PUNCT
ajlm-297	56	65	d	d	NOUN
ajlm-297	56	66	,	,	PUNCT
ajlm-297	56	67	e	e	NOUN
ajlm-297	56	68	,	,	PUNCT
ajlm-297	56	69	e	e	NOUN
ajlm-297	56	70	)	)	PUNCT
ajlm-297	56	71	and	and	CCONJ
ajlm-297	56	72	kell	kell	PROPN
ajlm-297	56	73	antigens	antigen	NOUN
ajlm-297	56	74	.	.	PUNCT
ajlm-297	57	1	plasma	plasma	NOUN
ajlm-297	57	2	samples	sample	NOUN
ajlm-297	57	3	of	of	ADP
ajlm-297	57	4	40	40	NUM
ajlm-297	57	5	blood	blood	NOUN
ajlm-297	57	6	donors	donor	NOUN
ajlm-297	57	7	were	be	AUX
ajlm-297	57	8	screened	screen	VERB
ajlm-297	57	9	for	for	ADP
ajlm-297	57	10	rbc	rbc	PROPN
ajlm-297	57	11	alloab	alloab	PROPN
ajlm-297	57	12	.	.	PUNCT
ajlm-297	58	1	patients	patient	NOUN
ajlm-297	58	2	were	be	AUX
ajlm-297	58	3	considered	consider	VERB
ajlm-297	58	4	to	to	PART
ajlm-297	58	5	be	be	AUX
ajlm-297	58	6	alloimmunised	alloimmunise	VERB
ajlm-297	58	7	if	if	SCONJ
ajlm-297	58	8	antibodies	antibodie	VERB
ajlm-297	58	9	to	to	ADP
ajlm-297	58	10	one	one	NUM
ajlm-297	58	11	or	or	CCONJ
ajlm-297	58	12	more	more	ADJ
ajlm-297	58	13	rbc	rbc	PROPN
ajlm-297	58	14	antigens	antigen	NOUN
ajlm-297	58	15	could	could	AUX
ajlm-297	58	16	be	be	AUX
ajlm-297	58	17	identified	identify	VERB
ajlm-297	58	18	,	,	PUNCT
ajlm-297	58	19	whilst	whilst	SCONJ
ajlm-297	58	20	autocontrol	autocontrol	NOUN
ajlm-297	58	21	and	and	CCONJ
ajlm-297	58	22	dat	dat	ADJ
ajlm-297	58	23	screening	screening	NOUN
ajlm-297	58	24	remained	remain	VERB
ajlm-297	58	25	negative	negative	ADJ
ajlm-297	58	26	.	.	PUNCT
ajlm-297	59	1	patients	patient	NOUN
ajlm-297	59	2	with	with	ADP
ajlm-297	59	3	a	a	DET
ajlm-297	59	4	positive	positive	ADJ
ajlm-297	59	5	autocontrol	autocontrol	NOUN
ajlm-297	59	6	,	,	PUNCT
ajlm-297	59	7	a	a	DET
ajlm-297	59	8	positive	positive	ADJ
ajlm-297	59	9	dat	dat	NOUN
ajlm-297	59	10	and	and	CCONJ
ajlm-297	59	11	a	a	DET
ajlm-297	59	12	reactive	reactive	ADJ
ajlm-297	59	13	acid	acid	NOUN
ajlm-297	59	14	eluate	eluate	NOUN
ajlm-297	59	15	were	be	AUX
ajlm-297	59	16	considered	consider	VERB
ajlm-297	59	17	to	to	PART
ajlm-297	59	18	be	be	AUX
ajlm-297	59	19	sensitised	sensitise	VERB
ajlm-297	59	20	to	to	PART
ajlm-297	59	21	have	have	VERB
ajlm-297	59	22	autoabs	autoab	NOUN
ajlm-297	59	23	to	to	PART
ajlm-297	59	24	rbcs	rbcs	VERB
ajlm-297	59	25	.	.	PUNCT
ajlm-297	60	1	in	in	ADP
ajlm-297	60	2	cases	case	NOUN
ajlm-297	60	3	with	with	ADP
ajlm-297	60	4	a	a	DET
ajlm-297	60	5	positive	positive	ADJ
ajlm-297	60	6	autocontrol	autocontrol	NOUN
ajlm-297	60	7	and	and	CCONJ
ajlm-297	60	8	a	a	DET
ajlm-297	60	9	positive	positive	ADJ
ajlm-297	60	10	dat	dat	NOUN
ajlm-297	60	11	,	,	PUNCT
ajlm-297	60	12	but	but	CCONJ
ajlm-297	60	13	a	a	DET
ajlm-297	60	14	non	non	ADJ
ajlm-297	60	15	-	-	ADJ
ajlm-297	60	16	reactive	reactive	ADJ
ajlm-297	60	17	acid	acid	NOUN
ajlm-297	60	18	eluate	eluate	ADJ
ajlm-297	60	19	,	,	PUNCT
ajlm-297	60	20	a	a	DET
ajlm-297	60	21	non	non	ADJ
ajlm-297	60	22	-	-	ADJ
ajlm-297	60	23	specific	specific	ADJ
ajlm-297	60	24	loading	loading	NOUN
ajlm-297	60	25	of	of	ADP
ajlm-297	60	26	the	the	DET
ajlm-297	60	27	rbc	rbc	PROPN
ajlm-297	60	28	surface	surface	PROPN
ajlm-297	60	29	with	with	ADP
ajlm-297	60	30	immunoglobulins	immunoglobulin	NOUN
ajlm-297	60	31	was	be	AUX
ajlm-297	60	32	assumed	assume	VERB
ajlm-297	60	33	.	.	PUNCT
ajlm-297	61	1	‘	'	PUNCT
ajlm-297	61	2	immune	immune	ADJ
ajlm-297	61	3	’	'	PUNCT
ajlm-297	61	4	antibodies	antibody	NOUN
ajlm-297	61	5	are	be	AUX
ajlm-297	61	6	formed	form	VERB
ajlm-297	61	7	after	after	ADP
ajlm-297	61	8	immunisation	immunisation	NOUN
ajlm-297	61	9	through	through	ADP
ajlm-297	61	10	pregnancy	pregnancy	NOUN
ajlm-297	61	11	and/or	and/or	CCONJ
ajlm-297	61	12	previous	previous	ADJ
ajlm-297	61	13	transfusions	transfusion	NOUN
ajlm-297	61	14	.	.	PUNCT
ajlm-297	62	1	‘	'	PUNCT
ajlm-297	62	2	naturally	naturally	ADV
ajlm-297	62	3	-	-	PUNCT
ajlm-297	62	4	occurring	occur	VERB
ajlm-297	62	5	’	'	PUNCT
ajlm-297	62	6	antibodies	antibody	NOUN
ajlm-297	62	7	are	be	AUX
ajlm-297	62	8	formed	form	VERB
ajlm-297	62	9	as	as	ADP
ajlm-297	62	10	a	a	DET
ajlm-297	62	11	result	result	NOUN
ajlm-297	62	12	of	of	ADP
ajlm-297	62	13	exposure	exposure	NOUN
ajlm-297	62	14	to	to	ADP
ajlm-297	62	15	environmental	environmental	ADJ
ajlm-297	62	16	agents	agent	NOUN
ajlm-297	62	17	similar	similar	ADJ
ajlm-297	62	18	to	to	ADP
ajlm-297	62	19	red	red	ADJ
ajlm-297	62	20	cell	cell	NOUN
ajlm-297	62	21	antigens	antigen	NOUN
ajlm-297	62	22	,	,	PUNCT
ajlm-297	62	23	such	such	ADJ
ajlm-297	62	24	as	as	ADP
ajlm-297	62	25	bacteria	bacteria	NOUN
ajlm-297	62	26	.	.	PUNCT
ajlm-297	63	1	statistical	statistical	ADJ
ajlm-297	63	2	analyses	analysis	NOUN
ajlm-297	63	3	statistical	statistical	ADJ
ajlm-297	63	4	software	software	NOUN
ajlm-297	63	5	packages	package	NOUN
ajlm-297	63	6	were	be	AUX
ajlm-297	63	7	used	use	VERB
ajlm-297	63	8	:	:	PUNCT
ajlm-297	63	9	excel	excel	VERB
ajlm-297	63	10	5.0	5.0	NUM
ajlm-297	63	11	(	(	PUNCT
ajlm-297	63	12	microsoft	microsoft	PROPN
ajlm-297	63	13	,	,	PUNCT
ajlm-297	63	14	redmond	redmond	PROPN
ajlm-297	63	15	,	,	PUNCT
ajlm-297	63	16	california	california	PROPN
ajlm-297	63	17	,	,	PUNCT
ajlm-297	63	18	united	united	PROPN
ajlm-297	63	19	states	states	PROPN
ajlm-297	63	20	1993	1993	NUM
ajlm-297	63	21	)	)	PUNCT
ajlm-297	63	22	for	for	ADP
ajlm-297	63	23	data	data	NOUN
ajlm-297	63	24	management	management	NOUN
ajlm-297	63	25	and	and	CCONJ
ajlm-297	63	26	statistical	statistical	ADJ
ajlm-297	63	27	package	package	NOUN
ajlm-297	63	28	for	for	ADP
ajlm-297	63	29	the	the	DET
ajlm-297	63	30	social	social	ADJ
ajlm-297	63	31	sciences	science	NOUN
ajlm-297	63	32	12.0	12.0	NUM
ajlm-297	63	33	(	(	PUNCT
ajlm-297	63	34	spss	spss	PROPN
ajlm-297	63	35	inc	inc	PROPN
ajlm-297	63	36	.	.	PROPN
ajlm-297	63	37	,	,	PUNCT
ajlm-297	63	38	chicago	chicago	PROPN
ajlm-297	63	39	,	,	PUNCT
ajlm-297	63	40	illinois	illinois	PROPN
ajlm-297	63	41	,	,	PUNCT
ajlm-297	63	42	united	united	PROPN
ajlm-297	63	43	states	states	PROPN
ajlm-297	63	44	2003	2003	NUM
ajlm-297	63	45	)	)	PUNCT
ajlm-297	63	46	was	be	AUX
ajlm-297	63	47	used	use	VERB
ajlm-297	63	48	for	for	ADP
ajlm-297	63	49	analysis	analysis	NOUN
ajlm-297	63	50	.	.	PUNCT
ajlm-297	64	1	student	student	NOUN
ajlm-297	64	2	's	's	PART
ajlm-297	64	3	t	t	PROPN
ajlm-297	64	4	-	-	PUNCT
ajlm-297	64	5	test	test	NOUN
ajlm-297	64	6	was	be	AUX
ajlm-297	64	7	used	use	VERB
ajlm-297	64	8	for	for	ADP
ajlm-297	64	9	variables	variable	NOUN
ajlm-297	64	10	with	with	ADP
ajlm-297	64	11	normal	normal	ADJ
ajlm-297	64	12	distribution	distribution	NOUN
ajlm-297	64	13	.	.	PUNCT
ajlm-297	65	1	categorical	categorical	ADJ
ajlm-297	65	2	variables	variable	NOUN
ajlm-297	65	3	of	of	ADP
ajlm-297	65	4	possible	possible	ADJ
ajlm-297	65	5	associations	association	NOUN
ajlm-297	65	6	between	between	ADP
ajlm-297	65	7	rbc	rbc	PROPN
ajlm-297	65	8	alloimmunisation	alloimmunisation	NOUN
ajlm-297	65	9	and	and	CCONJ
ajlm-297	65	10	sex	sex	NOUN
ajlm-297	65	11	,	,	PUNCT
ajlm-297	65	12	units	unit	NOUN
ajlm-297	65	13	of	of	ADP
ajlm-297	65	14	blood	blood	NOUN
ajlm-297	65	15	transfusion	transfusion	NOUN
ajlm-297	65	16	,	,	PUNCT
ajlm-297	65	17	diagnosis	diagnosis	NOUN
ajlm-297	65	18	of	of	ADP
ajlm-297	65	19	scd	scd	NOUN
ajlm-297	65	20	or	or	CCONJ
ajlm-297	65	21	solid	solid	ADJ
ajlm-297	65	22	and	and	CCONJ
ajlm-297	65	23	haematological	haematological	ADJ
ajlm-297	65	24	malignancy	malignancy	NOUN
ajlm-297	65	25	were	be	AUX
ajlm-297	65	26	compared	compare	VERB
ajlm-297	65	27	using	use	VERB
ajlm-297	65	28	the	the	DET
ajlm-297	65	29	chi	chi	ADJ
ajlm-297	65	30	-	-	PUNCT
ajlm-297	65	31	squared	square	VERB
ajlm-297	65	32	test	test	NOUN
ajlm-297	65	33	.	.	PUNCT
ajlm-297	66	1	groups	group	NOUN
ajlm-297	66	2	were	be	AUX
ajlm-297	66	3	assumed	assume	VERB
ajlm-297	66	4	to	to	PART
ajlm-297	66	5	differ	differ	VERB
ajlm-297	66	6	significantly	significantly	ADV
ajlm-297	66	7	when	when	SCONJ
ajlm-297	66	8	the	the	DET
ajlm-297	66	9	probability	probability	NOUN
ajlm-297	66	10	level	level	NOUN
ajlm-297	66	11	was	be	AUX
ajlm-297	66	12	less	less	ADJ
ajlm-297	66	13	than	than	ADP
ajlm-297	66	14	0.05	0.05	NUM
ajlm-297	66	15	.	.	PUNCT
ajlm-297	67	1	ethical	ethical	ADJ
ajlm-297	67	2	considerations	consideration	NOUN
ajlm-297	67	3	ethical	ethical	ADJ
ajlm-297	67	4	approval	approval	NOUN
ajlm-297	67	5	was	be	AUX
ajlm-297	67	6	obtained	obtain	VERB
ajlm-297	67	7	from	from	ADP
ajlm-297	67	8	knh	knh	PROPN
ajlm-297	67	9	/	/	SYM
ajlm-297	67	10	university	university	PROPN
ajlm-297	67	11	of	of	ADP
ajlm-297	67	12	nairobi	nairobi	PROPN
ajlm-297	67	13	ethics	ethics	PROPN
ajlm-297	67	14	review	review	PROPN
ajlm-297	67	15	committee	committee	NOUN
ajlm-297	67	16	.	.	PUNCT
ajlm-297	68	1	both	both	PRON
ajlm-297	68	2	oral	oral	ADJ
ajlm-297	68	3	and	and	CCONJ
ajlm-297	68	4	written	write	VERB
ajlm-297	68	5	informed	informed	ADJ
ajlm-297	68	6	consent	consent	NOUN
ajlm-297	68	7	was	be	AUX
ajlm-297	68	8	obtained	obtain	VERB
ajlm-297	68	9	from	from	ADP
ajlm-297	68	10	patients	patient	NOUN
ajlm-297	68	11	or	or	CCONJ
ajlm-297	68	12	their	their	PRON
ajlm-297	68	13	guardians	guardian	NOUN
ajlm-297	68	14	.	.	PUNCT
ajlm-297	69	1	donors	donor	NOUN
ajlm-297	69	2	completed	complete	VERB
ajlm-297	69	3	a	a	DET
ajlm-297	69	4	questionnaire	questionnaire	NOUN
ajlm-297	69	5	provided	provide	VERB
ajlm-297	69	6	by	by	ADP
ajlm-297	69	7	the	the	DET
ajlm-297	69	8	blood	blood	NOUN
ajlm-297	69	9	bank	bank	NOUN
ajlm-297	69	10	services	service	NOUN
ajlm-297	69	11	and	and	CCONJ
ajlm-297	69	12	signed	sign	VERB
ajlm-297	69	13	a	a	DET
ajlm-297	69	14	consent	consent	NOUN
ajlm-297	69	15	form	form	NOUN
ajlm-297	69	16	.	.	PUNCT
ajlm-297	70	1	results	result	VERB
ajlm-297	70	2	top	top	ADJ
ajlm-297	70	3	↑	↑	PROPN
ajlm-297	70	4	patient	patient	ADJ
ajlm-297	70	5	data	datum	NOUN
ajlm-297	70	6	of	of	ADP
ajlm-297	70	7	the	the	DET
ajlm-297	70	8	samples	sample	NOUN
ajlm-297	70	9	from	from	ADP
ajlm-297	70	10	300	300	NUM
ajlm-297	70	11	patients	patient	NOUN
ajlm-297	70	12	who	who	PRON
ajlm-297	70	13	met	meet	VERB
ajlm-297	70	14	the	the	DET
ajlm-297	70	15	inclusion	inclusion	NOUN
ajlm-297	70	16	criteria	criterion	NOUN
ajlm-297	70	17	,	,	PUNCT
ajlm-297	70	18	72	72	NUM
ajlm-297	70	19	samples	sample	NOUN
ajlm-297	70	20	could	could	AUX
ajlm-297	70	21	not	not	PART
ajlm-297	70	22	be	be	AUX
ajlm-297	70	23	evaluated	evaluate	VERB
ajlm-297	70	24	for	for	ADP
ajlm-297	70	25	the	the	DET
ajlm-297	70	26	following	follow	VERB
ajlm-297	70	27	reasons	reason	NOUN
ajlm-297	70	28	:	:	PUNCT
ajlm-297	70	29	insufficient	insufficient	ADJ
ajlm-297	70	30	sample	sample	NOUN
ajlm-297	70	31	because	because	SCONJ
ajlm-297	70	32	of	of	ADP
ajlm-297	70	33	leakage	leakage	NOUN
ajlm-297	70	34	during	during	ADP
ajlm-297	70	35	shipment	shipment	NOUN
ajlm-297	70	36	(	(	PUNCT
ajlm-297	70	37	n	n	NOUN
ajlm-297	70	38	=	=	NUM
ajlm-297	70	39	40	40	NUM
ajlm-297	70	40	)	)	PUNCT
ajlm-297	70	41	;	;	PUNCT
ajlm-297	70	42	samples	sample	NOUN
ajlm-297	70	43	breaking	break	VERB
ajlm-297	70	44	in	in	ADP
ajlm-297	70	45	the	the	DET
ajlm-297	70	46	centrifuge	centrifuge	NOUN
ajlm-297	70	47	whilst	whilst	SCONJ
ajlm-297	70	48	processing	processing	NOUN
ajlm-297	70	49	(	(	PUNCT
ajlm-297	70	50	n	n	NOUN
ajlm-297	70	51	=	=	NUM
ajlm-297	70	52	20	20	NUM
ajlm-297	70	53	)	)	PUNCT
ajlm-297	70	54	;	;	PUNCT
ajlm-297	70	55	and	and	CCONJ
ajlm-297	70	56	lack	lack	NOUN
ajlm-297	70	57	of	of	ADP
ajlm-297	70	58	proper	proper	ADJ
ajlm-297	70	59	labeling	labeling	NOUN
ajlm-297	70	60	(	(	PUNCT
ajlm-297	70	61	n	n	NOUN
ajlm-297	70	62	=	=	NUM
ajlm-297	70	63	12	12	NUM
ajlm-297	70	64	)	)	PUNCT
ajlm-297	70	65	.	.	PUNCT
ajlm-297	71	1	a	a	DET
ajlm-297	71	2	total	total	NOUN
ajlm-297	71	3	of	of	ADP
ajlm-297	71	4	228	228	NUM
ajlm-297	71	5	samples	sample	NOUN
ajlm-297	71	6	were	be	AUX
ajlm-297	71	7	analysed	analyse	VERB
ajlm-297	71	8	,	,	PUNCT
ajlm-297	71	9	including	include	VERB
ajlm-297	71	10	137	137	NUM
ajlm-297	71	11	from	from	ADP
ajlm-297	71	12	scd	scd	NOUN
ajlm-297	71	13	patients	patient	NOUN
ajlm-297	71	14	,	,	PUNCT
ajlm-297	71	15	48	48	NUM
ajlm-297	71	16	from	from	ADP
ajlm-297	71	17	hm	hm	INTJ
ajlm-297	71	18	patients	patient	NOUN
ajlm-297	71	19	and	and	CCONJ
ajlm-297	71	20	43	43	NUM
ajlm-297	71	21	from	from	ADP
ajlm-297	71	22	sm	sm	PROPN
ajlm-297	71	23	patients	patient	NOUN
ajlm-297	71	24	,	,	PUNCT
ajlm-297	71	25	with	with	ADP
ajlm-297	71	26	a	a	DET
ajlm-297	71	27	median	median	ADJ
ajlm-297	71	28	number	number	NOUN
ajlm-297	71	29	of	of	ADP
ajlm-297	71	30	two	two	NUM
ajlm-297	71	31	to	to	PART
ajlm-297	71	32	three	three	NUM
ajlm-297	71	33	transfusions	transfusion	NOUN
ajlm-297	71	34	per	per	ADP
ajlm-297	71	35	group	group	NOUN
ajlm-297	71	36	(	(	PUNCT
ajlm-297	71	37	table	table	NOUN
ajlm-297	71	38	1	1	NUM
ajlm-297	71	39	)	)	PUNCT
ajlm-297	71	40	.	.	PUNCT
ajlm-297	72	1	of	of	ADP
ajlm-297	72	2	these	these	PRON
ajlm-297	72	3	,	,	PUNCT
ajlm-297	72	4	117	117	NUM
ajlm-297	72	5	(	(	PUNCT
ajlm-297	72	6	51.3	51.3	NUM
ajlm-297	72	7	%	%	NOUN
ajlm-297	72	8	)	)	PUNCT
ajlm-297	72	9	were	be	AUX
ajlm-297	72	10	women	woman	NOUN
ajlm-297	72	11	,	,	PUNCT
ajlm-297	72	12	of	of	ADP
ajlm-297	72	13	whom	whom	PRON
ajlm-297	72	14	22	22	NUM
ajlm-297	72	15	(	(	PUNCT
ajlm-297	72	16	18.8	18.8	NUM
ajlm-297	72	17	%	%	NOUN
ajlm-297	72	18	)	)	PUNCT
ajlm-297	72	19	had	have	VERB
ajlm-297	72	20	a	a	DET
ajlm-297	72	21	history	history	NOUN
ajlm-297	72	22	of	of	ADP
ajlm-297	72	23	pregnancy	pregnancy	NOUN
ajlm-297	72	24	.	.	PUNCT
ajlm-297	73	1	overall	overall	ADV
ajlm-297	73	2	,	,	PUNCT
ajlm-297	73	3	the	the	DET
ajlm-297	73	4	mean	mean	ADJ
ajlm-297	73	5	age	age	NOUN
ajlm-297	73	6	at	at	ADP
ajlm-297	73	7	the	the	DET
ajlm-297	73	8	time	time	NOUN
ajlm-297	73	9	of	of	ADP
ajlm-297	73	10	blood	blood	NOUN
ajlm-297	73	11	transfusion	transfusion	NOUN
ajlm-297	73	12	was	be	AUX
ajlm-297	73	13	aged	age	VERB
ajlm-297	73	14	17.2	17.2	NUM
ajlm-297	73	15	years	year	NOUN
ajlm-297	73	16	(	(	PUNCT
ajlm-297	73	17	range	range	NOUN
ajlm-297	73	18	:	:	PUNCT
ajlm-297	73	19	1–93	1–93	NUM
ajlm-297	73	20	)	)	PUNCT
ajlm-297	73	21	.	.	PUNCT
ajlm-297	74	1	cancer	cancer	NOUN
ajlm-297	74	2	patients	patient	NOUN
ajlm-297	74	3	,	,	PUNCT
ajlm-297	74	4	in	in	ADP
ajlm-297	74	5	particular	particular	ADJ
ajlm-297	74	6	sm	sm	PROPN
ajlm-297	74	7	patients	patient	NOUN
ajlm-297	74	8	,	,	PUNCT
ajlm-297	74	9	were	be	AUX
ajlm-297	74	10	significantly	significantly	ADV
ajlm-297	74	11	older	old	ADJ
ajlm-297	74	12	than	than	ADP
ajlm-297	74	13	scd	scd	NOUN
ajlm-297	74	14	and	and	CCONJ
ajlm-297	74	15	hm	hm	INTJ
ajlm-297	74	16	patients	patient	NOUN
ajlm-297	74	17	(	(	PUNCT
ajlm-297	74	18	p	p	X
ajlm-297	74	19	<	<	X
ajlm-297	74	20	0.001	0.001	NUM
ajlm-297	74	21	)	)	PUNCT
ajlm-297	74	22	.	.	PUNCT
ajlm-297	75	1	indeed	indeed	ADV
ajlm-297	75	2	,	,	PUNCT
ajlm-297	75	3	the	the	DET
ajlm-297	75	4	majority	majority	NOUN
ajlm-297	75	5	of	of	ADP
ajlm-297	75	6	patients	patient	NOUN
ajlm-297	75	7	were	be	AUX
ajlm-297	75	8	children	child	NOUN
ajlm-297	75	9	aged	age	VERB
ajlm-297	75	10	16	16	NUM
ajlm-297	75	11	years	year	NOUN
ajlm-297	75	12	or	or	CCONJ
ajlm-297	75	13	younger	young	ADJ
ajlm-297	75	14	(	(	PUNCT
ajlm-297	75	15	n	n	NOUN
ajlm-297	75	16	=	=	SYM
ajlm-297	75	17	159	159	NUM
ajlm-297	75	18	;	;	PUNCT
ajlm-297	75	19	70	70	NUM
ajlm-297	75	20	%	%	NOUN
ajlm-297	75	21	)	)	PUNCT
ajlm-297	75	22	;	;	PUNCT
ajlm-297	75	23	14	14	NUM
ajlm-297	75	24	%	%	NOUN
ajlm-297	75	25	were	be	AUX
ajlm-297	75	26	aged	age	VERB
ajlm-297	75	27	three	three	NUM
ajlm-297	75	28	years	year	NOUN
ajlm-297	75	29	or	or	CCONJ
ajlm-297	75	30	younger	young	ADJ
ajlm-297	75	31	(	(	PUNCT
ajlm-297	75	32	figures	figure	NOUN
ajlm-297	75	33	1	1	NUM
ajlm-297	75	34	and	and	CCONJ
ajlm-297	75	35	2	2	NUM
ajlm-297	75	36	)	)	PUNCT
ajlm-297	75	37	.	.	PUNCT
ajlm-297	76	1	there	there	PRON
ajlm-297	76	2	were	be	VERB
ajlm-297	76	3	no	no	DET
ajlm-297	76	4	significant	significant	ADJ
ajlm-297	76	5	differences	difference	NOUN
ajlm-297	76	6	in	in	ADP
ajlm-297	76	7	the	the	DET
ajlm-297	76	8	female	female	NOUN
ajlm-297	76	9	to	to	ADP
ajlm-297	76	10	male	male	ADJ
ajlm-297	76	11	ratios	ratio	NOUN
ajlm-297	76	12	between	between	ADP
ajlm-297	76	13	the	the	DET
ajlm-297	76	14	groups	group	NOUN
ajlm-297	76	15	.	.	PUNCT
ajlm-297	77	1	figure	figure	VERB
ajlm-297	77	2	1	1	NUM
ajlm-297	77	3	:	:	PUNCT
ajlm-297	77	4	transfused	transfused	ADJ
ajlm-297	77	5	sickle	sickle	NOUN
ajlm-297	77	6	cell	cell	NOUN
ajlm-297	77	7	disease	disease	NOUN
ajlm-297	77	8	patients	patient	NOUN
ajlm-297	77	9	by	by	ADP
ajlm-297	77	10	age	age	NOUN
ajlm-297	77	11	,	,	PUNCT
ajlm-297	77	12	sex	sex	NOUN
ajlm-297	77	13	and	and	CCONJ
ajlm-297	77	14	seropositivity	seropositivity	NOUN
ajlm-297	77	15	at	at	ADP
ajlm-297	77	16	kenyatta	kenyatta	PROPN
ajlm-297	77	17	national	national	PROPN
ajlm-297	77	18	hospital	hospital	PROPN
ajlm-297	77	19	,	,	PUNCT
ajlm-297	77	20	nairobi	nairobi	PROPN
ajlm-297	77	21	,	,	PUNCT
ajlm-297	77	22	kenya	kenya	PROPN
ajlm-297	77	23	,	,	PUNCT
ajlm-297	77	24	2014	2014	NUM
ajlm-297	77	25	.	.	PUNCT
ajlm-297	78	1	figure	figure	NOUN
ajlm-297	78	2	2	2	NUM
ajlm-297	78	3	:	:	PUNCT
ajlm-297	78	4	transfused	transfused	ADJ
ajlm-297	78	5	cancer	cancer	NOUN
ajlm-297	78	6	patients	patient	NOUN
ajlm-297	78	7	by	by	ADP
ajlm-297	78	8	age	age	NOUN
ajlm-297	78	9	,	,	PUNCT
ajlm-297	78	10	sex	sex	NOUN
ajlm-297	78	11	and	and	CCONJ
ajlm-297	78	12	seropositivity	seropositivity	NOUN
ajlm-297	78	13	at	at	ADP
ajlm-297	78	14	kenyatta	kenyatta	PROPN
ajlm-297	78	15	national	national	PROPN
ajlm-297	78	16	hospital	hospital	PROPN
ajlm-297	78	17	,	,	PUNCT
ajlm-297	78	18	nairobi	nairobi	PROPN
ajlm-297	78	19	,	,	PUNCT
ajlm-297	78	20	kenya	kenya	PROPN
ajlm-297	78	21	,	,	PUNCT
ajlm-297	78	22	2014	2014	NUM
ajlm-297	78	23	.	.	PUNCT
ajlm-297	79	1	table	table	NOUN
ajlm-297	79	2	1	1	NUM
ajlm-297	79	3	:	:	PUNCT
ajlm-297	79	4	 	 	SPACE
ajlm-297	79	5	characteristics	characteristic	NOUN
ajlm-297	79	6	of	of	ADP
ajlm-297	79	7	transfused	transfused	ADJ
ajlm-297	79	8	sickle	sickle	NOUN
ajlm-297	79	9	cell	cell	NOUN
ajlm-297	79	10	disease	disease	NOUN
ajlm-297	79	11	and	and	CCONJ
ajlm-297	79	12	cancer	cancer	NOUN
ajlm-297	79	13	patients	patient	NOUN
ajlm-297	79	14	at	at	ADP
ajlm-297	79	15	kenyatta	kenyatta	PROPN
ajlm-297	79	16	national	national	PROPN
ajlm-297	79	17	hospital	hospital	PROPN
ajlm-297	79	18	,	,	PUNCT
ajlm-297	79	19	nairobi	nairobi	PROPN
ajlm-297	79	20	,	,	PUNCT
ajlm-297	79	21	kenya	kenya	PROPN
ajlm-297	79	22	,	,	PUNCT
ajlm-297	79	23	2014	2014	NUM
ajlm-297	79	24	.	.	PUNCT
ajlm-297	80	1	patients	patient	NOUN
ajlm-297	80	2	received	receive	VERB
ajlm-297	80	3	abo⁄rhesus	abo⁄rhesus	PROPN
ajlm-297	80	4	d	d	PROPN
ajlm-297	80	5	compatible	compatible	ADJ
ajlm-297	80	6	and	and	CCONJ
ajlm-297	80	7	non	non	ADJ
ajlm-297	80	8	-	-	ADJ
ajlm-297	80	9	leucocyte	leucocyte	ADJ
ajlm-297	80	10	-	-	PUNCT
ajlm-297	80	11	depleted	deplete	VERB
ajlm-297	80	12	whole	whole	ADJ
ajlm-297	80	13	blood	blood	NOUN
ajlm-297	80	14	units	unit	NOUN
ajlm-297	80	15	(	(	PUNCT
ajlm-297	80	16	n	n	NOUN
ajlm-297	80	17	=	=	SYM
ajlm-297	80	18	532	532	NUM
ajlm-297	80	19	)	)	PUNCT
ajlm-297	80	20	,	,	PUNCT
ajlm-297	80	21	packed	pack	VERB
ajlm-297	80	22	rbc	rbc	PROPN
ajlm-297	80	23	transfusions	transfusion	NOUN
ajlm-297	80	24	(	(	PUNCT
ajlm-297	80	25	n	n	NOUN
ajlm-297	80	26	=	=	SYM
ajlm-297	80	27	85	85	NUM
ajlm-297	80	28	)	)	PUNCT
ajlm-297	80	29	and	and	CCONJ
ajlm-297	80	30	platelet	platelet	NOUN
ajlm-297	80	31	transfusions	transfusion	NOUN
ajlm-297	80	32	(	(	PUNCT
ajlm-297	80	33	n	n	NOUN
ajlm-297	80	34	=	=	SYM
ajlm-297	80	35	68	68	NUM
ajlm-297	80	36	)	)	PUNCT
ajlm-297	80	37	,	,	PUNCT
ajlm-297	80	38	totaling	total	VERB
ajlm-297	80	39	685	685	NUM
ajlm-297	80	40	units	unit	NOUN
ajlm-297	80	41	of	of	ADP
ajlm-297	80	42	blood	blood	NOUN
ajlm-297	80	43	in	in	ADP
ajlm-297	80	44	593	593	NUM
ajlm-297	80	45	transfusion	transfusion	NOUN
ajlm-297	80	46	events	event	NOUN
ajlm-297	80	47	(	(	PUNCT
ajlm-297	80	48	i.e.	i.e.	X
ajlm-297	80	49	,	,	PUNCT
ajlm-297	80	50	1	1	NUM
ajlm-297	80	51	transfusion	transfusion	NOUN
ajlm-297	80	52	unit	unit	NOUN
ajlm-297	80	53	per	per	ADP
ajlm-297	80	54	transfusion	transfusion	NOUN
ajlm-297	80	55	episode	episode	NOUN
ajlm-297	80	56	or	or	CCONJ
ajlm-297	80	57	a	a	DET
ajlm-297	80	58	mean	mean	NOUN
ajlm-297	80	59	of	of	ADP
ajlm-297	80	60	2.7	2.7	NUM
ajlm-297	80	61	transfusion	transfusion	NOUN
ajlm-297	80	62	units	unit	NOUN
ajlm-297	80	63	per	per	ADP
ajlm-297	80	64	patient	patient	NOUN
ajlm-297	80	65	)	)	PUNCT
ajlm-297	80	66	.	.	PUNCT
ajlm-297	81	1	of	of	ADP
ajlm-297	81	2	the	the	DET
ajlm-297	81	3	scd	scd	NOUN
ajlm-297	81	4	patients	patient	NOUN
ajlm-297	81	5	,	,	PUNCT
ajlm-297	81	6	90	90	NUM
ajlm-297	81	7	%	%	NOUN
ajlm-297	81	8	were	be	AUX
ajlm-297	81	9	transfused	transfuse	VERB
ajlm-297	81	10	because	because	SCONJ
ajlm-297	81	11	of	of	ADP
ajlm-297	81	12	severe	severe	ADJ
ajlm-297	81	13	anaemia	anaemia	NOUN
ajlm-297	81	14	–	–	PUNCT
ajlm-297	81	15	haemoglobin	haemoglobin	NOUN
ajlm-297	81	16	less	less	ADJ
ajlm-297	81	17	than	than	ADP
ajlm-297	81	18	5–6	5–6	NUM
ajlm-297	81	19	g	g	NOUN
ajlm-297	81	20	/	/	SYM
ajlm-297	81	21	dl	dl	PROPN
ajlm-297	81	22	according	accord	VERB
ajlm-297	81	23	to	to	ADP
ajlm-297	81	24	world	world	PROPN
ajlm-297	81	25	health	health	NOUN
ajlm-297	81	26	organization	organization	NOUN
ajlm-297	81	27	guidelines.18	guidelines.18	NOUN
ajlm-297	81	28	transfusion	transfusion	NOUN
ajlm-297	81	29	in	in	ADP
ajlm-297	81	30	malignancy	malignancy	NOUN
ajlm-297	81	31	patients	patient	NOUN
ajlm-297	81	32	was	be	AUX
ajlm-297	81	33	mainly	mainly	ADV
ajlm-297	81	34	a	a	DET
ajlm-297	81	35	result	result	NOUN
ajlm-297	81	36	of	of	ADP
ajlm-297	81	37	anaemia	anaemia	NOUN
ajlm-297	81	38	caused	cause	VERB
ajlm-297	81	39	by	by	ADP
ajlm-297	81	40	intensive	intensive	ADJ
ajlm-297	81	41	chemotherapy	chemotherapy	NOUN
ajlm-297	81	42	,	,	PUNCT
ajlm-297	81	43	by	by	ADP
ajlm-297	81	44	the	the	DET
ajlm-297	81	45	disease	disease	NOUN
ajlm-297	81	46	process	process	NOUN
ajlm-297	81	47	and/or	and/or	CCONJ
ajlm-297	81	48	surgical	surgical	ADJ
ajlm-297	81	49	interventions	intervention	NOUN
ajlm-297	81	50	.	.	PUNCT
ajlm-297	82	1	all	all	DET
ajlm-297	82	2	cancer	cancer	NOUN
ajlm-297	82	3	patients	patient	NOUN
ajlm-297	82	4	were	be	AUX
ajlm-297	82	5	receiving	receive	VERB
ajlm-297	82	6	chemotherapy	chemotherapy	NOUN
ajlm-297	82	7	at	at	ADP
ajlm-297	82	8	the	the	DET
ajlm-297	82	9	time	time	NOUN
ajlm-297	82	10	of	of	ADP
ajlm-297	82	11	enrollment	enrollment	NOUN
ajlm-297	82	12	into	into	ADP
ajlm-297	82	13	the	the	DET
ajlm-297	82	14	study	study	NOUN
ajlm-297	82	15	.	.	PUNCT
ajlm-297	83	1	hm	hm	INTJ
ajlm-297	83	2	patients	patient	NOUN
ajlm-297	83	3	had	have	VERB
ajlm-297	83	4	the	the	DET
ajlm-297	83	5	following	follow	VERB
ajlm-297	83	6	types	type	NOUN
ajlm-297	83	7	of	of	ADP
ajlm-297	83	8	malignancies	malignancy	NOUN
ajlm-297	83	9	:	:	PUNCT
ajlm-297	83	10	acute	acute	ADJ
ajlm-297	83	11	lymphoblastic	lymphoblastic	ADJ
ajlm-297	83	12	leukaemia	leukaemia	NOUN
ajlm-297	83	13	(	(	PUNCT
ajlm-297	83	14	n	n	NOUN
ajlm-297	83	15	=	=	SYM
ajlm-297	83	16	15	15	NUM
ajlm-297	83	17	)	)	PUNCT
ajlm-297	83	18	,	,	PUNCT
ajlm-297	83	19	chronic	chronic	ADJ
ajlm-297	83	20	lymphoblastic	lymphoblastic	ADJ
ajlm-297	83	21	leukaemia	leukaemia	NOUN
ajlm-297	83	22	(	(	PUNCT
ajlm-297	83	23	n	n	NOUN
ajlm-297	83	24	=	=	SYM
ajlm-297	83	25	10	10	NUM
ajlm-297	83	26	)	)	PUNCT
ajlm-297	83	27	,	,	PUNCT
ajlm-297	83	28	hodgkin	hodgkin	PROPN
ajlm-297	83	29	's	's	PART
ajlm-297	83	30	lymphoma	lymphoma	NOUN
ajlm-297	83	31	(	(	PUNCT
ajlm-297	83	32	n	n	NOUN
ajlm-297	83	33	=	=	SYM
ajlm-297	83	34	9	9	NUM
ajlm-297	83	35	)	)	PUNCT
ajlm-297	83	36	,	,	PUNCT
ajlm-297	83	37	multiple	multiple	ADJ
ajlm-297	83	38	myeloma	myeloma	NOUN
ajlm-297	83	39	(	(	PUNCT
ajlm-297	83	40	n	n	NOUN
ajlm-297	83	41	=	=	SYM
ajlm-297	83	42	6	6	NUM
ajlm-297	83	43	)	)	PUNCT
ajlm-297	83	44	,	,	PUNCT
ajlm-297	83	45	acute	acute	ADJ
ajlm-297	83	46	myeloid	myeloid	NOUN
ajlm-297	83	47	leukaemia	leukaemia	NOUN
ajlm-297	83	48	(	(	PUNCT
ajlm-297	83	49	n	n	NOUN
ajlm-297	83	50	=	=	SYM
ajlm-297	83	51	5	5	NUM
ajlm-297	83	52	)	)	PUNCT
ajlm-297	83	53	and	and	CCONJ
ajlm-297	83	54	chronic	chronic	ADJ
ajlm-297	83	55	myeloid	myeloid	NOUN
ajlm-297	83	56	leukaemia	leukaemia	NOUN
ajlm-297	83	57	(	(	PUNCT
ajlm-297	83	58	n	n	NOUN
ajlm-297	83	59	=	=	SYM
ajlm-297	83	60	3	3	NUM
ajlm-297	83	61	)	)	PUNCT
ajlm-297	83	62	.	.	PUNCT
ajlm-297	84	1	sm	sm	PROPN
ajlm-297	84	2	patients	patient	NOUN
ajlm-297	84	3	had	have	VERB
ajlm-297	84	4	the	the	DET
ajlm-297	84	5	following	follow	VERB
ajlm-297	84	6	types	type	NOUN
ajlm-297	84	7	of	of	ADP
ajlm-297	84	8	malignancies	malignancy	NOUN
ajlm-297	84	9	:	:	PUNCT
ajlm-297	84	10	abdominal	abdominal	ADJ
ajlm-297	84	11	tumour	tumour	NOUN
ajlm-297	84	12	(	(	PUNCT
ajlm-297	84	13	n	n	NOUN
ajlm-297	84	14	=	=	SYM
ajlm-297	84	15	1	1	NUM
ajlm-297	84	16	)	)	PUNCT
ajlm-297	84	17	,	,	PUNCT
ajlm-297	84	18	bladder	bladder	NOUN
ajlm-297	84	19	(	(	PUNCT
ajlm-297	84	20	n	n	NOUN
ajlm-297	84	21	=	=	SYM
ajlm-297	84	22	2	2	NUM
ajlm-297	84	23	)	)	PUNCT
ajlm-297	84	24	,	,	PUNCT
ajlm-297	84	25	breast	breast	NOUN
ajlm-297	84	26	(	(	PUNCT
ajlm-297	84	27	n	n	NOUN
ajlm-297	84	28	=	=	SYM
ajlm-297	84	29	8)	8)	NUM
ajlm-297	84	30	,	,	PUNCT
ajlm-297	84	31	cervical	cervical	ADJ
ajlm-297	84	32	(	(	PUNCT
ajlm-297	84	33	n	n	NOUN
ajlm-297	84	34	=	=	SYM
ajlm-297	84	35	4	4	NUM
ajlm-297	84	36	)	)	PUNCT
ajlm-297	84	37	,	,	PUNCT
ajlm-297	84	38	colon	colon	NOUN
ajlm-297	84	39	(	(	PUNCT
ajlm-297	84	40	n	n	NOUN
ajlm-297	84	41	=	=	SYM
ajlm-297	84	42	3	3	NUM
ajlm-297	84	43	)	)	PUNCT
ajlm-297	84	44	,	,	PUNCT
ajlm-297	84	45	hepatocellular	hepatocellular	NOUN
ajlm-297	84	46	(	(	PUNCT
ajlm-297	84	47	n	n	NOUN
ajlm-297	84	48	=	=	SYM
ajlm-297	84	49	2	2	NUM
ajlm-297	84	50	)	)	PUNCT
ajlm-297	84	51	,	,	PUNCT
ajlm-297	84	52	mouth	mouth	NOUN
ajlm-297	84	53	(	(	PUNCT
ajlm-297	84	54	n	n	NOUN
ajlm-297	84	55	=	=	SYM
ajlm-297	84	56	1	1	NUM
ajlm-297	84	57	)	)	PUNCT
ajlm-297	84	58	,	,	PUNCT
ajlm-297	84	59	nasopharyngeal	nasopharyngeal	NOUN
ajlm-297	84	60	(	(	PUNCT
ajlm-297	84	61	n	n	NOUN
ajlm-297	84	62	=	=	SYM
ajlm-297	84	63	1	1	NUM
ajlm-297	84	64	)	)	PUNCT
ajlm-297	84	65	,	,	PUNCT
ajlm-297	84	66	pancreatic	pancreatic	NOUN
ajlm-297	84	67	(	(	PUNCT
ajlm-297	84	68	n	n	NOUN
ajlm-297	84	69	=	=	SYM
ajlm-297	84	70	2	2	NUM
ajlm-297	84	71	)	)	PUNCT
ajlm-297	84	72	,	,	PUNCT
ajlm-297	84	73	prostate	prostate	NOUN
ajlm-297	84	74	(	(	PUNCT
ajlm-297	84	75	n	n	NOUN
ajlm-297	84	76	=	=	SYM
ajlm-297	84	77	4	4	NUM
ajlm-297	84	78	)	)	PUNCT
ajlm-297	84	79	,	,	PUNCT
ajlm-297	84	80	rectum	rectum	NOUN
ajlm-297	84	81	(	(	PUNCT
ajlm-297	84	82	n	n	NOUN
ajlm-297	84	83	=	=	SYM
ajlm-297	84	84	4	4	NUM
ajlm-297	84	85	)	)	PUNCT
ajlm-297	84	86	,	,	PUNCT
ajlm-297	84	87	rhabdomyosarcoma	rhabdomyosarcoma	NOUN
ajlm-297	84	88	(	(	PUNCT
ajlm-297	84	89	n	n	NOUN
ajlm-297	84	90	=	=	SYM
ajlm-297	84	91	4	4	NUM
ajlm-297	84	92	)	)	PUNCT
ajlm-297	84	93	,	,	PUNCT
ajlm-297	84	94	sinonasal	sinonasal	VERB
ajlm-297	84	95	tumour	tumour	NOUN
ajlm-297	84	96	(	(	PUNCT
ajlm-297	84	97	n	n	NOUN
ajlm-297	84	98	=	=	SYM
ajlm-297	84	99	1	1	NUM
ajlm-297	84	100	)	)	PUNCT
ajlm-297	84	101	,	,	PUNCT
ajlm-297	84	102	squamous	squamous	ADJ
ajlm-297	84	103	cell	cell	NOUN
ajlm-297	84	104	carcinoma	carcinoma	NOUN
ajlm-297	84	105	(	(	PUNCT
ajlm-297	84	106	n	n	NOUN
ajlm-297	84	107	=	=	SYM
ajlm-297	84	108	2	2	NUM
ajlm-297	84	109	)	)	PUNCT
ajlm-297	84	110	and	and	CCONJ
ajlm-297	84	111	stomach	stomach	NOUN
ajlm-297	84	112	cancer	cancer	NOUN
ajlm-297	84	113	(	(	PUNCT
ajlm-297	84	114	n	n	NOUN
ajlm-297	84	115	=	=	NOUN
ajlm-297	84	116	4	4	NUM
ajlm-297	84	117	)	)	PUNCT
ajlm-297	84	118	.	.	PUNCT
ajlm-297	85	1	the	the	DET
ajlm-297	85	2	p	p	NOUN
ajlm-297	85	3	-	-	PUNCT
ajlm-297	85	4	value	value	NOUN
ajlm-297	85	5	for	for	ADP
ajlm-297	85	6	the	the	DET
ajlm-297	85	7	number	number	NOUN
ajlm-297	85	8	of	of	ADP
ajlm-297	85	9	blood	blood	NOUN
ajlm-297	85	10	units	unit	NOUN
ajlm-297	85	11	transfused	transfuse	VERB
ajlm-297	85	12	was	be	AUX
ajlm-297	85	13	0.004	0.004	NUM
ajlm-297	85	14	,	,	PUNCT
ajlm-297	85	15	which	which	PRON
ajlm-297	85	16	was	be	AUX
ajlm-297	85	17	statistically	statistically	ADV
ajlm-297	85	18	significant	significant	ADJ
ajlm-297	85	19	as	as	SCONJ
ajlm-297	85	20	cancer	cancer	NOUN
ajlm-297	85	21	patients	patient	NOUN
ajlm-297	85	22	received	receive	VERB
ajlm-297	85	23	more	more	ADJ
ajlm-297	85	24	transfusions	transfusion	NOUN
ajlm-297	85	25	.	.	PUNCT
ajlm-297	86	1	serological	serological	ADJ
ajlm-297	86	2	results	result	NOUN
ajlm-297	86	3	the	the	DET
ajlm-297	86	4	overall	overall	ADJ
ajlm-297	86	5	prevalence	prevalence	NOUN
ajlm-297	86	6	of	of	ADP
ajlm-297	86	7	rbc	rbc	PROPN
ajlm-297	86	8	immunisation	immunisation	NOUN
ajlm-297	86	9	was	be	AUX
ajlm-297	86	10	16.7	16.7	NUM
ajlm-297	86	11	%	%	NOUN
ajlm-297	86	12	,	,	PUNCT
ajlm-297	86	13	with	with	ADP
ajlm-297	86	14	38	38	NUM
ajlm-297	86	15	of	of	ADP
ajlm-297	86	16	the	the	DET
ajlm-297	86	17	228	228	NUM
ajlm-297	86	18	patients	patient	NOUN
ajlm-297	86	19	testing	test	VERB
ajlm-297	86	20	positive	positive	ADJ
ajlm-297	86	21	for	for	ADP
ajlm-297	86	22	antibody	antibody	NOUN
ajlm-297	86	23	screening	screen	VERB
ajlm-297	86	24	.	.	PUNCT
ajlm-297	87	1	the	the	DET
ajlm-297	87	2	prevalence	prevalence	NOUN
ajlm-297	87	3	of	of	ADP
ajlm-297	87	4	rbc	rbc	PROPN
ajlm-297	87	5	immunisation	immunisation	NOUN
ajlm-297	87	6	amongst	amongst	ADP
ajlm-297	87	7	scd	scd	PROPN
ajlm-297	87	8	patients	patient	NOUN
ajlm-297	87	9	was	be	AUX
ajlm-297	87	10	20.4	20.4	NUM
ajlm-297	87	11	%	%	NOUN
ajlm-297	87	12	(	(	PUNCT
ajlm-297	87	13	28	28	NUM
ajlm-297	87	14	of	of	ADP
ajlm-297	87	15	137	137	NUM
ajlm-297	87	16	patients	patient	NOUN
ajlm-297	87	17	)	)	PUNCT
ajlm-297	87	18	and	and	CCONJ
ajlm-297	87	19	amongst	amongst	ADP
ajlm-297	87	20	malignancy	malignancy	NOUN
ajlm-297	87	21	patients	patient	NOUN
ajlm-297	87	22	,	,	PUNCT
ajlm-297	87	23	11.0	11.0	NUM
ajlm-297	87	24	%	%	NOUN
ajlm-297	87	25	(	(	PUNCT
ajlm-297	87	26	dat+	dat+	PROPN
ajlm-297	87	27	,	,	PUNCT
ajlm-297	87	28	n	n	NOUN
ajlm-297	87	29	=	=	SYM
ajlm-297	87	30	8	8	NUM
ajlm-297	87	31	plus	plus	CCONJ
ajlm-297	87	32	alloab+	alloab+	PROPN
ajlm-297	87	33	,	,	PUNCT
ajlm-297	87	34	n	n	NOUN
ajlm-297	87	35	=	=	SYM
ajlm-297	87	36	2	2	NUM
ajlm-297	87	37	;	;	PUNCT
ajlm-297	87	38	altogether	altogether	ADV
ajlm-297	87	39	10	10	NUM
ajlm-297	87	40	out	out	ADP
ajlm-297	87	41	of	of	ADP
ajlm-297	87	42	91	91	NUM
ajlm-297	87	43	patients	patient	NOUN
ajlm-297	87	44	)	)	PUNCT
ajlm-297	87	45	.	.	PUNCT
ajlm-297	88	1	rbc	rbc	PROPN
ajlm-297	88	2	alloantibody	alloantibody	ADJ
ajlm-297	88	3	identification	identification	NOUN
ajlm-297	88	4	only	only	ADV
ajlm-297	88	5	38	38	NUM
ajlm-297	88	6	patients	patient	NOUN
ajlm-297	88	7	were	be	AUX
ajlm-297	88	8	positive	positive	ADJ
ajlm-297	88	9	for	for	ADP
ajlm-297	88	10	the	the	DET
ajlm-297	88	11	antibody	antibody	NOUN
ajlm-297	88	12	screening	screen	VERB
ajlm-297	88	13	,	,	PUNCT
ajlm-297	88	14	and	and	CCONJ
ajlm-297	88	15	rbc	rbc	PROPN
ajlm-297	88	16	alloantibodies	alloantibody	NOUN
ajlm-297	88	17	were	be	AUX
ajlm-297	88	18	detected	detect	VERB
ajlm-297	88	19	in	in	ADP
ajlm-297	88	20	only	only	ADV
ajlm-297	88	21	6	6	NUM
ajlm-297	88	22	of	of	ADP
ajlm-297	88	23	228	228	NUM
ajlm-297	88	24	patients	patient	NOUN
ajlm-297	88	25	(	(	PUNCT
ajlm-297	88	26	2.6	2.6	NUM
ajlm-297	88	27	%	%	NOUN
ajlm-297	88	28	)	)	PUNCT
ajlm-297	88	29	(	(	PUNCT
ajlm-297	88	30	table	table	NOUN
ajlm-297	88	31	2	2	NUM
ajlm-297	88	32	)	)	PUNCT
ajlm-297	88	33	.	.	PUNCT
ajlm-297	89	1	the	the	DET
ajlm-297	89	2	rate	rate	NOUN
ajlm-297	89	3	of	of	ADP
ajlm-297	89	4	alloab	alloab	PROPN
ajlm-297	89	5	formation	formation	NOUN
ajlm-297	89	6	amongst	amongst	ADP
ajlm-297	89	7	scd	scd	PROPN
ajlm-297	89	8	patients	patient	NOUN
ajlm-297	89	9	was	be	AUX
ajlm-297	89	10	2.9	2.9	NUM
ajlm-297	89	11	%	%	NOUN
ajlm-297	89	12	(	(	PUNCT
ajlm-297	89	13	4	4	NUM
ajlm-297	89	14	of	of	ADP
ajlm-297	89	15	137	137	NUM
ajlm-297	89	16	)	)	PUNCT
ajlm-297	89	17	and	and	CCONJ
ajlm-297	89	18	4.2	4.2	NUM
ajlm-297	89	19	%	%	NOUN
ajlm-297	89	20	(	(	PUNCT
ajlm-297	89	21	2	2	NUM
ajlm-297	89	22	of	of	ADP
ajlm-297	89	23	48	48	NUM
ajlm-297	89	24	)	)	PUNCT
ajlm-297	89	25	amongst	amongst	ADP
ajlm-297	89	26	hm	hm	DET
ajlm-297	89	27	patients	patient	NOUN
ajlm-297	89	28	,	,	PUNCT
ajlm-297	89	29	whereas	whereas	SCONJ
ajlm-297	89	30	the	the	DET
ajlm-297	89	31	prevalence	prevalence	NOUN
ajlm-297	89	32	amongst	amongst	ADP
ajlm-297	89	33	sm	sm	PROPN
ajlm-297	89	34	patients	patient	NOUN
ajlm-297	89	35	for	for	ADP
ajlm-297	89	36	alloab	alloab	PROPN
ajlm-297	89	37	identification	identification	NOUN
ajlm-297	89	38	was	be	AUX
ajlm-297	89	39	0	0	NUM
ajlm-297	89	40	.	.	PUNCT
ajlm-297	90	1	the	the	DET
ajlm-297	90	2	specificities	specificity	NOUN
ajlm-297	90	3	of	of	ADP
ajlm-297	90	4	the	the	DET
ajlm-297	90	5	alloabs	alloab	NOUN
ajlm-297	90	6	from	from	ADP
ajlm-297	90	7	the	the	DET
ajlm-297	90	8	scd	scd	NOUN
ajlm-297	90	9	patients	patient	NOUN
ajlm-297	90	10	were	be	AUX
ajlm-297	90	11	anti	anti	ADJ
ajlm-297	90	12	-	-	ADJ
ajlm-297	90	13	cw	cw	ADJ
ajlm-297	90	14	,	,	PUNCT
ajlm-297	90	15	anti	anti	ADJ
ajlm-297	90	16	-	-	ADJ
ajlm-297	90	17	s	s	ADJ
ajlm-297	90	18	,	,	PUNCT
ajlm-297	90	19	anti	anti	ADJ
ajlm-297	90	20	-	-	NOUN
ajlm-297	90	21	cob	cob	ADJ
ajlm-297	90	22	(	(	PUNCT
ajlm-297	90	23	probably	probably	ADV
ajlm-297	90	24	immune	immune	ADJ
ajlm-297	90	25	in	in	ADP
ajlm-297	90	26	nature	nature	NOUN
ajlm-297	90	27	)	)	PUNCT
ajlm-297	90	28	and	and	CCONJ
ajlm-297	90	29	anti	anti	NOUN
ajlm-297	90	30	-	-	NOUN
ajlm-297	90	31	m	m	VERB
ajlm-297	90	32	(	(	PUNCT
ajlm-297	90	33	probably	probably	ADV
ajlm-297	90	34	naturally	naturally	ADV
ajlm-297	90	35	occurring	occur	VERB
ajlm-297	90	36	)	)	PUNCT
ajlm-297	90	37	.	.	PUNCT
ajlm-297	91	1	in	in	ADP
ajlm-297	91	2	addition	addition	NOUN
ajlm-297	91	3	,	,	PUNCT
ajlm-297	91	4	there	there	PRON
ajlm-297	91	5	was	be	VERB
ajlm-297	91	6	one	one	NUM
ajlm-297	91	7	anti	anti	ADJ
ajlm-297	91	8	-	-	ADJ
ajlm-297	91	9	k	k	ADJ
ajlm-297	91	10	(	(	PUNCT
ajlm-297	91	11	immune	immune	NOUN
ajlm-297	91	12	)	)	PUNCT
ajlm-297	91	13	and	and	CCONJ
ajlm-297	91	14	one	one	NUM
ajlm-297	91	15	anti	anti	ADJ
ajlm-297	91	16	-	-	ADJ
ajlm-297	91	17	lea	lea	ADJ
ajlm-297	91	18	(	(	PUNCT
ajlm-297	91	19	natural	natural	ADJ
ajlm-297	91	20	)	)	PUNCT
ajlm-297	91	21	in	in	ADP
ajlm-297	91	22	the	the	DET
ajlm-297	91	23	two	two	NUM
ajlm-297	91	24	hm	hm	INTJ
ajlm-297	91	25	patients	patient	NOUN
ajlm-297	91	26	,	,	PUNCT
ajlm-297	91	27	whereas	whereas	SCONJ
ajlm-297	91	28	the	the	DET
ajlm-297	91	29	sm	sm	PROPN
ajlm-297	91	30	group	group	NOUN
ajlm-297	91	31	showed	show	VERB
ajlm-297	91	32	no	no	DET
ajlm-297	91	33	rbc	rbc	PROPN
ajlm-297	91	34	alloimmunisation	alloimmunisation	NOUN
ajlm-297	91	35	.	.	PUNCT
ajlm-297	92	1	the	the	DET
ajlm-297	92	2	rate	rate	NOUN
ajlm-297	92	3	of	of	ADP
ajlm-297	92	4	alloimmunisation	alloimmunisation	NOUN
ajlm-297	92	5	was	be	AUX
ajlm-297	92	6	6.14	6.14	NUM
ajlm-297	92	7	%	%	NOUN
ajlm-297	92	8	for	for	ADP
ajlm-297	92	9	men	man	NOUN
ajlm-297	92	10	versus	versus	ADP
ajlm-297	92	11	8.33	8.33	NUM
ajlm-297	92	12	%	%	NOUN
ajlm-297	92	13	for	for	ADP
ajlm-297	92	14	women	woman	NOUN
ajlm-297	92	15	;	;	PUNCT
ajlm-297	92	16	the	the	DET
ajlm-297	92	17	difference	difference	NOUN
ajlm-297	92	18	was	be	AUX
ajlm-297	92	19	not	not	PART
ajlm-297	92	20	statistically	statistically	ADV
ajlm-297	92	21	significant	significant	ADJ
ajlm-297	92	22	(	(	PUNCT
ajlm-297	92	23	p	p	X
ajlm-297	92	24	=	=	NOUN
ajlm-297	92	25	0.25	0.25	NUM
ajlm-297	92	26	)	)	PUNCT
ajlm-297	92	27	.	.	PUNCT
ajlm-297	93	1	table	table	NOUN
ajlm-297	93	2	2	2	NUM
ajlm-297	93	3	:	:	PUNCT
ajlm-297	93	4	 	 	SPACE
ajlm-297	93	5	serological	serological	ADJ
ajlm-297	93	6	results	result	NOUN
ajlm-297	93	7	of	of	ADP
ajlm-297	93	8	transfused	transfused	ADJ
ajlm-297	93	9	sickle	sickle	NOUN
ajlm-297	93	10	cell	cell	NOUN
ajlm-297	93	11	disease	disease	NOUN
ajlm-297	93	12	and	and	CCONJ
ajlm-297	93	13	cancer	cancer	NOUN
ajlm-297	93	14	patients	patient	NOUN
ajlm-297	93	15	at	at	ADP
ajlm-297	93	16	kenyatta	kenyatta	PROPN
ajlm-297	93	17	national	national	PROPN
ajlm-297	93	18	hospital	hospital	PROPN
ajlm-297	93	19	,	,	PUNCT
ajlm-297	93	20	nairobi	nairobi	PROPN
ajlm-297	93	21	,	,	PUNCT
ajlm-297	93	22	kenya	kenya	PROPN
ajlm-297	93	23	,	,	PUNCT
ajlm-297	93	24	2014	2014	NUM
ajlm-297	93	25	.	.	PUNCT
ajlm-297	94	1	red	red	ADJ
ajlm-297	94	2	cell	cell	NOUN
ajlm-297	94	3	autoimmunisation	autoimmunisation	NOUN
ajlm-297	94	4	of	of	ADP
ajlm-297	94	5	the	the	DET
ajlm-297	94	6	228	228	NUM
ajlm-297	94	7	patients	patient	NOUN
ajlm-297	94	8	,	,	PUNCT
ajlm-297	94	9	32	32	NUM
ajlm-297	94	10	patients	patient	NOUN
ajlm-297	94	11	(	(	PUNCT
ajlm-297	94	12	14.0	14.0	NUM
ajlm-297	94	13	%	%	NOUN
ajlm-297	94	14	)	)	PUNCT
ajlm-297	94	15	presented	present	VERB
ajlm-297	94	16	a	a	DET
ajlm-297	94	17	positive	positive	ADJ
ajlm-297	94	18	dat	dat	NOUN
ajlm-297	94	19	(	(	PUNCT
ajlm-297	94	20	table	table	NOUN
ajlm-297	94	21	2	2	NUM
ajlm-297	94	22	)	)	PUNCT
ajlm-297	94	23	.	.	PUNCT
ajlm-297	95	1	fifty	fifty	NUM
ajlm-297	95	2	per	per	ADP
ajlm-297	95	3	cent	cent	NOUN
ajlm-297	95	4	of	of	ADP
ajlm-297	95	5	these	these	DET
ajlm-297	95	6	patients	patient	NOUN
ajlm-297	95	7	(	(	PUNCT
ajlm-297	95	8	16	16	NUM
ajlm-297	95	9	of	of	ADP
ajlm-297	95	10	32	32	NUM
ajlm-297	95	11	)	)	PUNCT
ajlm-297	95	12	were	be	AUX
ajlm-297	95	13	positive	positive	ADJ
ajlm-297	95	14	for	for	ADP
ajlm-297	95	15	anti	anti	ADJ
ajlm-297	95	16	-	-	NOUN
ajlm-297	95	17	igg	igg	NOUN
ajlm-297	95	18	alone	alone	ADV
ajlm-297	95	19	,	,	PUNCT
ajlm-297	95	20	whereas	whereas	SCONJ
ajlm-297	95	21	18.8	18.8	NUM
ajlm-297	95	22	%	%	NOUN
ajlm-297	95	23	(	(	PUNCT
ajlm-297	95	24	6	6	NUM
ajlm-297	95	25	of	of	ADP
ajlm-297	95	26	32	32	NUM
ajlm-297	95	27	)	)	PUNCT
ajlm-297	95	28	showed	show	VERB
ajlm-297	95	29	reactions	reaction	NOUN
ajlm-297	95	30	to	to	ADP
ajlm-297	95	31	anti	anti	ADJ
ajlm-297	95	32	-	-	ADJ
ajlm-297	95	33	igg	igg	ADJ
ajlm-297	95	34	plus	plus	CCONJ
ajlm-297	95	35	anti	anti	ADJ
ajlm-297	95	36	-	-	ADJ
ajlm-297	95	37	c3c	c3c	NOUN
ajlm-297	95	38	or	or	CCONJ
ajlm-297	95	39	c3d	c3d	NOUN
ajlm-297	95	40	.	.	PUNCT
ajlm-297	96	1	out	out	ADP
ajlm-297	96	2	of	of	ADP
ajlm-297	96	3	the	the	DET
ajlm-297	96	4	subset	subset	NOUN
ajlm-297	96	5	of	of	ADP
ajlm-297	96	6	21	21	NUM
ajlm-297	96	7	igg	igg	PROPN
ajlm-297	96	8	-	-	PUNCT
ajlm-297	96	9	positive	positive	ADJ
ajlm-297	96	10	patients	patient	NOUN
ajlm-297	96	11	,	,	PUNCT
ajlm-297	96	12	the	the	DET
ajlm-297	96	13	acid	acid	PROPN
ajlm-297	96	14	eluate	eluate	NOUN
ajlm-297	96	15	was	be	AUX
ajlm-297	96	16	reactive	reactive	ADJ
ajlm-297	96	17	in	in	ADP
ajlm-297	96	18	seven	seven	NUM
ajlm-297	96	19	,	,	PUNCT
ajlm-297	96	20	thereby	thereby	ADV
ajlm-297	96	21	indicating	indicate	VERB
ajlm-297	96	22	a	a	DET
ajlm-297	96	23	true	true	ADJ
ajlm-297	96	24	rbc	rbc	PROPN
ajlm-297	96	25	autoab	autoab	PROPN
ajlm-297	96	26	prevalence	prevalence	NOUN
ajlm-297	96	27	of	of	ADP
ajlm-297	96	28	3.1	3.1	NUM
ajlm-297	96	29	%	%	NOUN
ajlm-297	96	30	for	for	ADP
ajlm-297	96	31	this	this	DET
ajlm-297	96	32	population	population	NOUN
ajlm-297	96	33	of	of	ADP
ajlm-297	96	34	patients	patient	NOUN
ajlm-297	96	35	(	(	PUNCT
ajlm-297	96	36	7	7	NUM
ajlm-297	96	37	of	of	ADP
ajlm-297	96	38	228	228	NUM
ajlm-297	96	39	)	)	PUNCT
ajlm-297	96	40	and	and	CCONJ
ajlm-297	96	41	33.3	33.3	NUM
ajlm-297	96	42	%	%	NOUN
ajlm-297	96	43	(	(	PUNCT
ajlm-297	96	44	7	7	NUM
ajlm-297	96	45	of	of	ADP
ajlm-297	96	46	32	32	NUM
ajlm-297	96	47	)	)	PUNCT
ajlm-297	96	48	amongst	amongst	ADP
ajlm-297	96	49	the	the	DET
ajlm-297	96	50	dat	dat	ADJ
ajlm-297	96	51	-	-	PUNCT
ajlm-297	96	52	positive	positive	ADJ
ajlm-297	96	53	patients	patient	NOUN
ajlm-297	96	54	.	.	PUNCT
ajlm-297	97	1	rbc	rbc	PROPN
ajlm-297	97	2	autoab	autoab	PROPN
ajlm-297	97	3	prevalence	prevalence	PROPN
ajlm-297	97	4	was	be	AUX
ajlm-297	97	5	5.1	5.1	NUM
ajlm-297	97	6	%	%	NOUN
ajlm-297	97	7	(	(	PUNCT
ajlm-297	97	8	7	7	NUM
ajlm-297	97	9	of	of	ADP
ajlm-297	97	10	137	137	NUM
ajlm-297	97	11	)	)	PUNCT
ajlm-297	97	12	amongst	amongst	ADP
ajlm-297	97	13	scd	scd	PROPN
ajlm-297	97	14	patients	patient	NOUN
ajlm-297	97	15	,	,	PUNCT
ajlm-297	97	16	whereas	whereas	SCONJ
ajlm-297	97	17	there	there	PRON
ajlm-297	97	18	were	be	VERB
ajlm-297	97	19	no	no	DET
ajlm-297	97	20	rbc	rbc	PROPN
ajlm-297	97	21	autoabs	autoab	NOUN
ajlm-297	97	22	amongst	amongst	ADP
ajlm-297	97	23	patients	patient	NOUN
ajlm-297	97	24	with	with	ADP
ajlm-297	97	25	malignancies	malignancy	NOUN
ajlm-297	97	26	.	.	PUNCT
ajlm-297	98	1	moreover	moreover	ADV
ajlm-297	98	2	,	,	PUNCT
ajlm-297	98	3	we	we	PRON
ajlm-297	98	4	observed	observe	VERB
ajlm-297	98	5	a	a	DET
ajlm-297	98	6	few	few	ADJ
ajlm-297	98	7	cases	case	NOUN
ajlm-297	98	8	(	(	PUNCT
ajlm-297	98	9	3	3	NUM
ajlm-297	98	10	of	of	ADP
ajlm-297	98	11	32	32	NUM
ajlm-297	98	12	)	)	PUNCT
ajlm-297	98	13	with	with	ADP
ajlm-297	98	14	isolated	isolated	ADJ
ajlm-297	98	15	igm	igm	NOUN
ajlm-297	98	16	or	or	CCONJ
ajlm-297	98	17	iga	iga	PROPN
ajlm-297	98	18	reactivity	reactivity	NOUN
ajlm-297	98	19	.	.	PUNCT
ajlm-297	99	1	the	the	DET
ajlm-297	99	2	majority	majority	NOUN
ajlm-297	99	3	(	(	PUNCT
ajlm-297	99	4	24	24	NUM
ajlm-297	99	5	of	of	ADP
ajlm-297	99	6	32	32	NUM
ajlm-297	99	7	)	)	PUNCT
ajlm-297	99	8	of	of	ADP
ajlm-297	99	9	the	the	DET
ajlm-297	99	10	dat	dat	ADJ
ajlm-297	99	11	-	-	PUNCT
ajlm-297	99	12	positive	positive	ADJ
ajlm-297	99	13	reactions	reaction	NOUN
ajlm-297	99	14	with	with	ADP
ajlm-297	99	15	anti	anti	ADJ
ajlm-297	99	16	-	-	ADJ
ajlm-297	99	17	igm	igm	ADJ
ajlm-297	99	18	and	and	CCONJ
ajlm-297	99	19	anti	anti	ADJ
ajlm-297	99	20	-	-	ADJ
ajlm-297	99	21	iga	iga	PROPN
ajlm-297	99	22	were	be	AUX
ajlm-297	99	23	observed	observe	VERB
ajlm-297	99	24	in	in	ADP
ajlm-297	99	25	the	the	DET
ajlm-297	99	26	scd	scd	PROPN
ajlm-297	99	27	group	group	NOUN
ajlm-297	99	28	.	.	PUNCT
ajlm-297	100	1	eighteen	eighteen	NUM
ajlm-297	100	2	per	per	ADP
ajlm-297	100	3	cent	cent	NOUN
ajlm-297	100	4	(	(	PUNCT
ajlm-297	100	5	24	24	NUM
ajlm-297	100	6	of	of	ADP
ajlm-297	100	7	137	137	NUM
ajlm-297	100	8	)	)	PUNCT
ajlm-297	100	9	of	of	ADP
ajlm-297	100	10	the	the	DET
ajlm-297	100	11	scd	scd	PROPN
ajlm-297	100	12	group	group	NOUN
ajlm-297	100	13	were	be	AUX
ajlm-297	100	14	dat	dat	ADJ
ajlm-297	100	15	positive	positive	ADJ
ajlm-297	100	16	compared	compare	VERB
ajlm-297	100	17	with	with	ADP
ajlm-297	100	18	8.8	8.8	NUM
ajlm-297	100	19	%	%	NOUN
ajlm-297	100	20	(	(	PUNCT
ajlm-297	100	21	8	8	NUM
ajlm-297	100	22	of	of	ADP
ajlm-297	100	23	91	91	NUM
ajlm-297	100	24	)	)	PUNCT
ajlm-297	100	25	in	in	ADP
ajlm-297	100	26	the	the	DET
ajlm-297	100	27	hm	hm	PROPN
ajlm-297	100	28	/	/	SYM
ajlm-297	100	29	sm	sm	PROPN
ajlm-297	100	30	group	group	NOUN
ajlm-297	100	31	.	.	PUNCT
ajlm-297	101	1	comparison	comparison	NOUN
ajlm-297	101	2	of	of	ADP
ajlm-297	101	3	combined	combined	ADJ
ajlm-297	101	4	rbc	rbc	PROPN
ajlm-297	101	5	alloand	alloand	PROPN
ajlm-297	101	6	autoimmunisation	autoimmunisation	NOUN
ajlm-297	101	7	in	in	ADP
ajlm-297	101	8	sickle	sickle	PROPN
ajlm-297	101	9	cell	cell	NOUN
ajlm-297	101	10	versus	versus	ADP
ajlm-297	101	11	cancer	cancer	NOUN
ajlm-297	101	12	patients	patient	NOUN
ajlm-297	101	13	the	the	DET
ajlm-297	101	14	prevalence	prevalence	NOUN
ajlm-297	101	15	of	of	ADP
ajlm-297	101	16	rbc	rbc	PROPN
ajlm-297	101	17	immunisation	immunisation	NOUN
ajlm-297	101	18	(	(	PUNCT
ajlm-297	101	19	demonstration	demonstration	NOUN
ajlm-297	101	20	of	of	ADP
ajlm-297	101	21	an	an	DET
ajlm-297	101	22	immune	immune	ADJ
ajlm-297	101	23	alloab	alloab	PROPN
ajlm-297	101	24	and	and	CCONJ
ajlm-297	101	25	a	a	DET
ajlm-297	101	26	positive	positive	ADJ
ajlm-297	101	27	dat	dat	NOUN
ajlm-297	101	28	)	)	PUNCT
ajlm-297	101	29	amongst	amongst	ADP
ajlm-297	101	30	scd	scd	PROPN
ajlm-297	101	31	patients	patient	NOUN
ajlm-297	101	32	was	be	AUX
ajlm-297	101	33	19.7	19.7	NUM
ajlm-297	101	34	%	%	NOUN
ajlm-297	101	35	(	(	PUNCT
ajlm-297	101	36	27	27	NUM
ajlm-297	101	37	of	of	ADP
ajlm-297	101	38	137	137	NUM
ajlm-297	101	39	)	)	PUNCT
ajlm-297	101	40	versus	versus	ADP
ajlm-297	101	41	9.9	9.9	NUM
ajlm-297	101	42	%	%	NOUN
ajlm-297	101	43	(	(	PUNCT
ajlm-297	101	44	9	9	NUM
ajlm-297	101	45	of	of	ADP
ajlm-297	101	46	91	91	NUM
ajlm-297	101	47	)	)	PUNCT
ajlm-297	101	48	.	.	PUNCT
ajlm-297	102	1	immune	immune	PROPN
ajlm-297	102	2	alloabs	alloab	NOUN
ajlm-297	102	3	were	be	AUX
ajlm-297	102	4	found	find	VERB
ajlm-297	102	5	in	in	ADP
ajlm-297	102	6	2.2	2.2	NUM
ajlm-297	102	7	%	%	NOUN
ajlm-297	102	8	(	(	PUNCT
ajlm-297	102	9	3	3	NUM
ajlm-297	102	10	of	of	ADP
ajlm-297	102	11	137	137	NUM
ajlm-297	102	12	)	)	PUNCT
ajlm-297	102	13	of	of	ADP
ajlm-297	102	14	the	the	DET
ajlm-297	102	15	scd	scd	NOUN
ajlm-297	102	16	patients	patient	NOUN
ajlm-297	102	17	versus	versus	ADP
ajlm-297	102	18	1.1	1.1	NUM
ajlm-297	102	19	%	%	NOUN
ajlm-297	102	20	(	(	PUNCT
ajlm-297	102	21	1	1	NUM
ajlm-297	102	22	of	of	ADP
ajlm-297	102	23	91	91	NUM
ajlm-297	102	24	)	)	PUNCT
ajlm-297	102	25	of	of	ADP
ajlm-297	102	26	the	the	DET
ajlm-297	102	27	patients	patient	NOUN
ajlm-297	102	28	with	with	ADP
ajlm-297	102	29	malignancies	malignancy	NOUN
ajlm-297	102	30	.	.	PUNCT
ajlm-297	103	1	with	with	ADP
ajlm-297	103	2	one	one	NUM
ajlm-297	103	3	exception	exception	NOUN
ajlm-297	103	4	(	(	PUNCT
ajlm-297	103	5	polyspecific	polyspecific	ADJ
ajlm-297	103	6	in	in	ADP
ajlm-297	103	7	eluate	eluate	ADJ
ajlm-297	103	8	,	,	PUNCT
ajlm-297	103	9	but	but	CCONJ
ajlm-297	103	10	auto	auto	NOUN
ajlm-297	103	11	-	-	PUNCT
ajlm-297	103	12	anti	anti	NOUN
ajlm-297	103	13	-	-	ADJ
ajlm-297	103	14	e	e	NOUN
ajlm-297	103	15	in	in	ADP
ajlm-297	103	16	serum	serum	NOUN
ajlm-297	103	17	)	)	PUNCT
ajlm-297	103	18	,	,	PUNCT
ajlm-297	103	19	these	these	DET
ajlm-297	103	20	autoabs	autoab	NOUN
ajlm-297	103	21	showed	show	VERB
ajlm-297	103	22	polyspecificity	polyspecificity	NOUN
ajlm-297	103	23	only	only	ADV
ajlm-297	103	24	.	.	PUNCT
ajlm-297	104	1	we	we	PRON
ajlm-297	104	2	also	also	ADV
ajlm-297	104	3	performed	perform	VERB
ajlm-297	104	4	a	a	DET
ajlm-297	104	5	comparison	comparison	NOUN
ajlm-297	104	6	for	for	ADP
ajlm-297	104	7	demographic	demographic	ADJ
ajlm-297	104	8	and	and	CCONJ
ajlm-297	104	9	transfusion	transfusion	NOUN
ajlm-297	104	10	variables	variable	NOUN
ajlm-297	104	11	between	between	ADP
ajlm-297	104	12	patients	patient	NOUN
ajlm-297	104	13	with	with	ADP
ajlm-297	104	14	and	and	CCONJ
ajlm-297	104	15	without	without	ADP
ajlm-297	104	16	serological	serological	ADJ
ajlm-297	104	17	reactivity	reactivity	NOUN
ajlm-297	104	18	(	(	PUNCT
ajlm-297	104	19	table	table	NOUN
ajlm-297	104	20	3	3	NUM
ajlm-297	104	21	)	)	PUNCT
ajlm-297	104	22	.	.	PUNCT
ajlm-297	105	1	we	we	PRON
ajlm-297	105	2	did	do	AUX
ajlm-297	105	3	not	not	PART
ajlm-297	105	4	find	find	VERB
ajlm-297	105	5	a	a	DET
ajlm-297	105	6	significant	significant	ADJ
ajlm-297	105	7	link	link	NOUN
ajlm-297	105	8	between	between	ADP
ajlm-297	105	9	patients	patient	NOUN
ajlm-297	105	10	’	’	PART
ajlm-297	105	11	sex	sex	NOUN
ajlm-297	105	12	,	,	PUNCT
ajlm-297	105	13	age	age	NOUN
ajlm-297	105	14	or	or	CCONJ
ajlm-297	105	15	number	number	NOUN
ajlm-297	105	16	of	of	ADP
ajlm-297	105	17	units	unit	NOUN
ajlm-297	105	18	of	of	ADP
ajlm-297	105	19	blood	blood	NOUN
ajlm-297	105	20	transfused	transfuse	VERB
ajlm-297	105	21	and	and	CCONJ
ajlm-297	105	22	the	the	DET
ajlm-297	105	23	positivity	positivity	NOUN
ajlm-297	105	24	of	of	ADP
ajlm-297	105	25	the	the	DET
ajlm-297	105	26	antibody	antibody	NOUN
ajlm-297	105	27	screening	screen	VERB
ajlm-297	105	28	.	.	PUNCT
ajlm-297	106	1	table	table	NOUN
ajlm-297	106	2	3	3	NUM
ajlm-297	106	3	:	:	PUNCT
ajlm-297	106	4	 	 	SPACE
ajlm-297	106	5	characteristics	characteristic	NOUN
ajlm-297	106	6	of	of	ADP
ajlm-297	106	7	immunised	immunise	VERB
ajlm-297	106	8	and	and	CCONJ
ajlm-297	106	9	non	non	ADJ
ajlm-297	106	10	-	-	ADJ
ajlm-297	106	11	immunised	immunise	VERB
ajlm-297	106	12	transfused	transfused	ADJ
ajlm-297	106	13	sickle	sickle	NOUN
ajlm-297	106	14	cell	cell	NOUN
ajlm-297	106	15	and	and	CCONJ
ajlm-297	106	16	cancer	cancer	NOUN
ajlm-297	106	17	patients	patient	NOUN
ajlm-297	106	18	at	at	ADP
ajlm-297	106	19	kenyatta	kenyatta	PROPN
ajlm-297	106	20	national	national	PROPN
ajlm-297	106	21	hospital	hospital	PROPN
ajlm-297	106	22	,	,	PUNCT
ajlm-297	106	23	2014	2014	NUM
ajlm-297	106	24	.	.	PUNCT
ajlm-297	107	1	healthy	healthy	ADJ
ajlm-297	107	2	donor	donor	NOUN
ajlm-297	107	3	phenotypes	phenotype	NOUN
ajlm-297	107	4	amongst	amongst	ADP
ajlm-297	107	5	the	the	DET
ajlm-297	107	6	blood	blood	NOUN
ajlm-297	107	7	donor	donor	NOUN
ajlm-297	107	8	samples	sample	NOUN
ajlm-297	107	9	,	,	PUNCT
ajlm-297	107	10	there	there	PRON
ajlm-297	107	11	were	be	VERB
ajlm-297	107	12	no	no	DET
ajlm-297	107	13	serological	serological	ADJ
ajlm-297	107	14	peculiarities	peculiarity	NOUN
ajlm-297	107	15	.	.	PUNCT
ajlm-297	108	1	fifty	fifty	NUM
ajlm-297	108	2	-	-	PUNCT
ajlm-297	108	3	one	one	NUM
ajlm-297	108	4	donors	donor	NOUN
ajlm-297	108	5	were	be	AUX
ajlm-297	108	6	phenotyped	phenotype	VERB
ajlm-297	108	7	for	for	ADP
ajlm-297	108	8	the	the	DET
ajlm-297	108	9	rhesus	rhesus	NOUN
ajlm-297	108	10	antigens	antigen	NOUN
ajlm-297	108	11	c	c	PROPN
ajlm-297	108	12	/	/	SYM
ajlm-297	108	13	c	c	NOUN
ajlm-297	108	14	,	,	PUNCT
ajlm-297	108	15	d	d	NOUN
ajlm-297	108	16	,	,	PUNCT
ajlm-297	108	17	e	e	NOUN
ajlm-297	108	18	/	/	SYM
ajlm-297	108	19	e	e	NOUN
ajlm-297	108	20	and	and	CCONJ
ajlm-297	108	21	for	for	ADP
ajlm-297	108	22	the	the	DET
ajlm-297	108	23	antigen	antigen	NOUN
ajlm-297	108	24	k	k	PROPN
ajlm-297	108	25	(	(	PUNCT
ajlm-297	108	26	table	table	NOUN
ajlm-297	108	27	4	4	NUM
ajlm-297	108	28	)	)	PUNCT
ajlm-297	108	29	.	.	PUNCT
ajlm-297	109	1	of	of	ADP
ajlm-297	109	2	these	these	PRON
ajlm-297	109	3	,	,	PUNCT
ajlm-297	109	4	29	29	NUM
ajlm-297	109	5	donors	donor	NOUN
ajlm-297	109	6	(	(	PUNCT
ajlm-297	109	7	57	57	NUM
ajlm-297	109	8	%	%	NOUN
ajlm-297	109	9	)	)	PUNCT
ajlm-297	109	10	showed	show	VERB
ajlm-297	109	11	the	the	DET
ajlm-297	109	12	rh	rh	PROPN
ajlm-297	109	13	phenotype	phenotype	NOUN
ajlm-297	109	14	ccd.ee	ccd.ee	PROPN
ajlm-297	109	15	,	,	PUNCT
ajlm-297	109	16	the	the	DET
ajlm-297	109	17	other	other	ADJ
ajlm-297	109	18	phenotypes	phenotype	NOUN
ajlm-297	109	19	were	be	AUX
ajlm-297	109	20	ccd.ee	ccd.ee	NOUN
ajlm-297	109	21	(	(	PUNCT
ajlm-297	109	22	n	n	NOUN
ajlm-297	109	23	=	=	NOUN
ajlm-297	109	24	13	13	NUM
ajlm-297	109	25	)	)	PUNCT
ajlm-297	109	26	,	,	PUNCT
ajlm-297	109	27	ccd.ee	ccd.ee	PROPN
ajlm-297	109	28	(	(	PUNCT
ajlm-297	109	29	n	n	NOUN
ajlm-297	109	30	=	=	SYM
ajlm-297	109	31	5	5	NUM
ajlm-297	109	32	)	)	PUNCT
ajlm-297	109	33	,	,	PUNCT
ajlm-297	109	34	ccddee	ccddee	X
ajlm-297	109	35	(	(	PUNCT
ajlm-297	109	36	n	n	NOUN
ajlm-297	109	37	=	=	SYM
ajlm-297	109	38	2	2	NUM
ajlm-297	109	39	)	)	PUNCT
ajlm-297	109	40	and	and	CCONJ
ajlm-297	109	41	single	single	ADJ
ajlm-297	109	42	cases	case	NOUN
ajlm-297	109	43	of	of	ADP
ajlm-297	109	44	ccddee	ccddee	PROPN
ajlm-297	109	45	(	(	PUNCT
ajlm-297	109	46	n	n	NOUN
ajlm-297	109	47	=	=	SYM
ajlm-297	109	48	1	1	NUM
ajlm-297	109	49	)	)	PUNCT
ajlm-297	109	50	and	and	CCONJ
ajlm-297	109	51	ccd.de	ccd.de	PROPN
ajlm-297	109	52	(	(	PUNCT
ajlm-297	109	53	n	n	NOUN
ajlm-297	109	54	=	=	SYM
ajlm-297	109	55	1	1	NUM
ajlm-297	109	56	)	)	PUNCT
ajlm-297	109	57	.	.	PUNCT
ajlm-297	110	1	none	none	NOUN
ajlm-297	110	2	of	of	ADP
ajlm-297	110	3	the	the	DET
ajlm-297	110	4	51	51	NUM
ajlm-297	110	5	donors	donor	NOUN
ajlm-297	110	6	were	be	AUX
ajlm-297	110	7	kell	kell	PROPN
ajlm-297	110	8	positive	positive	ADJ
ajlm-297	110	9	.	.	PUNCT
ajlm-297	111	1	table	table	NOUN
ajlm-297	111	2	4	4	NUM
ajlm-297	111	3	:	:	PUNCT
ajlm-297	111	4	 	 	SPACE
ajlm-297	111	5	rhesus	rhesus	NOUN
ajlm-297	111	6	and	and	CCONJ
ajlm-297	111	7	kell	kell	PROPN
ajlm-297	111	8	phenotypes	phenotype	NOUN
ajlm-297	111	9	amongst	amongst	ADP
ajlm-297	111	10	51	51	NUM
ajlm-297	111	11	healthy	healthy	ADJ
ajlm-297	111	12	kenyan	kenyan	ADJ
ajlm-297	111	13	blood	blood	NOUN
ajlm-297	111	14	donors	donor	NOUN
ajlm-297	111	15	at	at	ADP
ajlm-297	111	16	kenyatta	kenyatta	PROPN
ajlm-297	111	17	national	national	PROPN
ajlm-297	111	18	hospital	hospital	PROPN
ajlm-297	111	19	,	,	PUNCT
ajlm-297	111	20	2014	2014	NUM
ajlm-297	111	21	.	.	PUNCT
ajlm-297	112	1	discussion	discussion	NOUN
ajlm-297	112	2	top	top	PROPN
ajlm-297	112	3	↑	↑	PROPN
ajlm-297	112	4	the	the	DET
ajlm-297	112	5	risk	risk	NOUN
ajlm-297	112	6	of	of	ADP
ajlm-297	112	7	alloimmunisation	alloimmunisation	NOUN
ajlm-297	112	8	is	be	AUX
ajlm-297	112	9	a	a	DET
ajlm-297	112	10	concern	concern	NOUN
ajlm-297	112	11	that	that	PRON
ajlm-297	112	12	needs	need	VERB
ajlm-297	112	13	to	to	PART
ajlm-297	112	14	be	be	AUX
ajlm-297	112	15	addressed	address	VERB
ajlm-297	112	16	and	and	CCONJ
ajlm-297	112	17	managed	manage	VERB
ajlm-297	112	18	,	,	PUNCT
ajlm-297	112	19	especially	especially	ADV
ajlm-297	112	20	amongst	amongst	ADP
ajlm-297	112	21	patients	patient	NOUN
ajlm-297	112	22	requiring	require	VERB
ajlm-297	112	23	multiple	multiple	ADJ
ajlm-297	112	24	blood	blood	NOUN
ajlm-297	112	25	transfusions	transfusion	NOUN
ajlm-297	112	26	,	,	PUNCT
ajlm-297	112	27	such	such	ADJ
ajlm-297	112	28	as	as	ADP
ajlm-297	112	29	those	those	PRON
ajlm-297	112	30	with	with	ADP
ajlm-297	112	31	scd	scd	NOUN
ajlm-297	112	32	and	and	CCONJ
ajlm-297	112	33	malignances	malignance	NOUN
ajlm-297	112	34	.	.	PUNCT
ajlm-297	113	1	this	this	DET
ajlm-297	113	2	investigation	investigation	NOUN
ajlm-297	113	3	sought	seek	VERB
ajlm-297	113	4	to	to	PART
ajlm-297	113	5	determine	determine	VERB
ajlm-297	113	6	the	the	DET
ajlm-297	113	7	magnitude	magnitude	NOUN
ajlm-297	113	8	of	of	ADP
ajlm-297	113	9	rbc	rbc	PROPN
ajlm-297	113	10	immunisation	immunisation	NOUN
ajlm-297	113	11	and	and	CCONJ
ajlm-297	113	12	to	to	PART
ajlm-297	113	13	identify	identify	VERB
ajlm-297	113	14	antibodies	antibody	NOUN
ajlm-297	113	15	amongst	amongst	ADP
ajlm-297	113	16	two	two	NUM
ajlm-297	113	17	transfused	transfused	ADJ
ajlm-297	113	18	patient	patient	ADJ
ajlm-297	113	19	groups	group	NOUN
ajlm-297	113	20	.	.	PUNCT
ajlm-297	114	1	in	in	ADP
ajlm-297	114	2	this	this	DET
ajlm-297	114	3	study	study	NOUN
ajlm-297	114	4	,	,	PUNCT
ajlm-297	114	5	we	we	PRON
ajlm-297	114	6	detected	detect	VERB
ajlm-297	114	7	a	a	DET
ajlm-297	114	8	significant	significant	ADJ
ajlm-297	114	9	proportion	proportion	NOUN
ajlm-297	114	10	of	of	ADP
ajlm-297	114	11	patients	patient	NOUN
ajlm-297	114	12	with	with	ADP
ajlm-297	114	13	some	some	DET
ajlm-297	114	14	degree	degree	NOUN
ajlm-297	114	15	of	of	ADP
ajlm-297	114	16	rbc	rbc	PROPN
ajlm-297	114	17	autoimmunisation	autoimmunisation	NOUN
ajlm-297	114	18	,	,	PUNCT
ajlm-297	114	19	as	as	SCONJ
ajlm-297	114	20	shown	show	VERB
ajlm-297	114	21	by	by	ADP
ajlm-297	114	22	a	a	DET
ajlm-297	114	23	positive	positive	ADJ
ajlm-297	114	24	dat	dat	NOUN
ajlm-297	114	25	in	in	ADP
ajlm-297	114	26	14.0	14.0	NUM
ajlm-297	114	27	%	%	NOUN
ajlm-297	114	28	of	of	ADP
ajlm-297	114	29	the	the	DET
ajlm-297	114	30	patients	patient	NOUN
ajlm-297	114	31	,	,	PUNCT
ajlm-297	114	32	seven	seven	NUM
ajlm-297	114	33	of	of	ADP
ajlm-297	114	34	whom	whom	PRON
ajlm-297	114	35	had	have	VERB
ajlm-297	114	36	true	true	ADJ
ajlm-297	114	37	rbc	rbc	PROPN
ajlm-297	114	38	autoantibodies	autoantibody	NOUN
ajlm-297	114	39	.	.	PUNCT
ajlm-297	115	1	eighteen	eighteen	NUM
ajlm-297	115	2	per	per	ADP
ajlm-297	115	3	cent	cent	NOUN
ajlm-297	115	4	of	of	ADP
ajlm-297	115	5	scd	scd	NOUN
ajlm-297	115	6	patients	patient	NOUN
ajlm-297	115	7	were	be	AUX
ajlm-297	115	8	dat	dat	ADV
ajlm-297	115	9	positive	positive	ADJ
ajlm-297	115	10	compared	compare	VERB
ajlm-297	115	11	with	with	ADP
ajlm-297	115	12	8.8	8.8	NUM
ajlm-297	115	13	%	%	NOUN
ajlm-297	115	14	of	of	ADP
ajlm-297	115	15	hm	hm	INTJ
ajlm-297	115	16	/	/	SYM
ajlm-297	115	17	sm	sm	PROPN
ajlm-297	115	18	patients	patient	NOUN
ajlm-297	115	19	.	.	PUNCT
ajlm-297	116	1	in	in	ADP
ajlm-297	116	2	contrast	contrast	NOUN
ajlm-297	116	3	,	,	PUNCT
ajlm-297	116	4	rbc	rbc	PROPN
ajlm-297	116	5	alloab	alloab	PROPN
ajlm-297	116	6	formation	formation	NOUN
ajlm-297	116	7	was	be	AUX
ajlm-297	116	8	low	low	ADJ
ajlm-297	116	9	,	,	PUNCT
ajlm-297	116	10	at	at	ADP
ajlm-297	116	11	only	only	ADV
ajlm-297	116	12	2.6	2.6	NUM
ajlm-297	116	13	%	%	NOUN
ajlm-297	116	14	.	.	PUNCT
ajlm-297	117	1	moreover	moreover	ADV
ajlm-297	117	2	,	,	PUNCT
ajlm-297	117	3	the	the	DET
ajlm-297	117	4	specificities	specificity	NOUN
ajlm-297	117	5	of	of	ADP
ajlm-297	117	6	the	the	DET
ajlm-297	117	7	demonstrated	demonstrate	VERB
ajlm-297	117	8	alloabs	alloab	NOUN
ajlm-297	117	9	do	do	AUX
ajlm-297	117	10	not	not	PART
ajlm-297	117	11	occur	occur	VERB
ajlm-297	117	12	often	often	ADV
ajlm-297	117	13	in	in	ADP
ajlm-297	117	14	daily	daily	ADJ
ajlm-297	117	15	laboratory	laboratory	NOUN
ajlm-297	117	16	results	result	NOUN
ajlm-297	117	17	.	.	PUNCT
ajlm-297	118	1	anti	anti	ADJ
ajlm-297	118	2	-	-	ADJ
ajlm-297	118	3	cw	cw	ADJ
ajlm-297	118	4	and	and	CCONJ
ajlm-297	118	5	anti	anti	ADJ
ajlm-297	118	6	-	-	ADJ
ajlm-297	118	7	s	s	X
ajlm-297	118	8	are	be	AUX
ajlm-297	118	9	comparatively	comparatively	ADV
ajlm-297	118	10	rare	rare	ADJ
ajlm-297	118	11	rhand	rhand	NOUN
ajlm-297	118	12	mns	mns	PROPN
ajlm-297	118	13	antibodies	antibodie	VERB
ajlm-297	118	14	,	,	PUNCT
ajlm-297	118	15	respectively	respectively	ADV
ajlm-297	118	16	;	;	PUNCT
ajlm-297	118	17	and	and	CCONJ
ajlm-297	119	1	anti	anti	ADJ
ajlm-297	119	2	-	-	NOUN
ajlm-297	119	3	cob	cob	NOUN
ajlm-297	119	4	is	be	AUX
ajlm-297	119	5	a	a	DET
ajlm-297	119	6	very	very	ADV
ajlm-297	119	7	rare	rare	ADJ
ajlm-297	119	8	rbc	rbc	PROPN
ajlm-297	119	9	alloab	alloab	PROPN
ajlm-297	119	10	specificity	specificity	NOUN
ajlm-297	119	11	of	of	ADP
ajlm-297	119	12	the	the	DET
ajlm-297	119	13	colton	colton	PROPN
ajlm-297	119	14	system	system	NOUN
ajlm-297	119	15	.	.	PUNCT
ajlm-297	120	1	the	the	DET
ajlm-297	120	2	one	one	NUM
ajlm-297	120	3	example	example	NOUN
ajlm-297	120	4	of	of	ADP
ajlm-297	120	5	anti	anti	ADJ
ajlm-297	120	6	-	-	PROPN
ajlm-297	120	7	k	k	ADJ
ajlm-297	120	8	that	that	SCONJ
ajlm-297	120	9	we	we	PRON
ajlm-297	120	10	detected	detect	VERB
ajlm-297	120	11	was	be	AUX
ajlm-297	120	12	the	the	DET
ajlm-297	120	13	only	only	ADJ
ajlm-297	120	14	common	common	ADJ
ajlm-297	120	15	rbc	rbc	PROPN
ajlm-297	120	16	alloab	alloab	PROPN
ajlm-297	120	17	specificity	specificity	NOUN
ajlm-297	120	18	.	.	PUNCT
ajlm-297	121	1	other	other	ADJ
ajlm-297	121	2	common	common	ADJ
ajlm-297	121	3	rbc	rbc	PROPN
ajlm-297	121	4	alloab	alloab	PROPN
ajlm-297	121	5	specificities	specificity	NOUN
ajlm-297	121	6	,	,	PUNCT
ajlm-297	121	7	such	such	ADJ
ajlm-297	121	8	as	as	ADP
ajlm-297	121	9	anti	anti	ADJ
ajlm-297	121	10	-	-	ADJ
ajlm-297	121	11	d	d	ADJ
ajlm-297	121	12	,	,	PUNCT
ajlm-297	121	13	anti	anti	ADJ
ajlm-297	121	14	-	-	ADJ
ajlm-297	121	15	e	e	ADJ
ajlm-297	121	16	,	,	PUNCT
ajlm-297	121	17	anti	anti	ADJ
ajlm-297	121	18	-	-	ADJ
ajlm-297	121	19	c	c	ADJ
ajlm-297	121	20	,	,	PUNCT
ajlm-297	121	21	anti	anti	ADJ
ajlm-297	121	22	-	-	ADJ
ajlm-297	121	23	c	c	ADJ
ajlm-297	121	24	,	,	PUNCT
ajlm-297	121	25	belonging	belong	VERB
ajlm-297	121	26	to	to	ADP
ajlm-297	121	27	the	the	DET
ajlm-297	121	28	rhesus	rhesus	NOUN
ajlm-297	121	29	system	system	NOUN
ajlm-297	121	30	,	,	PUNCT
ajlm-297	121	31	or	or	CCONJ
ajlm-297	121	32	those	those	PRON
ajlm-297	121	33	of	of	ADP
ajlm-297	121	34	the	the	DET
ajlm-297	121	35	kell	kell	PROPN
ajlm-297	121	36	system	system	NOUN
ajlm-297	121	37	(	(	PUNCT
ajlm-297	121	38	other	other	ADJ
ajlm-297	121	39	than	than	ADP
ajlm-297	121	40	anti	anti	ADJ
ajlm-297	121	41	-	-	ADJ
ajlm-297	121	42	k	k	NOUN
ajlm-297	121	43	)	)	PUNCT
ajlm-297	121	44	,	,	PUNCT
ajlm-297	121	45	the	the	DET
ajlm-297	121	46	duffy	duffy	NOUN
ajlm-297	121	47	or	or	CCONJ
ajlm-297	121	48	the	the	DET
ajlm-297	121	49	kidd	kidd	PROPN
ajlm-297	121	50	blood	blood	NOUN
ajlm-297	121	51	group	group	NOUN
ajlm-297	121	52	systems	system	NOUN
ajlm-297	121	53	,	,	PUNCT
ajlm-297	121	54	were	be	AUX
ajlm-297	121	55	not	not	PART
ajlm-297	121	56	found	find	VERB
ajlm-297	121	57	in	in	ADP
ajlm-297	121	58	our	our	PRON
ajlm-297	121	59	study	study	NOUN
ajlm-297	121	60	population	population	NOUN
ajlm-297	121	61	.	.	PUNCT
ajlm-297	122	1	in	in	ADP
ajlm-297	122	2	this	this	DET
ajlm-297	122	3	study	study	NOUN
ajlm-297	122	4	,	,	PUNCT
ajlm-297	122	5	the	the	DET
ajlm-297	122	6	frequency	frequency	NOUN
ajlm-297	122	7	of	of	ADP
ajlm-297	122	8	alloimmunisation	alloimmunisation	NOUN
ajlm-297	122	9	across	across	ADP
ajlm-297	122	10	all	all	DET
ajlm-297	122	11	patients	patient	NOUN
ajlm-297	122	12	was	be	AUX
ajlm-297	122	13	determined	determine	VERB
ajlm-297	122	14	to	to	PART
ajlm-297	122	15	be	be	AUX
ajlm-297	122	16	2.6	2.6	NUM
ajlm-297	122	17	%	%	NOUN
ajlm-297	122	18	;	;	PUNCT
ajlm-297	122	19	and	and	CCONJ
ajlm-297	122	20	the	the	DET
ajlm-297	122	21	rate	rate	NOUN
ajlm-297	122	22	of	of	ADP
ajlm-297	122	23	alloab	alloab	PROPN
ajlm-297	122	24	formation	formation	NOUN
ajlm-297	122	25	was	be	AUX
ajlm-297	122	26	2.2	2.2	NUM
ajlm-297	122	27	%	%	NOUN
ajlm-297	122	28	amongst	amongst	ADP
ajlm-297	122	29	patients	patient	NOUN
ajlm-297	122	30	with	with	ADP
ajlm-297	122	31	malignancies	malignancy	NOUN
ajlm-297	122	32	and	and	CCONJ
ajlm-297	122	33	2.9	2.9	NUM
ajlm-297	122	34	%	%	NOUN
ajlm-297	122	35	amongst	amongst	ADP
ajlm-297	122	36	scd	scd	PROPN
ajlm-297	122	37	patients	patient	NOUN
ajlm-297	122	38	.	.	PUNCT
ajlm-297	123	1	there	there	PRON
ajlm-297	123	2	may	may	AUX
ajlm-297	123	3	be	be	AUX
ajlm-297	123	4	several	several	ADJ
ajlm-297	123	5	reasons	reason	NOUN
ajlm-297	123	6	for	for	ADP
ajlm-297	123	7	these	these	DET
ajlm-297	123	8	unexpected	unexpected	ADJ
ajlm-297	123	9	findings	finding	NOUN
ajlm-297	123	10	.	.	PUNCT
ajlm-297	124	1	firstly	firstly	ADV
ajlm-297	124	2	,	,	PUNCT
ajlm-297	124	3	the	the	DET
ajlm-297	124	4	total	total	ADJ
ajlm-297	124	5	numbers	number	NOUN
ajlm-297	124	6	of	of	ADP
ajlm-297	124	7	transfusions	transfusion	NOUN
ajlm-297	124	8	and	and	CCONJ
ajlm-297	124	9	the	the	DET
ajlm-297	124	10	numbers	number	NOUN
ajlm-297	124	11	of	of	ADP
ajlm-297	124	12	transfusion	transfusion	NOUN
ajlm-297	124	13	events	event	NOUN
ajlm-297	124	14	were	be	AUX
ajlm-297	124	15	low	low	ADJ
ajlm-297	124	16	,	,	PUNCT
ajlm-297	124	17	never	never	ADV
ajlm-297	124	18	exceeding	exceed	VERB
ajlm-297	124	19	the	the	DET
ajlm-297	124	20	mean	mean	ADJ
ajlm-297	124	21	values	value	NOUN
ajlm-297	124	22	of	of	ADP
ajlm-297	124	23	three	three	NUM
ajlm-297	124	24	transfusion	transfusion	NOUN
ajlm-297	124	25	events	event	NOUN
ajlm-297	124	26	per	per	ADP
ajlm-297	124	27	patient	patient	NOUN
ajlm-297	124	28	.	.	PUNCT
ajlm-297	125	1	this	this	PRON
ajlm-297	125	2	was	be	AUX
ajlm-297	125	3	particularly	particularly	ADV
ajlm-297	125	4	true	true	ADJ
ajlm-297	125	5	for	for	ADP
ajlm-297	125	6	the	the	DET
ajlm-297	125	7	scd	scd	PROPN
ajlm-297	125	8	patients	patient	NOUN
ajlm-297	125	9	,	,	PUNCT
ajlm-297	125	10	who	who	PRON
ajlm-297	125	11	are	be	AUX
ajlm-297	125	12	known	know	VERB
ajlm-297	125	13	to	to	PART
ajlm-297	125	14	be	be	AUX
ajlm-297	125	15	at	at	ADP
ajlm-297	125	16	high	high	ADJ
ajlm-297	125	17	risk	risk	NOUN
ajlm-297	125	18	for	for	ADP
ajlm-297	125	19	rbc	rbc	PROPN
ajlm-297	125	20	alloab	alloab	PROPN
ajlm-297	125	21	formation.3,10,19	formation.3,10,19	PROPN
ajlm-297	125	22	however	however	ADV
ajlm-297	125	23	,	,	PUNCT
ajlm-297	125	24	scd	scd	PROPN
ajlm-297	125	25	patients	patient	NOUN
ajlm-297	125	26	showed	show	VERB
ajlm-297	125	27	the	the	DET
ajlm-297	125	28	lowest	low	ADJ
ajlm-297	125	29	values	value	NOUN
ajlm-297	125	30	for	for	ADP
ajlm-297	125	31	transfused	transfused	ADJ
ajlm-297	125	32	rbc	rbc	PROPN
ajlm-297	125	33	units	unit	NOUN
ajlm-297	125	34	per	per	ADP
ajlm-297	125	35	patient	patient	NOUN
ajlm-297	125	36	and	and	CCONJ
ajlm-297	125	37	transfusion	transfusion	NOUN
ajlm-297	125	38	events	event	NOUN
ajlm-297	125	39	per	per	ADP
ajlm-297	125	40	patient	patient	NOUN
ajlm-297	125	41	in	in	ADP
ajlm-297	125	42	our	our	PRON
ajlm-297	125	43	study	study	NOUN
ajlm-297	125	44	.	.	PUNCT
ajlm-297	126	1	the	the	DET
ajlm-297	126	2	rbc	rbc	PROPN
ajlm-297	126	3	alloimmunisation	alloimmunisation	NOUN
ajlm-297	126	4	rate	rate	NOUN
ajlm-297	126	5	of	of	ADP
ajlm-297	126	6	2.9	2.9	NUM
ajlm-297	126	7	%	%	NOUN
ajlm-297	126	8	amongst	amongst	ADP
ajlm-297	126	9	our	our	PRON
ajlm-297	126	10	scd	scd	NOUN
ajlm-297	126	11	patients	patient	NOUN
ajlm-297	126	12	is	be	AUX
ajlm-297	126	13	comparable	comparable	ADJ
ajlm-297	126	14	to	to	ADP
ajlm-297	126	15	a	a	DET
ajlm-297	126	16	study	study	NOUN
ajlm-297	126	17	in	in	ADP
ajlm-297	126	18	a	a	DET
ajlm-297	126	19	jamaican	jamaican	ADJ
ajlm-297	126	20	cohort,19	cohort,19	NOUN
ajlm-297	126	21	where	where	SCONJ
ajlm-297	126	22	the	the	DET
ajlm-297	126	23	rate	rate	NOUN
ajlm-297	126	24	was	be	AUX
ajlm-297	126	25	2.6	2.6	NUM
ajlm-297	126	26	%	%	NOUN
ajlm-297	126	27	amongst	amongst	ADP
ajlm-297	126	28	115	115	NUM
ajlm-297	126	29	transfused	transfuse	VERB
ajlm-297	126	30	scd	scd	NOUN
ajlm-297	126	31	patients	patient	NOUN
ajlm-297	126	32	and	and	CCONJ
ajlm-297	126	33	1.6	1.6	NUM
ajlm-297	126	34	%	%	NOUN
ajlm-297	126	35	amongst	amongst	ADP
ajlm-297	126	36	the	the	DET
ajlm-297	126	37	total	total	ADJ
ajlm-297	126	38	number	number	NOUN
ajlm-297	126	39	of	of	ADP
ajlm-297	126	40	190	190	NUM
ajlm-297	126	41	patients	patient	NOUN
ajlm-297	126	42	.	.	PUNCT
ajlm-297	127	1	however	however	ADV
ajlm-297	127	2	,	,	PUNCT
ajlm-297	127	3	this	this	DET
ajlm-297	127	4	rate	rate	NOUN
ajlm-297	127	5	differs	differ	VERB
ajlm-297	127	6	considerably	considerably	ADV
ajlm-297	127	7	from	from	ADP
ajlm-297	127	8	that	that	PRON
ajlm-297	127	9	reported	report	VERB
ajlm-297	127	10	in	in	ADP
ajlm-297	127	11	a	a	DET
ajlm-297	127	12	ugandan	ugandan	ADJ
ajlm-297	127	13	study	study	NOUN
ajlm-297	127	14	of	of	ADP
ajlm-297	127	15	428	428	NUM
ajlm-297	127	16	scd	scd	NOUN
ajlm-297	127	17	patients	patient	NOUN
ajlm-297	127	18	,	,	PUNCT
ajlm-297	127	19	where	where	SCONJ
ajlm-297	127	20	the	the	DET
ajlm-297	127	21	prevalence	prevalence	NOUN
ajlm-297	127	22	rate	rate	NOUN
ajlm-297	127	23	was	be	AUX
ajlm-297	127	24	6.1%.3	6.1%.3	ADJ
ajlm-297	127	25	although	although	SCONJ
ajlm-297	127	26	the	the	DET
ajlm-297	127	27	mean	mean	ADJ
ajlm-297	127	28	number	number	NOUN
ajlm-297	127	29	of	of	ADP
ajlm-297	127	30	transfusions	transfusion	NOUN
ajlm-297	127	31	was	be	AUX
ajlm-297	127	32	three	three	NUM
ajlm-297	127	33	blood	blood	NOUN
ajlm-297	127	34	units	unit	NOUN
ajlm-297	127	35	in	in	ADP
ajlm-297	127	36	all	all	PRON
ajlm-297	127	37	of	of	ADP
ajlm-297	127	38	these	these	DET
ajlm-297	127	39	studies	study	NOUN
ajlm-297	127	40	,	,	PUNCT
ajlm-297	127	41	21	21	NUM
ajlm-297	127	42	of	of	ADP
ajlm-297	127	43	the	the	DET
ajlm-297	127	44	26	26	NUM
ajlm-297	127	45	alloimmunised	alloimmunise	VERB
ajlm-297	127	46	patients	patient	NOUN
ajlm-297	127	47	in	in	ADP
ajlm-297	127	48	the	the	DET
ajlm-297	127	49	ugandan	ugandan	PROPN
ajlm-297	127	50	study	study	NOUN
ajlm-297	127	51	had	have	AUX
ajlm-297	127	52	received	receive	VERB
ajlm-297	127	53	up	up	ADP
ajlm-297	127	54	to	to	PART
ajlm-297	127	55	10	10	NUM
ajlm-297	127	56	blood	blood	NOUN
ajlm-297	127	57	units	unit	NOUN
ajlm-297	127	58	.	.	PUNCT
ajlm-297	128	1	this	this	PRON
ajlm-297	128	2	is	be	AUX
ajlm-297	128	3	marginally	marginally	ADV
ajlm-297	128	4	higher	high	ADJ
ajlm-297	128	5	than	than	ADP
ajlm-297	128	6	the	the	DET
ajlm-297	128	7	maximum	maximum	ADJ
ajlm-297	128	8	number	number	NOUN
ajlm-297	128	9	(	(	PUNCT
ajlm-297	128	10	n	n	NOUN
ajlm-297	128	11	=	=	SYM
ajlm-297	128	12	8)	8)	NUM
ajlm-297	128	13	of	of	ADP
ajlm-297	128	14	transfusions	transfusion	NOUN
ajlm-297	128	15	observed	observe	VERB
ajlm-297	128	16	in	in	ADP
ajlm-297	128	17	our	our	PRON
ajlm-297	128	18	study	study	NOUN
ajlm-297	128	19	.	.	PUNCT
ajlm-297	129	1	our	our	PRON
ajlm-297	129	2	scd	scd	NOUN
ajlm-297	129	3	patients	patient	NOUN
ajlm-297	129	4	received	receive	VERB
ajlm-297	129	5	a	a	DET
ajlm-297	129	6	mean	mean	NOUN
ajlm-297	129	7	of	of	ADP
ajlm-297	129	8	2.4	2.4	NUM
ajlm-297	129	9	units	unit	NOUN
ajlm-297	129	10	of	of	ADP
ajlm-297	129	11	transfusions	transfusion	NOUN
ajlm-297	129	12	,	,	PUNCT
ajlm-297	129	13	hm	hm	PRON
ajlm-297	129	14	patients	patient	NOUN
ajlm-297	129	15	received	receive	VERB
ajlm-297	129	16	4.7	4.7	NUM
ajlm-297	129	17	units	unit	NOUN
ajlm-297	129	18	and	and	CCONJ
ajlm-297	129	19	sm	sm	PROPN
ajlm-297	129	20	patients	patient	NOUN
ajlm-297	129	21	received	receive	VERB
ajlm-297	129	22	3.0	3.0	NUM
ajlm-297	129	23	units	unit	NOUN
ajlm-297	129	24	.	.	PUNCT
ajlm-297	130	1	therefore	therefore	ADV
ajlm-297	130	2	,	,	PUNCT
ajlm-297	130	3	all	all	DET
ajlm-297	130	4	groups	group	NOUN
ajlm-297	130	5	were	be	AUX
ajlm-297	130	6	exposed	expose	VERB
ajlm-297	130	7	to	to	ADP
ajlm-297	130	8	minimal	minimal	ADJ
ajlm-297	130	9	antigenic	antigenic	ADJ
ajlm-297	130	10	challenge	challenge	NOUN
ajlm-297	130	11	.	.	PUNCT
ajlm-297	131	1	numerous	numerous	ADJ
ajlm-297	131	2	studies	study	NOUN
ajlm-297	131	3	have	have	AUX
ajlm-297	131	4	reported	report	VERB
ajlm-297	131	5	that	that	SCONJ
ajlm-297	131	6	the	the	DET
ajlm-297	131	7	rate	rate	NOUN
ajlm-297	131	8	of	of	ADP
ajlm-297	131	9	rbc	rbc	PROPN
ajlm-297	131	10	alloimmunisation	alloimmunisation	NOUN
ajlm-297	131	11	increases	increase	VERB
ajlm-297	131	12	with	with	ADP
ajlm-297	131	13	the	the	DET
ajlm-297	131	14	number	number	NOUN
ajlm-297	131	15	of	of	ADP
ajlm-297	131	16	transfusions.3,10,19,20,21,22	transfusions.3,10,19,20,21,22	PRON
ajlm-297	131	17	this	this	PRON
ajlm-297	131	18	could	could	AUX
ajlm-297	131	19	explain	explain	VERB
ajlm-297	131	20	the	the	DET
ajlm-297	131	21	low	low	ADJ
ajlm-297	131	22	alloimmunisation	alloimmunisation	NOUN
ajlm-297	131	23	rate	rate	NOUN
ajlm-297	131	24	amongst	amongst	ADP
ajlm-297	131	25	our	our	PRON
ajlm-297	131	26	study	study	NOUN
ajlm-297	131	27	participants	participant	NOUN
ajlm-297	131	28	compared	compare	VERB
ajlm-297	131	29	with	with	ADP
ajlm-297	131	30	their	their	PRON
ajlm-297	131	31	counterparts	counterpart	NOUN
ajlm-297	131	32	in	in	ADP
ajlm-297	131	33	developed	develop	VERB
ajlm-297	131	34	countries	country	NOUN
ajlm-297	131	35	who	who	PRON
ajlm-297	131	36	received	receive	VERB
ajlm-297	131	37	more	more	ADJ
ajlm-297	131	38	transfusions	transfusion	NOUN
ajlm-297	131	39	.	.	PUNCT
ajlm-297	132	1	secondly	secondly	ADV
ajlm-297	132	2	,	,	PUNCT
ajlm-297	132	3	many	many	ADJ
ajlm-297	132	4	other	other	ADJ
ajlm-297	132	5	studies	study	NOUN
ajlm-297	132	6	have	have	AUX
ajlm-297	132	7	reported	report	VERB
ajlm-297	132	8	higher	high	ADJ
ajlm-297	132	9	percentages	percentage	NOUN
ajlm-297	132	10	of	of	ADP
ajlm-297	132	11	rbc	rbc	PROPN
ajlm-297	132	12	alloimmunisation	alloimmunisation	PROPN
ajlm-297	132	13	in	in	ADP
ajlm-297	132	14	haemoglo­binopathies	haemoglo­binopathie	NOUN
ajlm-297	132	15	,	,	PUNCT
ajlm-297	132	16	such	such	ADJ
ajlm-297	132	17	as	as	ADP
ajlm-297	132	18	scd	scd	NOUN
ajlm-297	132	19	or	or	CCONJ
ajlm-297	132	20	thalassaemia	thalassaemia	NOUN
ajlm-297	132	21	,	,	PUNCT
ajlm-297	132	22	including	include	VERB
ajlm-297	132	23	uganda3	uganda3	NOUN
ajlm-297	132	24	(	(	PUNCT
ajlm-297	132	25	scd	scd	PROPN
ajlm-297	132	26	,	,	PUNCT
ajlm-297	132	27	alloab	alloab	NOUN
ajlm-297	132	28	6.1	6.1	NUM
ajlm-297	132	29	%	%	NOUN
ajlm-297	132	30	amongst	amongst	ADP
ajlm-297	132	31	428	428	NUM
ajlm-297	132	32	patients	patient	NOUN
ajlm-297	132	33	)	)	PUNCT
ajlm-297	132	34	,	,	PUNCT
ajlm-297	132	35	tunisia21	tunisia21	NOUN
ajlm-297	132	36	(	(	PUNCT
ajlm-297	132	37	scd	scd	NOUN
ajlm-297	132	38	and	and	CCONJ
ajlm-297	132	39	thalassaemia	thalassaemia	NOUN
ajlm-297	132	40	,	,	PUNCT
ajlm-297	132	41	alloab	alloab	PROPN
ajlm-297	132	42	7.8	7.8	NUM
ajlm-297	132	43	%	%	NOUN
ajlm-297	132	44	amongst	amongst	ADP
ajlm-297	132	45	309	309	NUM
ajlm-297	132	46	patients	patient	NOUN
ajlm-297	132	47	)	)	PUNCT
ajlm-297	132	48	,	,	PUNCT
ajlm-297	132	49	italy23	italy23	NOUN
ajlm-297	132	50	(	(	PUNCT
ajlm-297	132	51	thalassaemia	thalassaemia	NOUN
ajlm-297	132	52	,	,	PUNCT
ajlm-297	132	53	alloab	alloab	PROPN
ajlm-297	132	54	5	5	NUM
ajlm-297	132	55	%	%	NOUN
ajlm-297	132	56	amongst	amongst	ADP
ajlm-297	132	57	1435	1435	NUM
ajlm-297	132	58	patients	patient	NOUN
ajlm-297	132	59	)	)	PUNCT
ajlm-297	132	60	and	and	CCONJ
ajlm-297	132	61	brazil24	brazil24	NOUN
ajlm-297	132	62	(	(	PUNCT
ajlm-297	132	63	scd	scd	PROPN
ajlm-297	132	64	,	,	PUNCT
ajlm-297	132	65	alloab	alloab	PROPN
ajlm-297	132	66	9.9	9.9	NUM
ajlm-297	132	67	%	%	NOUN
ajlm-297	132	68	amongst	amongst	ADP
ajlm-297	132	69	828	828	NUM
ajlm-297	132	70	patients	patient	NOUN
ajlm-297	132	71	)	)	PUNCT
ajlm-297	132	72	.	.	PUNCT
ajlm-297	133	1	these	these	DET
ajlm-297	133	2	studies	study	NOUN
ajlm-297	133	3	included	include	VERB
ajlm-297	133	4	a	a	DET
ajlm-297	133	5	significantly	significantly	ADV
ajlm-297	133	6	higher	high	ADJ
ajlm-297	133	7	number	number	NOUN
ajlm-297	133	8	of	of	ADP
ajlm-297	133	9	patients	patient	NOUN
ajlm-297	133	10	;	;	PUNCT
ajlm-297	133	11	thus	thus	ADV
ajlm-297	133	12	,	,	PUNCT
ajlm-297	133	13	the	the	DET
ajlm-297	133	14	relatively	relatively	ADV
ajlm-297	133	15	low	low	ADJ
ajlm-297	133	16	number	number	NOUN
ajlm-297	133	17	of	of	ADP
ajlm-297	133	18	patients	patient	NOUN
ajlm-297	133	19	in	in	ADP
ajlm-297	133	20	our	our	PRON
ajlm-297	133	21	study	study	NOUN
ajlm-297	133	22	might	might	AUX
ajlm-297	133	23	be	be	AUX
ajlm-297	133	24	a	a	DET
ajlm-297	133	25	second	second	ADJ
ajlm-297	133	26	limiting	limit	VERB
ajlm-297	133	27	factor	factor	NOUN
ajlm-297	133	28	.	.	PUNCT
ajlm-297	134	1	the	the	DET
ajlm-297	134	2	low	low	ADJ
ajlm-297	134	3	rates	rate	NOUN
ajlm-297	134	4	in	in	ADP
ajlm-297	134	5	our	our	PRON
ajlm-297	134	6	study	study	NOUN
ajlm-297	134	7	also	also	ADV
ajlm-297	134	8	differ	differ	VERB
ajlm-297	134	9	from	from	ADP
ajlm-297	134	10	studies	study	NOUN
ajlm-297	134	11	conducted	conduct	VERB
ajlm-297	134	12	in	in	ADP
ajlm-297	134	13	populations	population	NOUN
ajlm-297	134	14	where	where	SCONJ
ajlm-297	134	15	there	there	PRON
ajlm-297	134	16	is	be	VERB
ajlm-297	134	17	high	high	ADJ
ajlm-297	134	18	heterogeneity	heterogeneity	NOUN
ajlm-297	134	19	between	between	ADP
ajlm-297	134	20	donors	donor	NOUN
ajlm-297	134	21	and	and	CCONJ
ajlm-297	134	22	patients	patient	NOUN
ajlm-297	134	23	.	.	PUNCT
ajlm-297	135	1	in	in	ADP
ajlm-297	135	2	a	a	DET
ajlm-297	135	3	study	study	NOUN
ajlm-297	135	4	by	by	ADP
ajlm-297	135	5	rosse	rosse	PROPN
ajlm-297	135	6	et	et	PROPN
ajlm-297	135	7	al	al	PROPN
ajlm-297	135	8	.	.	PROPN
ajlm-297	135	9	,10	,10	PUNCT
ajlm-297	135	10	involving	involve	VERB
ajlm-297	135	11	1814	1814	NUM
ajlm-297	135	12	scd	scd	NOUN
ajlm-297	135	13	patients	patient	NOUN
ajlm-297	135	14	with	with	ADP
ajlm-297	135	15	an	an	DET
ajlm-297	135	16	rbc	rbc	PROPN
ajlm-297	135	17	alloimmunisation	alloimmunisation	NOUN
ajlm-297	135	18	rate	rate	NOUN
ajlm-297	135	19	of	of	ADP
ajlm-297	135	20	18.6	18.6	NUM
ajlm-297	135	21	%	%	NOUN
ajlm-297	135	22	,	,	PUNCT
ajlm-297	135	23	the	the	DET
ajlm-297	135	24	donors	donor	NOUN
ajlm-297	135	25	were	be	AUX
ajlm-297	135	26	of	of	ADP
ajlm-297	135	27	european	european	ADJ
ajlm-297	135	28	-	-	PUNCT
ajlm-297	135	29	american	american	PROPN
ajlm-297	135	30	ancestry	ancestry	NOUN
ajlm-297	135	31	and	and	CCONJ
ajlm-297	135	32	the	the	DET
ajlm-297	135	33	scd	scd	NOUN
ajlm-297	135	34	patients	patient	NOUN
ajlm-297	135	35	were	be	AUX
ajlm-297	135	36	of	of	ADP
ajlm-297	135	37	african	african	ADJ
ajlm-297	135	38	-	-	PUNCT
ajlm-297	135	39	american	american	ADJ
ajlm-297	135	40	ancestry	ancestry	NOUN
ajlm-297	135	41	.	.	PUNCT
ajlm-297	136	1	thirdly	thirdly	ADV
ajlm-297	136	2	,	,	PUNCT
ajlm-297	136	3	patients	patient	NOUN
ajlm-297	136	4	in	in	ADP
ajlm-297	136	5	our	our	PRON
ajlm-297	136	6	study	study	NOUN
ajlm-297	136	7	were	be	AUX
ajlm-297	136	8	predominantly	predominantly	ADV
ajlm-297	136	9	children	child	NOUN
ajlm-297	136	10	aged	age	VERB
ajlm-297	136	11	16	16	NUM
ajlm-297	136	12	years	year	NOUN
ajlm-297	136	13	or	or	CCONJ
ajlm-297	136	14	younger	young	ADJ
ajlm-297	136	15	(	(	PUNCT
ajlm-297	136	16	n	n	NOUN
ajlm-297	136	17	=	=	SYM
ajlm-297	136	18	159	159	NUM
ajlm-297	136	19	;	;	PUNCT
ajlm-297	136	20	70	70	NUM
ajlm-297	136	21	%	%	NOUN
ajlm-297	136	22	)	)	PUNCT
ajlm-297	136	23	,	,	PUNCT
ajlm-297	136	24	14	14	NUM
ajlm-297	136	25	%	%	NOUN
ajlm-297	136	26	were	be	AUX
ajlm-297	136	27	aged	age	VERB
ajlm-297	136	28	≤	≤	NUM
ajlm-297	136	29	3	3	NUM
ajlm-297	136	30	years	year	NOUN
ajlm-297	136	31	.	.	PUNCT
ajlm-297	137	1	studies	study	NOUN
ajlm-297	137	2	of	of	ADP
ajlm-297	137	3	paediatric	paediatric	ADJ
ajlm-297	137	4	patients	patient	NOUN
ajlm-297	137	5	have	have	AUX
ajlm-297	137	6	reported	report	VERB
ajlm-297	137	7	lower	low	ADJ
ajlm-297	137	8	rbc	rbc	PROPN
ajlm-297	137	9	alloimmunisation	alloimmunisation	NOUN
ajlm-297	137	10	rates	rate	NOUN
ajlm-297	137	11	.	.	PUNCT
ajlm-297	138	1	aygun	aygun	VERB
ajlm-297	138	2	et	et	NOUN
ajlm-297	138	3	al.25	al.25	ADV
ajlm-297	138	4	and	and	CCONJ
ajlm-297	138	5	sarnaik	sarnaik	NOUN
ajlm-297	138	6	et	et	PROPN
ajlm-297	138	7	al.21	al.21	PROPN
ajlm-297	138	8	concluded	conclude	VERB
ajlm-297	138	9	that	that	SCONJ
ajlm-297	138	10	children	child	NOUN
ajlm-297	138	11	with	with	ADP
ajlm-297	138	12	scd	scd	PROPN
ajlm-297	138	13	who	who	PRON
ajlm-297	138	14	were	be	AUX
ajlm-297	138	15	hypertransfused	hypertransfuse	VERB
ajlm-297	138	16	had	have	VERB
ajlm-297	138	17	a	a	DET
ajlm-297	138	18	lower	low	ADJ
ajlm-297	138	19	frequency	frequency	NOUN
ajlm-297	138	20	of	of	ADP
ajlm-297	138	21	alloimmunisation	alloimmunisation	NOUN
ajlm-297	138	22	as	as	SCONJ
ajlm-297	138	23	compared	compare	VERB
ajlm-297	138	24	with	with	ADP
ajlm-297	138	25	adults.21	adults.21	PROPN
ajlm-297	138	26	another	another	DET
ajlm-297	138	27	study	study	NOUN
ajlm-297	138	28	involving	involve	VERB
ajlm-297	138	29	167	167	NUM
ajlm-297	138	30	paediatric	paediatric	ADJ
ajlm-297	138	31	and	and	CCONJ
ajlm-297	138	32	62	62	NUM
ajlm-297	138	33	adult	adult	NOUN
ajlm-297	138	34	scd	scd	NOUN
ajlm-297	138	35	patients	patient	NOUN
ajlm-297	138	36	supported	support	VERB
ajlm-297	138	37	this	this	DET
ajlm-297	138	38	observation	observation	NOUN
ajlm-297	138	39	,	,	PUNCT
ajlm-297	138	40	where	where	SCONJ
ajlm-297	138	41	the	the	DET
ajlm-297	138	42	rates	rate	NOUN
ajlm-297	138	43	of	of	ADP
ajlm-297	138	44	alloand	alloand	PROPN
ajlm-297	138	45	autoimmunisation	autoimmunisation	NOUN
ajlm-297	138	46	in	in	ADP
ajlm-297	138	47	children	child	NOUN
ajlm-297	138	48	and	and	CCONJ
ajlm-297	138	49	adults	adult	NOUN
ajlm-297	138	50	were	be	AUX
ajlm-297	138	51	29	29	NUM
ajlm-297	138	52	%	%	NOUN
ajlm-297	138	53	and	and	CCONJ
ajlm-297	138	54	8	8	NUM
ajlm-297	138	55	%	%	NOUN
ajlm-297	138	56	;	;	PUNCT
ajlm-297	138	57	47	47	NUM
ajlm-297	138	58	%	%	NOUN
ajlm-297	138	59	and	and	CCONJ
ajlm-297	138	60	9.7	9.7	NUM
ajlm-297	138	61	%	%	NOUN
ajlm-297	138	62	,	,	PUNCT
ajlm-297	138	63	respectively.26	respectively.26	VERB
ajlm-297	138	64	other	other	ADJ
ajlm-297	138	65	authors	author	NOUN
ajlm-297	138	66	advocate	advocate	VERB
ajlm-297	138	67	that	that	SCONJ
ajlm-297	138	68	transfusion	transfusion	NOUN
ajlm-297	138	69	started	start	VERB
ajlm-297	138	70	when	when	SCONJ
ajlm-297	138	71	patients	patient	NOUN
ajlm-297	138	72	are	be	AUX
ajlm-297	138	73	young	young	ADJ
ajlm-297	138	74	(	(	PUNCT
ajlm-297	138	75	aged	aged	ADJ
ajlm-297	138	76	1–3	1–3	NUM
ajlm-297	138	77	years	year	NOUN
ajlm-297	138	78	)	)	PUNCT
ajlm-297	138	79	may	may	AUX
ajlm-297	138	80	induce	induce	VERB
ajlm-297	138	81	immune	immune	ADJ
ajlm-297	138	82	tolerance	tolerance	NOUN
ajlm-297	138	83	against	against	ADP
ajlm-297	138	84	alloimmunisation.9	alloimmunisation.9	PROPN
ajlm-297	138	85	the	the	DET
ajlm-297	138	86	fact	fact	NOUN
ajlm-297	138	87	that	that	SCONJ
ajlm-297	138	88	14	14	NUM
ajlm-297	138	89	%	%	NOUN
ajlm-297	138	90	of	of	ADP
ajlm-297	138	91	our	our	PRON
ajlm-297	138	92	study	study	NOUN
ajlm-297	138	93	patients	patient	NOUN
ajlm-297	138	94	were	be	AUX
ajlm-297	138	95	aged	age	VERB
ajlm-297	138	96	≤	≤	NUM
ajlm-297	138	97	3	3	NUM
ajlm-297	138	98	years	year	NOUN
ajlm-297	138	99	could	could	AUX
ajlm-297	138	100	have	have	AUX
ajlm-297	138	101	contributed	contribute	VERB
ajlm-297	138	102	to	to	ADP
ajlm-297	138	103	the	the	DET
ajlm-297	138	104	low	low	ADJ
ajlm-297	138	105	rate	rate	NOUN
ajlm-297	138	106	of	of	ADP
ajlm-297	138	107	rbc	rbc	PROPN
ajlm-297	138	108	alloab	alloab	PROPN
ajlm-297	138	109	formation	formation	NOUN
ajlm-297	138	110	that	that	PRON
ajlm-297	138	111	we	we	PRON
ajlm-297	138	112	observed	observe	VERB
ajlm-297	138	113	.	.	PUNCT
ajlm-297	139	1	fourth	fourth	ADV
ajlm-297	139	2	,	,	PUNCT
ajlm-297	139	3	the	the	DET
ajlm-297	139	4	prevalence	prevalence	NOUN
ajlm-297	139	5	of	of	ADP
ajlm-297	139	6	rbc	rbc	PROPN
ajlm-297	139	7	alloimmunisation	alloimmunisation	NOUN
ajlm-297	139	8	amongst	amongst	ADP
ajlm-297	139	9	our	our	PRON
ajlm-297	139	10	cancer	cancer	NOUN
ajlm-297	139	11	patients	patient	NOUN
ajlm-297	139	12	was	be	AUX
ajlm-297	139	13	low	low	ADJ
ajlm-297	139	14	(	(	PUNCT
ajlm-297	139	15	2.2	2.2	NUM
ajlm-297	139	16	%	%	NOUN
ajlm-297	139	17	)	)	PUNCT
ajlm-297	139	18	,	,	PUNCT
ajlm-297	139	19	with	with	ADP
ajlm-297	139	20	only	only	ADV
ajlm-297	139	21	two	two	NUM
ajlm-297	139	22	hm	hm	INTJ
ajlm-297	139	23	patients	patient	NOUN
ajlm-297	139	24	and	and	CCONJ
ajlm-297	139	25	no	no	DET
ajlm-297	139	26	alloabs	alloab	NOUN
ajlm-297	139	27	amongst	amongst	ADP
ajlm-297	139	28	sm	sm	PROPN
ajlm-297	139	29	patients	patient	NOUN
ajlm-297	139	30	.	.	PUNCT
ajlm-297	140	1	this	this	PRON
ajlm-297	140	2	is	be	AUX
ajlm-297	140	3	lower	low	ADJ
ajlm-297	140	4	than	than	ADP
ajlm-297	140	5	that	that	PRON
ajlm-297	140	6	in	in	ADP
ajlm-297	140	7	the	the	DET
ajlm-297	140	8	ugandan	ugandan	PROPN
ajlm-297	140	9	study	study	NOUN
ajlm-297	140	10	,	,	PUNCT
ajlm-297	140	11	where	where	SCONJ
ajlm-297	140	12	the	the	DET
ajlm-297	140	13	rate	rate	NOUN
ajlm-297	140	14	was	be	AUX
ajlm-297	140	15	8.3	8.3	NUM
ajlm-297	140	16	%	%	NOUN
ajlm-297	140	17	amongst	amongst	ADP
ajlm-297	140	18	cancer	cancer	NOUN
ajlm-297	140	19	patients	patient	NOUN
ajlm-297	140	20	.	.	PUNCT
ajlm-297	141	1	shahida	shahida	NOUN
ajlm-297	141	2	et	et	PROPN
ajlm-297	141	3	al.22	al.22	PROPN
ajlm-297	141	4	studied	study	VERB
ajlm-297	141	5	150	150	NUM
ajlm-297	141	6	cancer	cancer	NOUN
ajlm-297	141	7	patients	patient	NOUN
ajlm-297	141	8	who	who	PRON
ajlm-297	141	9	had	have	VERB
ajlm-297	141	10	at	at	ADV
ajlm-297	141	11	least	least	ADJ
ajlm-297	141	12	five	five	NUM
ajlm-297	141	13	transfusions	transfusion	NOUN
ajlm-297	141	14	and	and	CCONJ
ajlm-297	141	15	found	find	VERB
ajlm-297	141	16	the	the	DET
ajlm-297	141	17	prevalence	prevalence	NOUN
ajlm-297	141	18	rate	rate	NOUN
ajlm-297	141	19	of	of	ADP
ajlm-297	141	20	alloabs	alloab	NOUN
ajlm-297	141	21	to	to	PART
ajlm-297	141	22	be	be	AUX
ajlm-297	141	23	6	6	NUM
ajlm-297	141	24	%	%	NOUN
ajlm-297	141	25	.	.	PUNCT
ajlm-297	142	1	in	in	ADP
ajlm-297	142	2	a	a	DET
ajlm-297	142	3	study	study	NOUN
ajlm-297	142	4	by	by	ADP
ajlm-297	142	5	seyfried	seyfried	NOUN
ajlm-297	142	6	and	and	CCONJ
ajlm-297	142	7	walewska11	walewska11	NOUN
ajlm-297	142	8	of	of	ADP
ajlm-297	142	9	1502	1502	NUM
ajlm-297	142	10	multi	multi	ADJ
ajlm-297	142	11	-	-	ADJ
ajlm-297	142	12	transfused	transfused	ADJ
ajlm-297	142	13	patients	patient	NOUN
ajlm-297	142	14	,	,	PUNCT
ajlm-297	142	15	the	the	DET
ajlm-297	142	16	overall	overall	ADJ
ajlm-297	142	17	incidence	incidence	NOUN
ajlm-297	142	18	of	of	ADP
ajlm-297	142	19	alloabs	alloab	NOUN
ajlm-297	142	20	was	be	AUX
ajlm-297	142	21	5.7	5.7	NUM
ajlm-297	142	22	%	%	NOUN
ajlm-297	142	23	,	,	PUNCT
ajlm-297	142	24	with	with	ADP
ajlm-297	142	25	the	the	DET
ajlm-297	142	26	lowest	low	ADJ
ajlm-297	142	27	rate	rate	NOUN
ajlm-297	142	28	found	find	VERB
ajlm-297	142	29	amongst	amongst	ADP
ajlm-297	142	30	patients	patient	NOUN
ajlm-297	142	31	with	with	ADP
ajlm-297	142	32	lymphoproliferative	lymphoproliferative	ADJ
ajlm-297	142	33	syndromes	syndrome	NOUN
ajlm-297	142	34	(	(	PUNCT
ajlm-297	142	35	1.8%).11	1.8%).11	NUM
ajlm-297	142	36	of	of	ADP
ajlm-297	142	37	note	note	NOUN
ajlm-297	142	38	,	,	PUNCT
ajlm-297	142	39	all	all	DET
ajlm-297	142	40	the	the	DET
ajlm-297	142	41	cancer	cancer	NOUN
ajlm-297	142	42	patients	patient	NOUN
ajlm-297	142	43	in	in	ADP
ajlm-297	142	44	our	our	PRON
ajlm-297	142	45	study	study	NOUN
ajlm-297	142	46	were	be	AUX
ajlm-297	142	47	undergoing	undergo	VERB
ajlm-297	142	48	chemotherapy	chemotherapy	NOUN
ajlm-297	142	49	at	at	ADP
ajlm-297	142	50	the	the	DET
ajlm-297	142	51	time	time	NOUN
ajlm-297	142	52	of	of	ADP
ajlm-297	142	53	transfusion	transfusion	NOUN
ajlm-297	142	54	.	.	PUNCT
ajlm-297	143	1	it	it	PRON
ajlm-297	143	2	has	have	AUX
ajlm-297	143	3	been	be	AUX
ajlm-297	143	4	observed	observe	VERB
ajlm-297	143	5	that	that	SCONJ
ajlm-297	143	6	patients	patient	NOUN
ajlm-297	143	7	with	with	ADP
ajlm-297	143	8	progressive	progressive	ADJ
ajlm-297	143	9	malignancies	malignancy	NOUN
ajlm-297	143	10	undergoing	undergo	VERB
ajlm-297	143	11	intensive	intensive	ADJ
ajlm-297	143	12	chemotherapy	chemotherapy	NOUN
ajlm-297	143	13	tend	tend	VERB
ajlm-297	143	14	to	to	PART
ajlm-297	143	15	have	have	VERB
ajlm-297	143	16	a	a	DET
ajlm-297	143	17	low	low	ADJ
ajlm-297	143	18	antibody	antibody	NOUN
ajlm-297	143	19	formation	formation	NOUN
ajlm-297	143	20	response	response	NOUN
ajlm-297	143	21	to	to	ADP
ajlm-297	143	22	foreign	foreign	ADJ
ajlm-297	143	23	antigens.26,27,28	antigens.26,27,28	PROPN
ajlm-297	143	24	finally	finally	ADV
ajlm-297	143	25	,	,	PUNCT
ajlm-297	143	26	a	a	DET
ajlm-297	143	27	majority	majority	NOUN
ajlm-297	143	28	(	(	PUNCT
ajlm-297	143	29	57	57	NUM
ajlm-297	143	30	%	%	NOUN
ajlm-297	143	31	)	)	PUNCT
ajlm-297	143	32	of	of	ADP
ajlm-297	143	33	our	our	PRON
ajlm-297	143	34	donor	donor	NOUN
ajlm-297	143	35	population	population	NOUN
ajlm-297	143	36	expressed	express	VERB
ajlm-297	143	37	the	the	DET
ajlm-297	143	38	rh	rh	PROPN
ajlm-297	143	39	formula	formula	NOUN
ajlm-297	143	40	of	of	ADP
ajlm-297	143	41	ccd.ee	ccd.ee	PROPN
ajlm-297	143	42	,	,	PUNCT
ajlm-297	143	43	which	which	PRON
ajlm-297	143	44	could	could	AUX
ajlm-297	143	45	partly	partly	ADV
ajlm-297	143	46	explain	explain	VERB
ajlm-297	143	47	why	why	SCONJ
ajlm-297	143	48	we	we	PRON
ajlm-297	143	49	did	do	AUX
ajlm-297	143	50	not	not	PART
ajlm-297	143	51	find	find	VERB
ajlm-297	143	52	rbc	rbc	PROPN
ajlm-297	143	53	alloantibodies	alloantibody	NOUN
ajlm-297	143	54	directed	direct	VERB
ajlm-297	143	55	against	against	ADP
ajlm-297	143	56	highly	highly	ADV
ajlm-297	143	57	immunogenic	immunogenic	ADJ
ajlm-297	143	58	antigens	antigen	NOUN
ajlm-297	143	59	such	such	ADJ
ajlm-297	143	60	as	as	ADP
ajlm-297	143	61	d	d	PROPN
ajlm-297	143	62	or	or	CCONJ
ajlm-297	143	63	e.	e.	PROPN
ajlm-297	143	64	a	a	DET
ajlm-297	143	65	study	study	NOUN
ajlm-297	143	66	by	by	ADP
ajlm-297	143	67	badjie	badjie	PROPN
ajlm-297	143	68	et	et	PROPN
ajlm-297	143	69	al	al	PROPN
ajlm-297	143	70	.	.	PROPN
ajlm-297	143	71	,29	,29	PUNCT
ajlm-297	143	72	conducted	conduct	VERB
ajlm-297	143	73	amongst	amongst	ADP
ajlm-297	143	74	800	800	NUM
ajlm-297	143	75	donors	donor	NOUN
ajlm-297	143	76	from	from	ADP
ajlm-297	143	77	various	various	ADJ
ajlm-297	143	78	ethnic	ethnic	ADJ
ajlm-297	143	79	groups	group	NOUN
ajlm-297	143	80	,	,	PUNCT
ajlm-297	143	81	found	find	VERB
ajlm-297	143	82	the	the	DET
ajlm-297	143	83	prevalence	prevalence	NOUN
ajlm-297	143	84	of	of	ADP
ajlm-297	143	85	the	the	DET
ajlm-297	143	86	ccd.ee	ccd.ee	PROPN
ajlm-297	143	87	phenotype	phenotype	NOUN
ajlm-297	143	88	to	to	PART
ajlm-297	143	89	be	be	AUX
ajlm-297	143	90	81.9	81.9	NUM
ajlm-297	143	91	%	%	NOUN
ajlm-297	143	92	in	in	ADP
ajlm-297	143	93	east	east	PROPN
ajlm-297	143	94	africa	africa	PROPN
ajlm-297	143	95	and	and	CCONJ
ajlm-297	143	96	a	a	DET
ajlm-297	143	97	study	study	NOUN
ajlm-297	143	98	by	by	ADP
ajlm-297	143	99	baby	baby	NOUN
ajlm-297	143	100	et	et	PROPN
ajlm-297	143	101	al.30	al.30	PROPN
ajlm-297	143	102	found	find	VERB
ajlm-297	143	103	a	a	DET
ajlm-297	143	104	prevalence	prevalence	NOUN
ajlm-297	143	105	of	of	ADP
ajlm-297	143	106	67.9	67.9	NUM
ajlm-297	143	107	%	%	NOUN
ajlm-297	143	108	in	in	ADP
ajlm-297	143	109	west	west	PROPN
ajlm-297	143	110	africa	africa	PROPN
ajlm-297	143	111	(	(	PUNCT
ajlm-297	143	112	mali	mali	PROPN
ajlm-297	143	113	)	)	PUNCT
ajlm-297	143	114	.	.	PUNCT
ajlm-297	144	1	these	these	DET
ajlm-297	144	2	results	result	NOUN
ajlm-297	144	3	suggest	suggest	VERB
ajlm-297	144	4	that	that	SCONJ
ajlm-297	144	5	a	a	DET
ajlm-297	144	6	large	large	ADJ
ajlm-297	144	7	proportion	proportion	NOUN
ajlm-297	144	8	of	of	ADP
ajlm-297	144	9	donors	donor	NOUN
ajlm-297	144	10	–	–	PUNCT
ajlm-297	144	11	exceeding	exceed	VERB
ajlm-297	144	12	50	50	NUM
ajlm-297	144	13	%	%	NOUN
ajlm-297	144	14	–	–	PUNCT
ajlm-297	144	15	and	and	CCONJ
ajlm-297	144	16	transfusion	transfusion	NOUN
ajlm-297	144	17	recipients	recipient	NOUN
ajlm-297	144	18	in	in	ADP
ajlm-297	144	19	africa	africa	PROPN
ajlm-297	144	20	share	share	PROPN
ajlm-297	144	21	equal	equal	ADJ
ajlm-297	144	22	rh	rh	NOUN
ajlm-297	144	23	phenotypes	phenotype	NOUN
ajlm-297	144	24	,	,	PUNCT
ajlm-297	144	25	so	so	SCONJ
ajlm-297	144	26	that	that	SCONJ
ajlm-297	144	27	rh	rh	PROPN
ajlm-297	144	28	antibodies	antibodie	VERB
ajlm-297	144	29	may	may	AUX
ajlm-297	144	30	be	be	AUX
ajlm-297	144	31	less	less	ADV
ajlm-297	144	32	frequently	frequently	ADV
ajlm-297	144	33	induced	induce	VERB
ajlm-297	144	34	than	than	ADP
ajlm-297	144	35	in	in	ADP
ajlm-297	144	36	other	other	ADJ
ajlm-297	144	37	parts	part	NOUN
ajlm-297	144	38	of	of	ADP
ajlm-297	144	39	the	the	DET
ajlm-297	144	40	world	world	NOUN
ajlm-297	144	41	.	.	PUNCT
ajlm-297	145	1	this	this	DET
ajlm-297	145	2	view	view	NOUN
ajlm-297	145	3	is	be	AUX
ajlm-297	145	4	also	also	ADV
ajlm-297	145	5	supported	support	VERB
ajlm-297	145	6	by	by	ADP
ajlm-297	145	7	the	the	DET
ajlm-297	145	8	low	low	ADJ
ajlm-297	145	9	numbers	number	NOUN
ajlm-297	145	10	for	for	ADP
ajlm-297	145	11	the	the	DET
ajlm-297	145	12	‘	'	PUNCT
ajlm-297	145	13	rr	rr	NOUN
ajlm-297	145	14	’	'	PUNCT
ajlm-297	145	15	(	(	PUNCT
ajlm-297	145	16	rhesus	rhesus	NOUN
ajlm-297	145	17	-	-	PUNCT
ajlm-297	145	18	d	d	ADJ
ajlm-297	145	19	negative	negative	ADJ
ajlm-297	145	20	)	)	PUNCT
ajlm-297	145	21	phenotype	phenotype	NOUN
ajlm-297	145	22	amongst	amongst	ADP
ajlm-297	145	23	our	our	PRON
ajlm-297	145	24	donor	donor	NOUN
ajlm-297	145	25	group	group	NOUN
ajlm-297	145	26	(	(	PUNCT
ajlm-297	145	27	only	only	ADV
ajlm-297	145	28	4	4	NUM
ajlm-297	145	29	%	%	NOUN
ajlm-297	145	30	)	)	PUNCT
ajlm-297	145	31	.	.	PUNCT
ajlm-297	146	1	this	this	DET
ajlm-297	146	2	phenomenon	phenomenon	NOUN
ajlm-297	146	3	might	might	AUX
ajlm-297	146	4	be	be	AUX
ajlm-297	146	5	also	also	ADV
ajlm-297	146	6	true	true	ADJ
ajlm-297	146	7	for	for	ADP
ajlm-297	146	8	kell	kell	PROPN
ajlm-297	146	9	antibody	antibody	NOUN
ajlm-297	146	10	formation	formation	NOUN
ajlm-297	146	11	,	,	PUNCT
ajlm-297	146	12	as	as	SCONJ
ajlm-297	146	13	we	we	PRON
ajlm-297	146	14	found	find	VERB
ajlm-297	146	15	no	no	DET
ajlm-297	146	16	kell	kell	PROPN
ajlm-297	146	17	positive	positive	ADJ
ajlm-297	146	18	individuals	individual	NOUN
ajlm-297	146	19	amongst	amongst	ADP
ajlm-297	146	20	our	our	PRON
ajlm-297	146	21	donors	donor	NOUN
ajlm-297	146	22	.	.	PUNCT
ajlm-297	147	1	it	it	PRON
ajlm-297	147	2	has	have	AUX
ajlm-297	147	3	been	be	AUX
ajlm-297	147	4	reported	report	VERB
ajlm-297	147	5	that	that	SCONJ
ajlm-297	147	6	more	more	ADJ
ajlm-297	147	7	than	than	ADP
ajlm-297	147	8	98	98	NUM
ajlm-297	147	9	%	%	NOUN
ajlm-297	147	10	of	of	ADP
ajlm-297	147	11	black	black	ADJ
ajlm-297	147	12	africans	africans	PROPN
ajlm-297	147	13	are	be	AUX
ajlm-297	147	14	kell	kell	PROPN
ajlm-297	147	15	negative.30,31	negative.30,31	PROPN
ajlm-297	147	16	we	we	PRON
ajlm-297	147	17	found	find	VERB
ajlm-297	147	18	a	a	DET
ajlm-297	147	19	positive	positive	ADJ
ajlm-297	147	20	dat	dat	NOUN
ajlm-297	147	21	in	in	ADP
ajlm-297	147	22	32	32	NUM
ajlm-297	147	23	(	(	PUNCT
ajlm-297	147	24	14.0	14.0	NUM
ajlm-297	147	25	%	%	NOUN
ajlm-297	147	26	)	)	PUNCT
ajlm-297	147	27	patients	patient	NOUN
ajlm-297	147	28	,	,	PUNCT
ajlm-297	147	29	with	with	ADP
ajlm-297	147	30	a	a	DET
ajlm-297	147	31	subgroup	subgroup	NOUN
ajlm-297	147	32	of	of	ADP
ajlm-297	147	33	seven	seven	NUM
ajlm-297	147	34	igg	igg	PROPN
ajlm-297	147	35	warm	warm	ADJ
ajlm-297	147	36	autoabs	autoab	NOUN
ajlm-297	147	37	,	,	PUNCT
ajlm-297	147	38	which	which	PRON
ajlm-297	147	39	can	can	AUX
ajlm-297	147	40	induce	induce	VERB
ajlm-297	147	41	significant	significant	ADJ
ajlm-297	147	42	clinical	clinical	ADJ
ajlm-297	147	43	autoimmune	autoimmune	ADJ
ajlm-297	147	44	haemolysis	haemolysis	NOUN
ajlm-297	147	45	.	.	PUNCT
ajlm-297	148	1	we	we	PRON
ajlm-297	148	2	did	do	AUX
ajlm-297	148	3	not	not	PART
ajlm-297	148	4	seek	seek	VERB
ajlm-297	148	5	information	information	NOUN
ajlm-297	148	6	about	about	ADP
ajlm-297	148	7	the	the	DET
ajlm-297	148	8	presence	presence	NOUN
ajlm-297	148	9	of	of	ADP
ajlm-297	148	10	autoimmune	autoimmune	ADJ
ajlm-297	148	11	haemolytic	haemolytic	PROPN
ajlm-297	148	12	anaemia	anaemia	NOUN
ajlm-297	148	13	in	in	ADP
ajlm-297	148	14	these	these	DET
ajlm-297	148	15	patients	patient	NOUN
ajlm-297	148	16	,	,	PUNCT
ajlm-297	148	17	because	because	SCONJ
ajlm-297	148	18	this	this	PRON
ajlm-297	148	19	can	can	AUX
ajlm-297	148	20	be	be	AUX
ajlm-297	148	21	clinically	clinically	ADV
ajlm-297	148	22	asymptomatic	asymptomatic	ADJ
ajlm-297	148	23	and	and	CCONJ
ajlm-297	148	24	the	the	DET
ajlm-297	148	25	reaction	reaction	NOUN
ajlm-297	148	26	can	can	AUX
ajlm-297	148	27	be	be	AUX
ajlm-297	148	28	masked	mask	VERB
ajlm-297	148	29	by	by	ADP
ajlm-297	148	30	the	the	DET
ajlm-297	148	31	severity	severity	NOUN
ajlm-297	148	32	of	of	ADP
ajlm-297	148	33	the	the	DET
ajlm-297	148	34	underlying	underlie	VERB
ajlm-297	148	35	disease	disease	NOUN
ajlm-297	148	36	and	and	CCONJ
ajlm-297	148	37	lack	lack	NOUN
ajlm-297	148	38	of	of	ADP
ajlm-297	148	39	adequate	adequate	ADJ
ajlm-297	148	40	post	post	ADJ
ajlm-297	148	41	-	-	ADJ
ajlm-297	148	42	transfusion	transfusion	ADJ
ajlm-297	148	43	records	record	NOUN
ajlm-297	148	44	.	.	PUNCT
ajlm-297	149	1	limitations	limitation	NOUN
ajlm-297	149	2	it	it	PRON
ajlm-297	149	3	has	have	AUX
ajlm-297	149	4	been	be	AUX
ajlm-297	149	5	reported	report	VERB
ajlm-297	149	6	that	that	SCONJ
ajlm-297	149	7	25	25	NUM
ajlm-297	149	8	%	%	NOUN
ajlm-297	149	9	of	of	ADP
ajlm-297	149	10	alloantibodies	alloantibody	NOUN
ajlm-297	149	11	become	become	VERB
ajlm-297	149	12	undetectable	undetectable	ADJ
ajlm-297	149	13	within	within	ADP
ajlm-297	149	14	a	a	DET
ajlm-297	149	15	median	median	NOUN
ajlm-297	149	16	of	of	ADP
ajlm-297	149	17	10	10	NUM
ajlm-297	149	18	months	month	NOUN
ajlm-297	149	19	of	of	ADP
ajlm-297	149	20	follow	follow	NOUN
ajlm-297	149	21	-	-	PUNCT
ajlm-297	149	22	up	up	NOUN
ajlm-297	149	23	,	,	PUNCT
ajlm-297	149	24	which	which	PRON
ajlm-297	149	25	may	may	AUX
ajlm-297	149	26	lead	lead	VERB
ajlm-297	149	27	to	to	ADP
ajlm-297	149	28	the	the	DET
ajlm-297	149	29	underestimation	underestimation	NOUN
ajlm-297	149	30	of	of	ADP
ajlm-297	149	31	the	the	DET
ajlm-297	149	32	prevalence	prevalence	NOUN
ajlm-297	149	33	of	of	ADP
ajlm-297	149	34	antibodies	antibody	NOUN
ajlm-297	149	35	formed.10,32	formed.10,32	VERB
ajlm-297	149	36	this	this	PRON
ajlm-297	149	37	can	can	AUX
ajlm-297	149	38	result	result	VERB
ajlm-297	149	39	in	in	ADP
ajlm-297	149	40	a	a	DET
ajlm-297	149	41	patient	patient	NOUN
ajlm-297	149	42	receiving	receive	VERB
ajlm-297	149	43	rbcs	rbc	NOUN
ajlm-297	149	44	and	and	CCONJ
ajlm-297	149	45	consequently	consequently	ADV
ajlm-297	149	46	experiencing	experience	VERB
ajlm-297	149	47	a	a	DET
ajlm-297	149	48	secondary	secondary	ADJ
ajlm-297	149	49	immune	immune	ADJ
ajlm-297	149	50	response	response	NOUN
ajlm-297	149	51	that	that	PRON
ajlm-297	149	52	may	may	AUX
ajlm-297	149	53	compromise	compromise	VERB
ajlm-297	149	54	the	the	DET
ajlm-297	149	55	benefit	benefit	NOUN
ajlm-297	149	56	of	of	ADP
ajlm-297	149	57	the	the	DET
ajlm-297	149	58	following	follow	VERB
ajlm-297	149	59	transfusion.33	transfusion.33	NOUN
ajlm-297	149	60	because	because	SCONJ
ajlm-297	149	61	this	this	PRON
ajlm-297	149	62	was	be	AUX
ajlm-297	149	63	a	a	DET
ajlm-297	149	64	cross	cross	ADJ
ajlm-297	149	65	-	-	ADJ
ajlm-297	149	66	sectional	sectional	ADJ
ajlm-297	149	67	study	study	NOUN
ajlm-297	149	68	,	,	PUNCT
ajlm-297	149	69	some	some	DET
ajlm-297	149	70	rbc	rbc	PROPN
ajlm-297	149	71	alloantibodies	alloantibody	NOUN
ajlm-297	149	72	might	might	AUX
ajlm-297	149	73	have	have	AUX
ajlm-297	149	74	been	be	AUX
ajlm-297	149	75	missed	miss	VERB
ajlm-297	149	76	,	,	PUNCT
ajlm-297	149	77	since	since	SCONJ
ajlm-297	149	78	they	they	PRON
ajlm-297	149	79	have	have	AUX
ajlm-297	149	80	been	be	AUX
ajlm-297	149	81	reported	report	VERB
ajlm-297	149	82	to	to	PART
ajlm-297	149	83	disappear	disappear	VERB
ajlm-297	149	84	with	with	ADP
ajlm-297	149	85	time.32,34	time.32,34	NOUN
ajlm-297	149	86	other	other	ADJ
ajlm-297	149	87	factors	factor	NOUN
ajlm-297	149	88	that	that	PRON
ajlm-297	149	89	might	might	AUX
ajlm-297	149	90	also	also	ADV
ajlm-297	149	91	be	be	AUX
ajlm-297	149	92	responsible	responsible	ADJ
ajlm-297	149	93	for	for	ADP
ajlm-297	149	94	the	the	DET
ajlm-297	149	95	disparity	disparity	NOUN
ajlm-297	149	96	in	in	ADP
ajlm-297	149	97	results	result	NOUN
ajlm-297	149	98	include	include	VERB
ajlm-297	149	99	:	:	PUNCT
ajlm-297	149	100	the	the	DET
ajlm-297	149	101	fact	fact	NOUN
ajlm-297	149	102	that	that	SCONJ
ajlm-297	149	103	the	the	DET
ajlm-297	149	104	majority	majority	NOUN
ajlm-297	149	105	of	of	ADP
ajlm-297	149	106	the	the	DET
ajlm-297	149	107	study	study	NOUN
ajlm-297	149	108	patients	patient	NOUN
ajlm-297	149	109	were	be	AUX
ajlm-297	149	110	children	child	NOUN
ajlm-297	149	111	;	;	PUNCT
ajlm-297	149	112	low	low	ADJ
ajlm-297	149	113	mean	mean	NOUN
ajlm-297	149	114	of	of	ADP
ajlm-297	149	115	transfused	transfused	ADJ
ajlm-297	149	116	units	unit	NOUN
ajlm-297	149	117	;	;	PUNCT
ajlm-297	149	118	inability	inability	NOUN
ajlm-297	149	119	to	to	PART
ajlm-297	149	120	meet	meet	VERB
ajlm-297	149	121	optimal	optimal	ADJ
ajlm-297	149	122	transfusion	transfusion	NOUN
ajlm-297	149	123	needs	need	NOUN
ajlm-297	149	124	for	for	ADP
ajlm-297	149	125	these	these	DET
ajlm-297	149	126	patient	patient	ADJ
ajlm-297	149	127	groups	group	NOUN
ajlm-297	149	128	;	;	PUNCT
ajlm-297	149	129	and	and	CCONJ
ajlm-297	149	130	the	the	DET
ajlm-297	149	131	frequency	frequency	NOUN
ajlm-297	149	132	of	of	ADP
ajlm-297	149	133	testing	testing	NOUN
ajlm-297	149	134	.	.	PUNCT
ajlm-297	150	1	conclusion	conclusion	NOUN
ajlm-297	150	2	in	in	ADP
ajlm-297	150	3	this	this	DET
ajlm-297	150	4	study	study	NOUN
ajlm-297	150	5	,	,	PUNCT
ajlm-297	150	6	we	we	PRON
ajlm-297	150	7	observed	observe	VERB
ajlm-297	150	8	a	a	DET
ajlm-297	150	9	low	low	ADJ
ajlm-297	150	10	rate	rate	NOUN
ajlm-297	150	11	of	of	ADP
ajlm-297	150	12	rbc	rbc	PROPN
ajlm-297	150	13	alloimmunisation	alloimmunisation	NOUN
ajlm-297	150	14	amongst	amongst	ADP
ajlm-297	150	15	both	both	PRON
ajlm-297	150	16	scd	scd	NOUN
ajlm-297	150	17	and	and	CCONJ
ajlm-297	150	18	cancer	cancer	NOUN
ajlm-297	150	19	patients	patient	NOUN
ajlm-297	150	20	.	.	PUNCT
ajlm-297	151	1	the	the	DET
ajlm-297	151	2	low	low	ADJ
ajlm-297	151	3	numbers	number	NOUN
ajlm-297	151	4	of	of	ADP
ajlm-297	151	5	transfusions	transfusion	NOUN
ajlm-297	151	6	and	and	CCONJ
ajlm-297	151	7	transfusion	transfusion	NOUN
ajlm-297	151	8	events	event	NOUN
ajlm-297	151	9	that	that	PRON
ajlm-297	151	10	are	be	AUX
ajlm-297	151	11	currently	currently	ADV
ajlm-297	151	12	being	be	AUX
ajlm-297	151	13	applied	apply	VERB
ajlm-297	151	14	at	at	ADP
ajlm-297	151	15	knh	knh	PROPN
ajlm-297	151	16	and	and	CCONJ
ajlm-297	151	17	the	the	DET
ajlm-297	151	18	relatively	relatively	ADV
ajlm-297	151	19	homogeneous	homogeneous	ADJ
ajlm-297	151	20	distribution	distribution	NOUN
ajlm-297	151	21	of	of	ADP
ajlm-297	151	22	rh-/k	rh-/k	PROPN
ajlm-297	151	23	-	-	PUNCT
ajlm-297	151	24	rbc	rbc	PROPN
ajlm-297	151	25	alloantigens	alloantigen	NOUN
ajlm-297	151	26	amongst	amongst	ADP
ajlm-297	151	27	kenyan	kenyan	ADJ
ajlm-297	151	28	donors	donor	NOUN
ajlm-297	151	29	provide	provide	VERB
ajlm-297	151	30	an	an	DET
ajlm-297	151	31	explanation	explanation	NOUN
ajlm-297	151	32	for	for	ADP
ajlm-297	151	33	the	the	DET
ajlm-297	151	34	low	low	ADJ
ajlm-297	151	35	alloab	alloab	PROPN
ajlm-297	151	36	frequency	frequency	NOUN
ajlm-297	151	37	amongst	amongst	ADP
ajlm-297	151	38	kenyan	kenyan	ADJ
ajlm-297	151	39	transfusion	transfusion	NOUN
ajlm-297	151	40	recipients	recipient	NOUN
ajlm-297	151	41	.	.	PUNCT
ajlm-297	152	1	at	at	ADP
ajlm-297	152	2	the	the	DET
ajlm-297	152	3	current	current	ADJ
ajlm-297	152	4	stage	stage	NOUN
ajlm-297	152	5	of	of	ADP
ajlm-297	152	6	the	the	DET
ajlm-297	152	7	kenya	kenya	PROPN
ajlm-297	152	8	health	health	PROPN
ajlm-297	152	9	care	care	NOUN
ajlm-297	152	10	system	system	NOUN
ajlm-297	152	11	,	,	PUNCT
ajlm-297	152	12	routine	routine	ADJ
ajlm-297	152	13	antibody	antibody	NOUN
ajlm-297	152	14	screenings	screening	NOUN
ajlm-297	152	15	or	or	CCONJ
ajlm-297	152	16	extended	extend	VERB
ajlm-297	152	17	rbc	rbc	PROPN
ajlm-297	152	18	antigen	antigen	NOUN
ajlm-297	152	19	matching	matching	NOUN
ajlm-297	152	20	do	do	AUX
ajlm-297	152	21	not	not	PART
ajlm-297	152	22	seem	seem	VERB
ajlm-297	152	23	to	to	PART
ajlm-297	152	24	be	be	AUX
ajlm-297	152	25	justified	justify	VERB
ajlm-297	152	26	,	,	PUNCT
ajlm-297	152	27	as	as	SCONJ
ajlm-297	152	28	the	the	DET
ajlm-297	152	29	relatively	relatively	ADV
ajlm-297	152	30	homogenous	homogenous	ADJ
ajlm-297	152	31	rbc	rbc	PROPN
ajlm-297	152	32	alloantigen	alloantigen	NOUN
ajlm-297	152	33	distribution	distribution	NOUN
ajlm-297	152	34	of	of	ADP
ajlm-297	152	35	kenyan	kenyan	ADJ
ajlm-297	152	36	blood	blood	NOUN
ajlm-297	152	37	donors	donor	NOUN
ajlm-297	152	38	provides	provide	VERB
ajlm-297	152	39	at	at	ADP
ajlm-297	152	40	least	least	ADJ
ajlm-297	152	41	some	some	PRON
ajlm-297	152	42	protection	protection	NOUN
ajlm-297	152	43	from	from	ADP
ajlm-297	152	44	immune	immune	ADJ
ajlm-297	152	45	rbc	rbc	PROPN
ajlm-297	152	46	alloab	alloab	PROPN
ajlm-297	152	47	formation	formation	PROPN
ajlm-297	152	48	.	.	PUNCT
ajlm-297	153	1	however	however	ADV
ajlm-297	153	2	,	,	PUNCT
ajlm-297	153	3	with	with	ADP
ajlm-297	153	4	improvements	improvement	NOUN
ajlm-297	153	5	in	in	ADP
ajlm-297	153	6	health	health	NOUN
ajlm-297	153	7	care	care	NOUN
ajlm-297	153	8	,	,	PUNCT
ajlm-297	153	9	more	more	ADJ
ajlm-297	153	10	scd	scd	NOUN
ajlm-297	153	11	and	and	CCONJ
ajlm-297	153	12	haemato	haemato	NOUN
ajlm-297	153	13	-	-	PUNCT
ajlm-297	153	14	oncology	oncology	NOUN
ajlm-297	153	15	patients	patient	NOUN
ajlm-297	153	16	are	be	AUX
ajlm-297	153	17	likely	likely	ADJ
ajlm-297	153	18	to	to	PART
ajlm-297	153	19	receive	receive	VERB
ajlm-297	153	20	a	a	DET
ajlm-297	153	21	more	more	ADV
ajlm-297	153	22	intensive	intensive	ADJ
ajlm-297	153	23	transfusion	transfusion	NOUN
ajlm-297	153	24	treatment	treatment	NOUN
ajlm-297	153	25	,	,	PUNCT
ajlm-297	153	26	which	which	PRON
ajlm-297	153	27	could	could	AUX
ajlm-297	153	28	lead	lead	VERB
ajlm-297	153	29	to	to	ADP
ajlm-297	153	30	an	an	DET
ajlm-297	153	31	increased	increase	VERB
ajlm-297	153	32	risk	risk	NOUN
ajlm-297	153	33	of	of	ADP
ajlm-297	153	34	rbc	rbc	PROPN
ajlm-297	153	35	alloimmunisation	alloimmunisation	PROPN
ajlm-297	153	36	.	.	PUNCT
ajlm-297	154	1	therefore	therefore	ADV
ajlm-297	154	2	,	,	PUNCT
ajlm-297	154	3	further	further	ADJ
ajlm-297	154	4	development	development	NOUN
ajlm-297	154	5	of	of	ADP
ajlm-297	154	6	the	the	DET
ajlm-297	154	7	healthcare	healthcare	NOUN
ajlm-297	154	8	system	system	NOUN
ajlm-297	154	9	in	in	ADP
ajlm-297	154	10	kenya	kenya	PROPN
ajlm-297	154	11	will	will	AUX
ajlm-297	154	12	require	require	VERB
ajlm-297	154	13	a	a	DET
ajlm-297	154	14	thorough	thorough	ADJ
ajlm-297	154	15	reconsideration	reconsideration	NOUN
ajlm-297	154	16	of	of	ADP
ajlm-297	154	17	the	the	DET
ajlm-297	154	18	pretransfusion	pretransfusion	NOUN
ajlm-297	154	19	laboratory	laboratory	NOUN
ajlm-297	154	20	practice	practice	NOUN
ajlm-297	154	21	,	,	PUNCT
ajlm-297	154	22	in	in	ADP
ajlm-297	154	23	particular	particular	ADJ
ajlm-297	154	24	,	,	PUNCT
ajlm-297	154	25	if	if	SCONJ
ajlm-297	154	26	transfusion	transfusion	NOUN
ajlm-297	154	27	frequencies	frequency	NOUN
ajlm-297	154	28	increase	increase	VERB
ajlm-297	154	29	and/or	and/or	CCONJ
ajlm-297	154	30	donor	donor	NOUN
ajlm-297	154	31	groups	group	NOUN
ajlm-297	154	32	change	change	VERB
ajlm-297	154	33	.	.	PUNCT
ajlm-297	155	1	trustworthiness	trustworthiness	NOUN
ajlm-297	155	2	top	top	PROPN
ajlm-297	155	3	↑	↑	PROPN
ajlm-297	155	4	this	this	DET
ajlm-297	155	5	study	study	NOUN
ajlm-297	155	6	reflects	reflect	VERB
ajlm-297	155	7	the	the	DET
ajlm-297	155	8	findings	finding	NOUN
ajlm-297	155	9	obtained	obtain	VERB
ajlm-297	155	10	from	from	ADP
ajlm-297	155	11	laboratory	laboratory	NOUN
ajlm-297	155	12	testing	testing	NOUN
ajlm-297	155	13	and	and	CCONJ
ajlm-297	155	14	analysis	analysis	NOUN
ajlm-297	155	15	as	as	SCONJ
ajlm-297	155	16	observed	observe	VERB
ajlm-297	155	17	by	by	ADP
ajlm-297	155	18	the	the	DET
ajlm-297	155	19	technical	technical	ADJ
ajlm-297	155	20	group	group	NOUN
ajlm-297	155	21	.	.	PUNCT
ajlm-297	156	1	reliability	reliability	NOUN
ajlm-297	156	2	and	and	CCONJ
ajlm-297	156	3	validity	validity	NOUN
ajlm-297	156	4	the	the	DET
ajlm-297	156	5	experimental	experimental	ADJ
ajlm-297	156	6	design	design	NOUN
ajlm-297	156	7	and	and	CCONJ
ajlm-297	156	8	procedures	procedure	NOUN
ajlm-297	156	9	used	use	VERB
ajlm-297	156	10	in	in	ADP
ajlm-297	156	11	this	this	DET
ajlm-297	156	12	study	study	NOUN
ajlm-297	156	13	are	be	AUX
ajlm-297	156	14	reliable	reliable	ADJ
ajlm-297	156	15	and	and	CCONJ
ajlm-297	156	16	valid	valid	ADJ
ajlm-297	156	17	as	as	SCONJ
ajlm-297	156	18	they	they	PRON
ajlm-297	156	19	have	have	AUX
ajlm-297	156	20	been	be	AUX
ajlm-297	156	21	used	use	VERB
ajlm-297	156	22	previously	previously	ADV
ajlm-297	156	23	in	in	ADP
ajlm-297	156	24	other	other	ADJ
ajlm-297	156	25	studies	study	NOUN
ajlm-297	156	26	,	,	PUNCT
ajlm-297	156	27	most	most	ADJ
ajlm-297	156	28	of	of	ADP
ajlm-297	156	29	which	which	PRON
ajlm-297	156	30	are	be	AUX
ajlm-297	156	31	cited	cite	VERB
ajlm-297	156	32	in	in	ADP
ajlm-297	156	33	this	this	DET
ajlm-297	156	34	article	article	NOUN
ajlm-297	156	35	.	.	PUNCT
ajlm-297	157	1	the	the	DET
ajlm-297	157	2	results	result	NOUN
ajlm-297	157	3	of	of	ADP
ajlm-297	157	4	the	the	DET
ajlm-297	157	5	experiments	experiment	NOUN
ajlm-297	157	6	in	in	ADP
ajlm-297	157	7	this	this	DET
ajlm-297	157	8	article	article	NOUN
ajlm-297	157	9	were	be	AUX
ajlm-297	157	10	obtained	obtain	VERB
ajlm-297	157	11	using	use	VERB
ajlm-297	157	12	specimens	specimen	NOUN
ajlm-297	157	13	collected	collect	VERB
ajlm-297	157	14	in	in	ADP
ajlm-297	157	15	various	various	ADJ
ajlm-297	157	16	clinics	clinic	NOUN
ajlm-297	157	17	at	at	ADP
ajlm-297	157	18	kenyatta	kenyatta	PROPN
ajlm-297	157	19	national	national	PROPN
ajlm-297	157	20	hospital	hospital	PROPN
ajlm-297	157	21	,	,	PUNCT
ajlm-297	157	22	kenya	kenya	PROPN
ajlm-297	157	23	and	and	CCONJ
ajlm-297	157	24	were	be	AUX
ajlm-297	157	25	analysed	analyse	VERB
ajlm-297	157	26	using	use	VERB
ajlm-297	157	27	standard	standard	ADJ
ajlm-297	157	28	procedures	procedure	NOUN
ajlm-297	157	29	in	in	ADP
ajlm-297	157	30	hannover	hannover	PROPN
ajlm-297	157	31	,	,	PUNCT
ajlm-297	157	32	germany	germany	PROPN
ajlm-297	157	33	.	.	PUNCT
ajlm-297	158	1	acknowledgements	acknowledgement	VERB
ajlm-297	158	2	top	top	PROPN
ajlm-297	158	3	↑	↑	PROPN
ajlm-297	158	4	the	the	DET
ajlm-297	158	5	authors	author	NOUN
ajlm-297	158	6	thank	thank	VERB
ajlm-297	158	7	the	the	DET
ajlm-297	158	8	staff	staff	NOUN
ajlm-297	158	9	of	of	ADP
ajlm-297	158	10	the	the	DET
ajlm-297	158	11	hematology	hematology	NOUN
ajlm-297	158	12	and	and	CCONJ
ajlm-297	158	13	oncology	oncology	NOUN
ajlm-297	158	14	clinics	clinic	NOUN
ajlm-297	158	15	and	and	CCONJ
ajlm-297	158	16	blood	blood	NOUN
ajlm-297	158	17	transfusion	transfusion	NOUN
ajlm-297	158	18	unit	unit	NOUN
ajlm-297	158	19	at	at	ADP
ajlm-297	158	20	knh	knh	PROPN
ajlm-297	158	21	,	,	PUNCT
ajlm-297	158	22	kenya	kenya	PROPN
ajlm-297	158	23	for	for	ADP
ajlm-297	158	24	their	their	PRON
ajlm-297	158	25	help	help	NOUN
ajlm-297	158	26	in	in	ADP
ajlm-297	158	27	recruiting	recruit	VERB
ajlm-297	158	28	patients	patient	NOUN
ajlm-297	158	29	and	and	CCONJ
ajlm-297	158	30	donors	donor	NOUN
ajlm-297	158	31	respectively	respectively	ADV
ajlm-297	158	32	.	.	PUNCT
ajlm-297	159	1	the	the	DET
ajlm-297	159	2	authors	author	NOUN
ajlm-297	159	3	also	also	ADV
ajlm-297	159	4	thank	thank	VERB
ajlm-297	159	5	knh	knh	PROPN
ajlm-297	159	6	research	research	NOUN
ajlm-297	159	7	and	and	CCONJ
ajlm-297	159	8	programs	program	NOUN
ajlm-297	159	9	department	department	PROPN
ajlm-297	159	10	for	for	ADP
ajlm-297	159	11	their	their	PRON
ajlm-297	159	12	monetary	monetary	ADJ
ajlm-297	159	13	support	support	NOUN
ajlm-297	159	14	.	.	PUNCT
ajlm-297	160	1	the	the	DET
ajlm-297	160	2	authors	author	NOUN
ajlm-297	160	3	thank	thank	VERB
ajlm-297	160	4	the	the	DET
ajlm-297	160	5	staff	staff	NOUN
ajlm-297	160	6	at	at	ADP
ajlm-297	160	7	the	the	DET
ajlm-297	160	8	institute	institute	NOUN
ajlm-297	160	9	for	for	ADP
ajlm-297	160	10	transfusion	transfusion	NOUN
ajlm-297	160	11	medicine	medicine	NOUN
ajlm-297	160	12	,	,	PUNCT
ajlm-297	160	13	hannover	hannover	PROPN
ajlm-297	160	14	medical	medical	PROPN
ajlm-297	160	15	school	school	PROPN
ajlm-297	160	16	,	,	PUNCT
ajlm-297	160	17	hannover	hannover	PROPN
ajlm-297	160	18	,	,	PUNCT
ajlm-297	160	19	germany	germany	PROPN
ajlm-297	160	20	,	,	PUNCT
ajlm-297	160	21	for	for	ADP
ajlm-297	160	22	providing	provide	VERB
ajlm-297	160	23	laboratory	laboratory	NOUN
ajlm-297	160	24	reagents	reagent	NOUN
ajlm-297	160	25	,	,	PUNCT
ajlm-297	160	26	space	space	NOUN
ajlm-297	160	27	and	and	CCONJ
ajlm-297	160	28	technical	technical	ADJ
ajlm-297	160	29	and	and	CCONJ
ajlm-297	160	30	medical	medical	ADJ
ajlm-297	160	31	advice	advice	NOUN
ajlm-297	160	32	.	.	PUNCT
ajlm-297	161	1	competing	compete	VERB
ajlm-297	161	2	interests	interest	NOUN
ajlm-297	161	3	the	the	DET
ajlm-297	161	4	authors	author	NOUN
ajlm-297	161	5	declare	declare	VERB
ajlm-297	161	6	that	that	SCONJ
ajlm-297	161	7	they	they	PRON
ajlm-297	161	8	have	have	VERB
ajlm-297	161	9	no	no	DET
ajlm-297	161	10	financial	financial	ADJ
ajlm-297	161	11	or	or	CCONJ
ajlm-297	161	12	personal	personal	ADJ
ajlm-297	161	13	relationship(s	relationship(s	NOUN
ajlm-297	161	14	)	)	PUNCT
ajlm-297	161	15	that	that	PRON
ajlm-297	161	16	may	may	AUX
ajlm-297	161	17	have	have	AUX
ajlm-297	161	18	inappropriately	inappropriately	ADV
ajlm-297	161	19	influenced	influence	VERB
ajlm-297	161	20	them	they	PRON
ajlm-297	161	21	in	in	ADP
ajlm-297	161	22	writing	write	VERB
ajlm-297	161	23	this	this	DET
ajlm-297	161	24	article	article	NOUN
ajlm-297	161	25	.	.	PUNCT
ajlm-297	162	1	authors	author	NOUN
ajlm-297	162	2	’	’	PART
ajlm-297	162	3	contributions	contribution	NOUN
ajlm-297	162	4	c.m	c.m	PROPN
ajlm-297	162	5	.	.	PUNCT
ajlm-297	163	1	(	(	PUNCT
ajlm-297	163	2	jomo	jomo	PROPN
ajlm-297	163	3	kenyatta	kenyatta	PROPN
ajlm-297	163	4	university	university	PROPN
ajlm-297	163	5	of	of	ADP
ajlm-297	163	6	agriculture	agriculture	PROPN
ajlm-297	163	7	and	and	CCONJ
ajlm-297	163	8	technology	technology	NOUN
ajlm-297	163	9	)	)	PUNCT
ajlm-297	163	10	was	be	AUX
ajlm-297	163	11	the	the	DET
ajlm-297	163	12	project	project	NOUN
ajlm-297	163	13	leader	leader	NOUN
ajlm-297	163	14	,	,	PUNCT
ajlm-297	163	15	developed	develop	VERB
ajlm-297	163	16	the	the	DET
ajlm-297	163	17	proposal	proposal	NOUN
ajlm-297	163	18	,	,	PUNCT
ajlm-297	163	19	obtained	obtain	VERB
ajlm-297	163	20	ethical	ethical	ADJ
ajlm-297	163	21	clearance	clearance	NOUN
ajlm-297	163	22	for	for	ADP
ajlm-297	163	23	the	the	DET
ajlm-297	163	24	study	study	NOUN
ajlm-297	163	25	,	,	PUNCT
ajlm-297	163	26	collected	collect	VERB
ajlm-297	163	27	and	and	CCONJ
ajlm-297	163	28	shipped	ship	VERB
ajlm-297	163	29	specimens	specimen	NOUN
ajlm-297	163	30	,	,	PUNCT
ajlm-297	163	31	performed	perform	VERB
ajlm-297	163	32	most	most	ADJ
ajlm-297	163	33	of	of	ADP
ajlm-297	163	34	the	the	DET
ajlm-297	163	35	experiments	experiment	NOUN
ajlm-297	163	36	and	and	CCONJ
ajlm-297	163	37	developed	develop	VERB
ajlm-297	163	38	the	the	DET
ajlm-297	163	39	manuscript	manuscript	NOUN
ajlm-297	163	40	.	.	PUNCT
ajlm-297	164	1	a.m.	a.m.	PROPN
ajlm-297	165	1	(	(	PUNCT
ajlm-297	165	2	jomo	jomo	PROPN
ajlm-297	165	3	kenyatta	kenyatta	PROPN
ajlm-297	165	4	university	university	PROPN
ajlm-297	165	5	of	of	ADP
ajlm-297	165	6	agriculture	agriculture	PROPN
ajlm-297	165	7	and	and	CCONJ
ajlm-297	165	8	technology	technology	NOUN
ajlm-297	165	9	)	)	PUNCT
ajlm-297	165	10	made	make	VERB
ajlm-297	165	11	conceptual	conceptual	ADJ
ajlm-297	165	12	contributions	contribution	NOUN
ajlm-297	165	13	.	.	PUNCT
ajlm-297	166	1	p.m.	p.m.	NOUN
ajlm-297	166	2	and	and	CCONJ
ajlm-297	166	3	j.r	j.r	PROPN
ajlm-297	166	4	.	.	PROPN
ajlm-297	167	1	(	(	PUNCT
ajlm-297	167	2	kenyatta	kenyatta	PROPN
ajlm-297	167	3	national	national	PROPN
ajlm-297	167	4	hospital	hospital	PROPN
ajlm-297	167	5	/	/	SYM
ajlm-297	167	6	university	university	PROPN
ajlm-297	167	7	of	of	ADP
ajlm-297	167	8	nairobi	nairobi	PROPN
ajlm-297	167	9	)	)	PUNCT
ajlm-297	167	10	were	be	AUX
ajlm-297	167	11	responsible	responsible	ADJ
ajlm-297	167	12	for	for	ADP
ajlm-297	167	13	experimental	experimental	ADJ
ajlm-297	167	14	and	and	CCONJ
ajlm-297	167	15	project	project	NOUN
ajlm-297	167	16	designs	design	NOUN
ajlm-297	167	17	.	.	PUNCT
ajlm-297	168	1	h.-g.h	h.-g.h	X
ajlm-297	168	2	.	.	PUNCT
ajlm-297	169	1	and	and	CCONJ
ajlm-297	169	2	r.b	r.b	PROPN
ajlm-297	169	3	.	.	PROPN
ajlm-297	169	4	(	(	PUNCT
ajlm-297	169	5	hannover	hannover	PROPN
ajlm-297	169	6	medical	medical	PROPN
ajlm-297	169	7	school	school	PROPN
ajlm-297	169	8	)	)	PUNCT
ajlm-297	169	9	provided	provide	VERB
ajlm-297	169	10	laboratory	laboratory	NOUN
ajlm-297	169	11	space	space	NOUN
ajlm-297	169	12	and	and	CCONJ
ajlm-297	169	13	reagents	reagent	NOUN
ajlm-297	169	14	and	and	CCONJ
ajlm-297	169	15	performed	perform	VERB
ajlm-297	169	16	some	some	PRON
ajlm-297	169	17	of	of	ADP
ajlm-297	169	18	the	the	DET
ajlm-297	169	19	experiments	experiment	NOUN
ajlm-297	169	20	.	.	PUNCT
ajlm-297	170	1	all	all	DET
ajlm-297	170	2	authors	author	NOUN
ajlm-297	170	3	were	be	AUX
ajlm-297	170	4	responsible	responsible	ADJ
ajlm-297	170	5	for	for	ADP
ajlm-297	170	6	polishing	polish	VERB
ajlm-297	170	7	and	and	CCONJ
ajlm-297	170	8	approving	approve	VERB
ajlm-297	170	9	the	the	DET
ajlm-297	170	10	final	final	ADJ
ajlm-297	170	11	manuscript	manuscript	NOUN
ajlm-297	170	12	.	.	PUNCT
ajlm-297	171	1	references	reference	NOUN
ajlm-297	171	2	top	top	VERB
ajlm-297	171	3	↑	↑	PROPN
ajlm-297	171	4	aluoch	aluoch	PROPN
ajlm-297	171	5	jr	jr	PROPN
ajlm-297	171	6	,	,	PUNCT
ajlm-297	171	7	aluoch	aluoch	PROPN
ajlm-297	171	8	lh	lh	PROPN
ajlm-297	171	9	.	.	PUNCT
ajlm-297	172	1	survey	survey	NOUN
ajlm-297	172	2	of	of	ADP
ajlm-297	172	3	sickle	sickle	NOUN
ajlm-297	172	4	disease	disease	NOUN
ajlm-297	172	5	in	in	ADP
ajlm-297	172	6	kenya	kenya	PROPN
ajlm-297	172	7	.	.	PUNCT
ajlm-297	173	1	trop	trop	PROPN
ajlm-297	173	2	geogr	geogr	VERB
ajlm-297	173	3	med	med	PROPN
ajlm-297	173	4	.	.	PUNCT
ajlm-297	174	1	1993;45(1):18–21	1993;45(1):18–21	X
ajlm-297	174	2	.	.	PUNCT
ajlm-297	174	3	strother	strother	PROPN
ajlm-297	174	4	rm	rm	PROPN
ajlm-297	174	5	,	,	PUNCT
ajlm-297	174	6	asirwa	asirwa	PROPN
ajlm-297	174	7	fc	fc	PROPN
ajlm-297	174	8	,	,	PUNCT
ajlm-297	174	9	busakhala	busakhala	PROPN
ajlm-297	174	10	nb	nb	PROPN
ajlm-297	174	11	,	,	PUNCT
ajlm-297	174	12	et	et	PROPN
ajlm-297	174	13	al	al	PROPN
ajlm-297	174	14	.	.	PUNCT
ajlm-297	175	1	the	the	DET
ajlm-297	175	2	evolution	evolution	NOUN
ajlm-297	175	3	of	of	ADP
ajlm-297	175	4	comprehensive	comprehensive	ADJ
ajlm-297	175	5	cancer	cancer	NOUN
ajlm-297	175	6	care	care	NOUN
ajlm-297	175	7	in	in	ADP
ajlm-297	175	8	western	western	ADJ
ajlm-297	175	9	kenya	kenya	PROPN
ajlm-297	175	10	.	.	PUNCT
ajlm-297	176	1	journal	journal	PROPN
ajlm-297	176	2	of	of	ADP
ajlm-297	176	3	cancer	cancer	NOUN
ajlm-297	176	4	policy	policy	NOUN
ajlm-297	176	5	.	.	PUNCT
ajlm-297	177	1	2013;1(1–2	2013;1(1–2	NUM
ajlm-297	177	2	):	):	PUNCT
ajlm-297	177	3	e25	e25	PROPN
ajlm-297	177	4	–	–	PUNCT
ajlm-297	177	5	e30	e30	NOUN
ajlm-297	177	6	.	.	PUNCT
ajlm-297	178	1	http://dx.doi.org/10.1016/j.jcpo.2013.04.001	http://dx.doi.org/10.1016/j.jcpo.2013.04.001	PROPN
ajlm-297	178	2	natukunda	natukunda	PROPN
ajlm-297	178	3	b	b	PROPN
ajlm-297	178	4	,	,	PUNCT
ajlm-297	178	5	schonewille	schonewille	NOUN
ajlm-297	178	6	h	h	NOUN
ajlm-297	178	7	,	,	PUNCT
ajlm-297	178	8	ndugwa	ndugwa	NOUN
ajlm-297	178	9	c	c	PROPN
ajlm-297	178	10	,	,	PUNCT
ajlm-297	178	11	et	et	PROPN
ajlm-297	178	12	al	al	PROPN
ajlm-297	178	13	.	.	PROPN
ajlm-297	178	14	red	red	ADJ
ajlm-297	178	15	blood	blood	NOUN
ajlm-297	178	16	cell	cell	NOUN
ajlm-297	178	17	alloimmunization	alloimmunization	NOUN
ajlm-297	178	18	in	in	ADP
ajlm-297	178	19	sickle	sickle	NOUN
ajlm-297	178	20	cell	cell	NOUN
ajlm-297	178	21	disease	disease	NOUN
ajlm-297	178	22	patients	patient	NOUN
ajlm-297	178	23	in	in	ADP
ajlm-297	178	24	uganda	uganda	PROPN
ajlm-297	178	25	.	.	PUNCT
ajlm-297	179	1	transfusion	transfusion	NOUN
ajlm-297	179	2	.	.	PUNCT
ajlm-297	180	1	2010;50(1):20–25	2010;50(1):20–25	X
ajlm-297	180	2	.	.	PUNCT
ajlm-297	180	3	http://dx.doi.org/10.1111/j.1537-2995.2009.02435.x	http://dx.doi.org/10.1111/j.1537-2995.2009.02435.x	PROPN
ajlm-297	180	4	klein	klein	PROPN
ajlm-297	180	5	hg	hg	PROPN
ajlm-297	180	6	,	,	PUNCT
ajlm-297	180	7	anstee	anstee	NOUN
ajlm-297	180	8	dj	dj	PROPN
ajlm-297	180	9	.	.	PUNCT
ajlm-297	180	10	immunology	immunology	NOUN
ajlm-297	180	11	of	of	ADP
ajlm-297	180	12	red	red	ADJ
ajlm-297	180	13	cells	cell	NOUN
ajlm-297	180	14	.	.	PUNCT
ajlm-297	181	1	in	in	ADP
ajlm-297	181	2	:	:	PUNCT
ajlm-297	181	3	klein	klein	PROPN
ajlm-297	181	4	hg	hg	PROPN
ajlm-297	181	5	,	,	PUNCT
ajlm-297	181	6	anstee	anstee	NOUN
ajlm-297	181	7	dj	dj	PROPN
ajlm-297	181	8	,	,	PUNCT
ajlm-297	181	9	editors	editor	NOUN
ajlm-297	181	10	.	.	PUNCT
ajlm-297	182	1	mollison	mollison	NOUN
ajlm-297	182	2	's	's	PART
ajlm-297	182	3	blood	blood	NOUN
ajlm-297	182	4	transfusion	transfusion	NOUN
ajlm-297	182	5	in	in	ADP
ajlm-297	182	6	clinical	clinical	ADJ
ajlm-297	182	7	medicine	medicine	NOUN
ajlm-297	182	8	.	.	PUNCT
ajlm-297	183	1	11th	11th	ADJ
ajlm-297	183	2	ed	ed	NOUN
ajlm-297	183	3	.	.	PUNCT
ajlm-297	184	1	oxford	oxford	PROPN
ajlm-297	184	2	:	:	PUNCT
ajlm-297	184	3	blackwell	blackwell	PROPN
ajlm-297	184	4	publishing	publishing	NOUN
ajlm-297	184	5	,	,	PUNCT
ajlm-297	184	6	2005	2005	NUM
ajlm-297	184	7	;	;	PUNCT
ajlm-297	185	1	p.	p.	PROPN
ajlm-297	185	2	48–113	48–113	NUM
ajlm-297	185	3	.	.	PUNCT
ajlm-297	186	1	http://dx.doi.org/10.1111/j.1537-2995.2007.01433.x	http://dx.doi.org/10.1111/j.1537-2995.2007.01433.x	PROPN
ajlm-297	186	2	bauer	bauer	PROPN
ajlm-297	186	3	mp	mp	PROPN
ajlm-297	186	4	,	,	PUNCT
ajlm-297	186	5	wiersum	wiersum	NOUN
ajlm-297	186	6	-	-	PUNCT
ajlm-297	186	7	osselton	osselton	PROPN
ajlm-297	186	8	j	j	PROPN
ajlm-297	186	9	,	,	PUNCT
ajlm-297	186	10	schipperus	schipperus	PROPN
ajlm-297	186	11	m	m	PROPN
ajlm-297	186	12	,	,	PUNCT
ajlm-297	186	13	et	et	PROPN
ajlm-297	186	14	al	al	PROPN
ajlm-297	186	15	.	.	PUNCT
ajlm-297	187	1	clinical	clinical	ADJ
ajlm-297	187	2	predictors	predictor	NOUN
ajlm-297	187	3	of	of	ADP
ajlm-297	187	4	alloimmunization	alloimmunization	NOUN
ajlm-297	187	5	after	after	ADP
ajlm-297	187	6	red	red	ADJ
ajlm-297	187	7	blood	blood	NOUN
ajlm-297	187	8	cell	cell	NOUN
ajlm-297	187	9	transfusion	transfusion	NOUN
ajlm-297	187	10	.	.	PUNCT
ajlm-297	188	1	transfusion	transfusion	NOUN
ajlm-297	188	2	.	.	PUNCT
ajlm-297	189	1	2007;47(11	2007;47(11	NUM
ajlm-297	189	2	):	):	PUNCT
ajlm-297	189	3	2066–2071	2066–2071	NUM
ajlm-297	189	4	.	.	PUNCT
ajlm-297	190	1	http://dx.doi.org/10.1111/j.1537-2995.2007.01433.x	http://dx.doi.org/10.1111/j.1537-2995.2007.01433.x	ADP
ajlm-297	190	2	de	de	PROPN
ajlm-297	190	3	la	la	PRON
ajlm-297	190	4	rubia	rubia	PROPN
ajlm-297	190	5	j	j	PROPN
ajlm-297	190	6	,	,	PUNCT
ajlm-297	190	7	arriaga	arriaga	PROPN
ajlm-297	190	8	f	f	PROPN
ajlm-297	190	9	,	,	PUNCT
ajlm-297	190	10	andreu	andreu	PROPN
ajlm-297	190	11	r	r	PROPN
ajlm-297	190	12	,	,	PUNCT
ajlm-297	190	13	et	et	PROPN
ajlm-297	190	14	al	al	PROPN
ajlm-297	190	15	.	.	PUNCT
ajlm-297	191	1	development	development	NOUN
ajlm-297	191	2	of	of	ADP
ajlm-297	191	3	non	non	ADJ
ajlm-297	191	4	-	-	ADJ
ajlm-297	191	5	abo	abo	ADJ
ajlm-297	191	6	rbc	rbc	PROPN
ajlm-297	191	7	alloantibodies	alloantibody	NOUN
ajlm-297	191	8	in	in	ADP
ajlm-297	191	9	patients	patient	NOUN
ajlm-297	191	10	undergoing	undergo	VERB
ajlm-297	191	11	allogeneic	allogeneic	ADJ
ajlm-297	191	12	hpc	hpc	NOUN
ajlm-297	191	13	transplantation	transplantation	NOUN
ajlm-297	191	14	.	.	PUNCT
ajlm-297	192	1	is	be	AUX
ajlm-297	192	2	abo	abo	ADJ
ajlm-297	192	3	incompatibility	incompatibility	NOUN
ajlm-297	192	4	a	a	DET
ajlm-297	192	5	predisposing	predispose	VERB
ajlm-297	192	6	factor	factor	NOUN
ajlm-297	192	7	?	?	PUNCT
ajlm-297	193	1	transfusion	transfusion	NOUN
ajlm-297	193	2	.	.	PUNCT
ajlm-297	194	1	2001;41(1):106–110	2001;41(1):106–110	X
ajlm-297	194	2	.	.	PUNCT
ajlm-297	195	1	http://dx.doi.org/10.1046/j.1537-2995.2001.41010106.x	http://dx.doi.org/10.1046/j.1537-2995.2001.41010106.x	PRON
ajlm-297	195	2	franchini	franchini	PROPN
ajlm-297	195	3	m	m	PROPN
ajlm-297	195	4	,	,	PUNCT
ajlm-297	195	5	gandini	gandini	VERB
ajlm-297	195	6	g	g	NOUN
ajlm-297	195	7	,	,	PUNCT
ajlm-297	195	8	aprili	aprili	PROPN
ajlm-297	195	9	g.	g.	PROPN
ajlm-297	195	10	non	non	ADJ
ajlm-297	195	11	-	-	ADJ
ajlm-297	195	12	abo	abo	ADJ
ajlm-297	195	13	red	red	ADJ
ajlm-297	195	14	blood	blood	NOUN
ajlm-297	195	15	cell	cell	NOUN
ajlm-297	195	16	alloantibodies	alloantibody	NOUN
ajlm-297	195	17	following	follow	VERB
ajlm-297	195	18	allogeneic	allogeneic	ADJ
ajlm-297	195	19	hematopoietic	hematopoietic	ADJ
ajlm-297	195	20	stem	stem	NOUN
ajlm-297	195	21	cell	cell	NOUN
ajlm-297	195	22	transplantation	transplantation	NOUN
ajlm-297	195	23	.	.	PUNCT
ajlm-297	196	1	bone	bone	NOUN
ajlm-297	196	2	marrow	marrow	PROPN
ajlm-297	196	3	transplant	transplant	NOUN
ajlm-297	196	4	.	.	PUNCT
ajlm-297	197	1	2004;33(12):1169–1172	2004;33(12):1169–1172	NOUN
ajlm-297	197	2	.	.	PUNCT
ajlm-297	198	1	http://dx.doi.org/10.1038/sj.bmt.1704524	http://dx.doi.org/10.1038/sj.bmt.1704524	PROPN
ajlm-297	198	2	ahrens	ahren	NOUN
ajlm-297	198	3	n	n	CCONJ
ajlm-297	198	4	,	,	PUNCT
ajlm-297	198	5	pruss	pruss	NOUN
ajlm-297	198	6	a	a	PRON
ajlm-297	198	7	,	,	PUNCT
ajlm-297	198	8	mayer	mayer	PROPN
ajlm-297	198	9	b	b	PROPN
ajlm-297	198	10	,	,	PUNCT
ajlm-297	198	11	et	et	PROPN
ajlm-297	198	12	al	al	PROPN
ajlm-297	198	13	.	.	PROPN
ajlm-297	198	14	association	association	PROPN
ajlm-297	198	15	between	between	ADP
ajlm-297	198	16	alloantibody	alloantibody	ADJ
ajlm-297	198	17	specificity	specificity	NOUN
ajlm-297	198	18	and	and	CCONJ
ajlm-297	198	19	autoantibodies	autoantibody	NOUN
ajlm-297	198	20	to	to	ADP
ajlm-297	198	21	red	red	ADJ
ajlm-297	198	22	blood	blood	NOUN
ajlm-297	198	23	cells	cell	NOUN
ajlm-297	198	24	.	.	PUNCT
ajlm-297	199	1	transfusion	transfusion	NOUN
ajlm-297	199	2	.	.	PUNCT
ajlm-297	200	1	2008;48(1):20–24	2008;48(1):20–24	X
ajlm-297	200	2	.	.	PUNCT
ajlm-297	201	1	singer	singer	PROPN
ajlm-297	201	2	st	st	PROPN
ajlm-297	201	3	,	,	PUNCT
ajlm-297	201	4	wu	wu	PROPN
ajlm-297	201	5	v	v	PROPN
ajlm-297	201	6	,	,	PUNCT
ajlm-297	201	7	mignacca	mignacca	ADJ
ajlm-297	201	8	r	r	NOUN
ajlm-297	201	9	,	,	PUNCT
ajlm-297	201	10	et	et	PROPN
ajlm-297	201	11	al	al	PROPN
ajlm-297	201	12	.	.	PROPN
ajlm-297	201	13	alloimmunization	alloimmunization	NOUN
ajlm-297	201	14	and	and	CCONJ
ajlm-297	201	15	erythrocyte	erythrocyte	NOUN
ajlm-297	201	16	autoimmunization	autoimmunization	NOUN
ajlm-297	201	17	in	in	ADP
ajlm-297	201	18	transfusion	transfusion	NOUN
ajlm-297	201	19	-	-	PUNCT
ajlm-297	201	20	dependent	dependent	ADJ
ajlm-297	201	21	thalassemia	thalassemia	NOUN
ajlm-297	201	22	patients	patient	NOUN
ajlm-297	201	23	of	of	ADP
ajlm-297	201	24	predominantly	predominantly	ADV
ajlm-297	201	25	asian	asian	ADJ
ajlm-297	201	26	descent	descent	NOUN
ajlm-297	201	27	.	.	PUNCT
ajlm-297	202	1	blood	blood	NOUN
ajlm-297	202	2	.	.	PUNCT
ajlm-297	203	1	2000;96(10):3369–3373	2000;96(10):3369–3373	NOUN
ajlm-297	203	2	.	.	PUNCT
ajlm-297	204	1	rosse	rosse	PROPN
ajlm-297	204	2	wf	wf	PROPN
ajlm-297	204	3	,	,	PUNCT
ajlm-297	204	4	gallagher	gallagher	PROPN
ajlm-297	204	5	d	d	PROPN
ajlm-297	204	6	,	,	PUNCT
ajlm-297	204	7	kinney	kinney	PROPN
ajlm-297	204	8	tr	tr	VERB
ajlm-297	204	9	,	,	PUNCT
ajlm-297	204	10	et	et	PROPN
ajlm-297	204	11	al	al	PROPN
ajlm-297	204	12	.	.	PUNCT
ajlm-297	205	1	transfusion	transfusion	NOUN
ajlm-297	205	2	and	and	CCONJ
ajlm-297	205	3	alloimmunization	alloimmunization	NOUN
ajlm-297	205	4	in	in	ADP
ajlm-297	205	5	sickle	sickle	NOUN
ajlm-297	205	6	cell	cell	NOUN
ajlm-297	205	7	disease	disease	NOUN
ajlm-297	205	8	.	.	PUNCT
ajlm-297	206	1	blood	blood	NOUN
ajlm-297	206	2	.	.	PUNCT
ajlm-297	207	1	1990;76(7):1431–1437	1990;76(7):1431–1437	NUM
ajlm-297	207	2	.	.	PUNCT
ajlm-297	208	1	seyfried	seyfried	PROPN
ajlm-297	208	2	h	h	NOUN
ajlm-297	208	3	,	,	PUNCT
ajlm-297	208	4	walewska	walewska	PROPN
ajlm-297	208	5	i.	i.	NOUN
ajlm-297	208	6	analysis	analysis	NOUN
ajlm-297	208	7	of	of	ADP
ajlm-297	208	8	immune	immune	ADJ
ajlm-297	208	9	response	response	NOUN
ajlm-297	208	10	to	to	ADP
ajlm-297	208	11	red	red	ADJ
ajlm-297	208	12	blood	blood	NOUN
ajlm-297	208	13	cell	cell	NOUN
ajlm-297	208	14	antigens	antigen	NOUN
ajlm-297	208	15	in	in	ADP
ajlm-297	208	16	multitransfused	multitransfuse	VERB
ajlm-297	208	17	patients	patient	NOUN
ajlm-297	208	18	with	with	ADP
ajlm-297	208	19	different	different	ADJ
ajlm-297	208	20	diseases	disease	NOUN
ajlm-297	208	21	.	.	PUNCT
ajlm-297	209	1	mater	mater	NOUN
ajlm-297	209	2	med	med	PROPN
ajlm-297	209	3	pol	pol	PROPN
ajlm-297	209	4	.	.	PUNCT
ajlm-297	210	1	1990;22(1	1990;22(1	NUM
ajlm-297	210	2	):	):	PUNCT
ajlm-297	210	3	21–25	21–25	NUM
ajlm-297	210	4	.	.	PUNCT
ajlm-297	211	1	norol	norol	PROPN
ajlm-297	211	2	f	f	PROPN
ajlm-297	211	3	,	,	PUNCT
ajlm-297	211	4	nadjahi	nadjahi	PROPN
ajlm-297	211	5	j	j	PROPN
ajlm-297	211	6	,	,	PUNCT
ajlm-297	211	7	bachir	bachir	ADJ
ajlm-297	211	8	d	d	NOUN
ajlm-297	211	9	,	,	PUNCT
ajlm-297	211	10	et	et	PROPN
ajlm-297	211	11	al	al	PROPN
ajlm-297	211	12	.	.	PUNCT
ajlm-297	212	1	[	[	X
ajlm-297	212	2	transfusion	transfusion	NOUN
ajlm-297	212	3	and	and	CCONJ
ajlm-297	212	4	alloimmunization	alloimmunization	NOUN
ajlm-297	212	5	in	in	ADP
ajlm-297	212	6	sickle	sickle	PROPN
ajlm-297	212	7	cell	cell	NOUN
ajlm-297	212	8	anemia	anemia	NOUN
ajlm-297	212	9	patients	patient	NOUN
ajlm-297	212	10	]	]	PUNCT
ajlm-297	212	11	article	article	NOUN
ajlm-297	212	12	in	in	ADP
ajlm-297	212	13	french	french	PROPN
ajlm-297	212	14	.	.	PUNCT
ajlm-297	213	1	transfus	transfus	PROPN
ajlm-297	213	2	clin	clin	PROPN
ajlm-297	213	3	biol	biol	PROPN
ajlm-297	213	4	.	.	PUNCT
ajlm-297	214	1	1994;1(1):27–34	1994;1(1):27–34	NUM
ajlm-297	214	2	.	.	PUNCT
ajlm-297	215	1	http://dx.doi.org/10.1016/s1246-7820(05)80054-0	http://dx.doi.org/10.1016/s1246-7820(05)80054-0	NOUN
ajlm-297	215	2	talano	talano	PROPN
ajlm-297	215	3	ja	ja	PROPN
ajlm-297	215	4	,	,	PUNCT
ajlm-297	215	5	hillery	hillery	PROPN
ajlm-297	215	6	ca	ca	PROPN
ajlm-297	215	7	,	,	PUNCT
ajlm-297	215	8	gottschall	gottschall	PROPN
ajlm-297	215	9	jl	jl	PROPN
ajlm-297	215	10	,	,	PUNCT
ajlm-297	215	11	et	et	PROPN
ajlm-297	215	12	al	al	PROPN
ajlm-297	215	13	.	.	PROPN
ajlm-297	215	14	delayed	delay	VERB
ajlm-297	215	15	hemolytic	hemolytic	ADJ
ajlm-297	215	16	transfusion	transfusion	NOUN
ajlm-297	215	17	reaction	reaction	NOUN
ajlm-297	215	18	/	/	SYM
ajlm-297	215	19	hyperhemolysis	hyperhemolysis	NOUN
ajlm-297	215	20	syndrome	syndrome	NOUN
ajlm-297	215	21	in	in	ADP
ajlm-297	215	22	children	child	NOUN
ajlm-297	215	23	with	with	ADP
ajlm-297	215	24	sickle	sickle	NOUN
ajlm-297	215	25	cell	cell	NOUN
ajlm-297	215	26	disease	disease	NOUN
ajlm-297	215	27	.	.	PUNCT
ajlm-297	216	1	pediatrics	pediatric	NOUN
ajlm-297	216	2	.	.	PUNCT
ajlm-297	217	1	2003;111(6	2003;111(6	NUM
ajlm-297	217	2	pt	pt	NOUN
ajlm-297	217	3	1);e661	1);e661	NUM
ajlm-297	217	4	–	–	PUNCT
ajlm-297	217	5	e665	e665	NUM
ajlm-297	217	6	.	.	PUNCT
ajlm-297	218	1	http://dx.doi.org/10.1542/peds.111.6.e661	http://dx.doi.org/10.1542/peds.111.6.e661	PROPN
ajlm-297	218	2	aly	aly	PROPN
ajlm-297	218	3	r	r	PROPN
ajlm-297	218	4	,	,	PUNCT
ajlm-297	218	5	el	el	PROPN
ajlm-297	218	6	-	-	PUNCT
ajlm-297	218	7	sharnoby	sharnoby	NOUN
ajlm-297	218	8	mr	mr	PROPN
ajlm-297	218	9	,	,	PUNCT
ajlm-297	218	10	hagag	hagag	PROPN
ajlm-297	218	11	aa	aa	PROPN
ajlm-297	218	12	.	.	PUNCT
ajlm-297	218	13	frequency	frequency	PROPN
ajlm-297	218	14	of	of	ADP
ajlm-297	218	15	red	red	ADJ
ajlm-297	218	16	cell	cell	NOUN
ajlm-297	218	17	alloimmunization	alloimmunization	NOUN
ajlm-297	218	18	in	in	ADP
ajlm-297	218	19	patients	patient	NOUN
ajlm-297	218	20	with	with	ADP
ajlm-297	218	21	sickle	sickle	PROPN
ajlm-297	218	22	cell	cell	NOUN
ajlm-297	218	23	anemia	anemia	NOUN
ajlm-297	218	24	in	in	ADP
ajlm-297	218	25	an	an	DET
ajlm-297	218	26	egyptian	egyptian	ADJ
ajlm-297	218	27	referral	referral	NOUN
ajlm-297	218	28	hospital	hospital	NOUN
ajlm-297	218	29	.	.	PUNCT
ajlm-297	219	1	transfus	transfus	PROPN
ajlm-297	219	2	apher	apher	PROPN
ajlm-297	219	3	sci	sci	PROPN
ajlm-297	219	4	.	.	PUNCT
ajlm-297	220	1	2012;47(3):253–257	2012;47(3):253–257	PROPN
ajlm-297	220	2	.	.	PUNCT
ajlm-297	221	1	http://dx.doi.org/10.1016/j.transci.2012.07.014	http://dx.doi.org/10.1016/j.transci.2012.07.014	PROPN
ajlm-297	221	2	guirat	guirat	NOUN
ajlm-297	221	3	-	-	PUNCT
ajlm-297	221	4	dhouib	dhouib	PROPN
ajlm-297	221	5	n	n	CCONJ
ajlm-297	221	6	,	,	PUNCT
ajlm-297	221	7	mezri	mezri	PROPN
ajlm-297	221	8	m	m	PROPN
ajlm-297	221	9	,	,	PUNCT
ajlm-297	221	10	hmida	hmida	PROPN
ajlm-297	221	11	h	h	PROPN
ajlm-297	221	12	,	,	PUNCT
ajlm-297	221	13	et	et	PROPN
ajlm-297	221	14	al	al	PROPN
ajlm-297	221	15	.	.	PROPN
ajlm-297	221	16	high	high	ADJ
ajlm-297	221	17	frequency	frequency	NOUN
ajlm-297	221	18	of	of	ADP
ajlm-297	221	19	autoimmunization	autoimmunization	NOUN
ajlm-297	221	20	among	among	ADP
ajlm-297	221	21	transfusion	transfusion	NOUN
ajlm-297	221	22	-	-	PUNCT
ajlm-297	221	23	dependent	dependent	ADJ
ajlm-297	221	24	tunisian	tunisian	ADJ
ajlm-297	221	25	thalassaemia	thalassaemia	NOUN
ajlm-297	221	26	patients	patient	NOUN
ajlm-297	221	27	.	.	PUNCT
ajlm-297	222	1	transfus	transfus	PROPN
ajlm-297	222	2	apher	apher	PROPN
ajlm-297	222	3	sci	sci	PROPN
ajlm-297	222	4	.	.	PUNCT
ajlm-297	223	1	2011;45(2):199–202	2011;45(2):199–202	NUM
ajlm-297	223	2	.	.	PUNCT
ajlm-297	224	1	http://dx.doi.org/10.1016/j.transci.2011.08.003	http://dx.doi.org/10.1016/j.transci.2011.08.003	PROPN
ajlm-297	224	2	natukunda	natukunda	PROPN
ajlm-297	224	3	b	b	PROPN
ajlm-297	224	4	,	,	PUNCT
ajlm-297	224	5	schonewille	schonewille	NOUN
ajlm-297	224	6	h	h	NOUN
ajlm-297	224	7	,	,	PUNCT
ajlm-297	224	8	van	van	PROPN
ajlm-297	224	9	de	de	X
ajlm-297	224	10	watering	watering	NOUN
ajlm-297	224	11	l	l	NOUN
ajlm-297	224	12	,	,	PUNCT
ajlm-297	224	13	et	et	PROPN
ajlm-297	224	14	al	al	PROPN
ajlm-297	224	15	.	.	PUNCT
ajlm-297	225	1	prevalence	prevalence	NOUN
ajlm-297	225	2	and	and	CCONJ
ajlm-297	225	3	specificities	specificity	NOUN
ajlm-297	225	4	of	of	ADP
ajlm-297	225	5	red	red	ADJ
ajlm-297	225	6	blood	blood	NOUN
ajlm-297	225	7	cell	cell	NOUN
ajlm-297	225	8	alloantibodies	alloantibody	NOUN
ajlm-297	225	9	in	in	ADP
ajlm-297	225	10	transfused	transfused	ADJ
ajlm-297	225	11	ugandans	ugandans	PROPN
ajlm-297	225	12	with	with	ADP
ajlm-297	225	13	different	different	ADJ
ajlm-297	225	14	diseases	disease	NOUN
ajlm-297	225	15	.	.	PUNCT
ajlm-297	226	1	vox	vox	PROPN
ajlm-297	226	2	sang	sing	VERB
ajlm-297	226	3	.	.	PUNCT
ajlm-297	227	1	2010;98(2):167–171	2010;98(2):167–171	X
ajlm-297	227	2	.	.	PUNCT
ajlm-297	228	1	http://dx.doi.org/10.1111/j.1423-0410.2009.01241.x	http://dx.doi.org/10.1111/j.1423-0410.2009.01241.x	NOUN
ajlm-297	228	2	fhi360	fhi360	PROPN
ajlm-297	228	3	.	.	PUNCT
ajlm-297	229	1	guidelines	guideline	NOUN
ajlm-297	229	2	for	for	ADP
ajlm-297	229	3	the	the	DET
ajlm-297	229	4	appropriate	appropriate	ADJ
ajlm-297	229	5	use	use	NOUN
ajlm-297	229	6	of	of	ADP
ajlm-297	229	7	blood	blood	NOUN
ajlm-297	229	8	and	and	CCONJ
ajlm-297	229	9	blood	blood	NOUN
ajlm-297	229	10	products	product	NOUN
ajlm-297	229	11	.	.	PUNCT
ajlm-297	230	1	second	second	ADJ
ajlm-297	230	2	edition	edition	NOUN
ajlm-297	230	3	april	april	PROPN
ajlm-297	230	4	2004	2004	NUM
ajlm-297	231	1	[	[	X
ajlm-297	231	2	document	document	NOUN
ajlm-297	231	3	on	on	ADP
ajlm-297	231	4	the	the	DET
ajlm-297	231	5	internet	internet	NOUN
ajlm-297	231	6	]	]	PUNCT
ajlm-297	231	7	.	.	PUNCT
ajlm-297	232	1	c2004	c2004	PROPN
ajlm-297	233	1	[	[	PUNCT
ajlm-297	233	2	20	20	NUM
ajlm-297	233	3	april	april	PROPN
ajlm-297	233	4	2014	2014	NUM
ajlm-297	233	5	]	]	PUNCT
ajlm-297	233	6	.	.	PUNCT
ajlm-297	234	1	available	available	ADJ
ajlm-297	234	2	from	from	ADP
ajlm-297	234	3	:	:	PUNCT
ajlm-297	234	4	http://www.fhi360.org/sites/default/files/media/documents/guidelines%20for%20the%20appropriate%20use%20of%20blood%20and%20blood%20products.pdf	http://www.fhi360.org/sites/default/files/media/documents/guidelines%20for%20the%20appropriate%20use%20of%20blood%20and%20blood%20products.pdf	PROPN
ajlm-297	234	5	world	world	PROPN
ajlm-297	234	6	health	health	PROPN
ajlm-297	234	7	organization	organization	PROPN
ajlm-297	234	8	.	.	PUNCT
ajlm-297	235	1	worldwide	worldwide	ADJ
ajlm-297	235	2	prevalence	prevalence	NOUN
ajlm-297	235	3	of	of	ADP
ajlm-297	235	4	anaemia	anaemia	NOUN
ajlm-297	235	5	1993–2005	1993–2005	NUM
ajlm-297	235	6	:	:	PUNCT
ajlm-297	236	1	who	who	PRON
ajlm-297	236	2	global	global	ADJ
ajlm-297	236	3	database	database	NOUN
ajlm-297	236	4	on	on	ADP
ajlm-297	236	5	anaemia	anaemia	NOUN
ajlm-297	236	6	[	[	X
ajlm-297	236	7	document	document	NOUN
ajlm-297	236	8	on	on	ADP
ajlm-297	236	9	the	the	DET
ajlm-297	236	10	internet	internet	NOUN
ajlm-297	236	11	]	]	PUNCT
ajlm-297	236	12	.	.	PUNCT
ajlm-297	237	1	c2008	c2008	NOUN
ajlm-297	238	1	[	[	X
ajlm-297	238	2	24	24	NUM
ajlm-297	238	3	april	april	PROPN
ajlm-297	238	4	2014	2014	NUM
ajlm-297	238	5	]	]	PUNCT
ajlm-297	238	6	.	.	PUNCT
ajlm-297	239	1	available	available	ADJ
ajlm-297	239	2	from	from	ADP
ajlm-297	239	3	:	:	PUNCT
ajlm-297	239	4	http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf	http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf	NOUN
ajlm-297	239	5	olujohungbe	olujohungbe	NOUN
ajlm-297	239	6	a	a	PRON
ajlm-297	239	7	,	,	PUNCT
ajlm-297	239	8	hambleton	hambleton	PROPN
ajlm-297	239	9	i	i	PRON
ajlm-297	239	10	,	,	PUNCT
ajlm-297	239	11	stephens	stephens	PROPN
ajlm-297	239	12	l	l	PROPN
ajlm-297	239	13	,	,	PUNCT
ajlm-297	239	14	et	et	PROPN
ajlm-297	239	15	al	al	PROPN
ajlm-297	239	16	.	.	PROPN
ajlm-297	239	17	red	red	PROPN
ajlm-297	239	18	cell	cell	NOUN
ajlm-297	239	19	antibodies	antibodie	VERB
ajlm-297	239	20	in	in	ADP
ajlm-297	239	21	patients	patient	NOUN
ajlm-297	239	22	with	with	ADP
ajlm-297	239	23	homozygous	homozygous	ADJ
ajlm-297	239	24	sickle	sickle	NOUN
ajlm-297	239	25	cell	cell	NOUN
ajlm-297	239	26	disease	disease	NOUN
ajlm-297	239	27	:	:	PUNCT
ajlm-297	239	28	a	a	DET
ajlm-297	239	29	comparison	comparison	NOUN
ajlm-297	239	30	of	of	ADP
ajlm-297	239	31	patients	patient	NOUN
ajlm-297	239	32	in	in	ADP
ajlm-297	239	33	jamaica	jamaica	PROPN
ajlm-297	239	34	and	and	CCONJ
ajlm-297	239	35	the	the	DET
ajlm-297	239	36	united	united	ADJ
ajlm-297	239	37	kingdom	kingdom	PROPN
ajlm-297	239	38	.	.	PUNCT
ajlm-297	240	1	br	br	PROPN
ajlm-297	240	2	j	j	PROPN
ajlm-297	240	3	haematol	haematol	NOUN
ajlm-297	240	4	.	.	PUNCT
ajlm-297	241	1	2001;113(3):661–665	2001;113(3):661–665	NUM
ajlm-297	241	2	.	.	PUNCT
ajlm-297	241	3	http://dx.doi.org/10.1046/j.1365-2141.2001.02819.x	http://dx.doi.org/10.1046/j.1365-2141.2001.02819.x	PRON
ajlm-297	241	4	hmida	hmida	PROPN
ajlm-297	241	5	s	s	PROPN
ajlm-297	241	6	,	,	PUNCT
ajlm-297	241	7	mojaat	mojaat	PROPN
ajlm-297	241	8	n	n	CCONJ
ajlm-297	241	9	,	,	PUNCT
ajlm-297	241	10	maamar	maamar	PROPN
ajlm-297	241	11	m	m	PROPN
ajlm-297	241	12	,	,	PUNCT
ajlm-297	241	13	et	et	PROPN
ajlm-297	241	14	al	al	PROPN
ajlm-297	241	15	.	.	PROPN
ajlm-297	241	16	red	red	ADJ
ajlm-297	241	17	cell	cell	NOUN
ajlm-297	241	18	alloantibodies	alloantibody	NOUN
ajlm-297	241	19	in	in	ADP
ajlm-297	241	20	patients	patient	NOUN
ajlm-297	241	21	with	with	ADP
ajlm-297	241	22	haemoglobinopathies	haemoglobinopathy	NOUN
ajlm-297	241	23	.	.	PUNCT
ajlm-297	242	1	nouv	nouv	PROPN
ajlm-297	242	2	rev	rev	VERB
ajlm-297	242	3	fr	fr	PROPN
ajlm-297	242	4	hematol	hematol	NOUN
ajlm-297	242	5	.	.	PUNCT
ajlm-297	243	1	1994;36(5):363–366	1994;36(5):363–366	X
ajlm-297	243	2	.	.	PUNCT
ajlm-297	244	1	sarnaik	sarnaik	PROPN
ajlm-297	244	2	s	s	PROPN
ajlm-297	244	3	,	,	PUNCT
ajlm-297	244	4	schornack	schornack	PROPN
ajlm-297	244	5	j	j	PROPN
ajlm-297	244	6	,	,	PUNCT
ajlm-297	244	7	lusher	lusher	PROPN
ajlm-297	244	8	jm	jm	PROPN
ajlm-297	244	9	.	.	PUNCT
ajlm-297	245	1	the	the	DET
ajlm-297	245	2	incidence	incidence	NOUN
ajlm-297	245	3	of	of	ADP
ajlm-297	245	4	development	development	NOUN
ajlm-297	245	5	of	of	ADP
ajlm-297	245	6	irregular	irregular	ADJ
ajlm-297	245	7	red	red	ADJ
ajlm-297	245	8	cell	cell	NOUN
ajlm-297	245	9	antibodies	antibodie	VERB
ajlm-297	245	10	in	in	ADP
ajlm-297	245	11	patients	patient	NOUN
ajlm-297	245	12	with	with	ADP
ajlm-297	245	13	sickle	sickle	NOUN
ajlm-297	245	14	cell	cell	NOUN
ajlm-297	245	15	anemia	anemia	NOUN
ajlm-297	245	16	.	.	PUNCT
ajlm-297	246	1	transfusion	transfusion	NOUN
ajlm-297	246	2	.	.	PUNCT
ajlm-297	247	1	1986;26(3	1986;26(3	NUM
ajlm-297	247	2	):	):	PUNCT
ajlm-297	247	3	249–252	249–252	NUM
ajlm-297	247	4	.	.	PUNCT
ajlm-297	248	1	http://dx.doi.org/10.1046/j.1537-2995.1986.26386209381.x	http://dx.doi.org/10.1046/j.1537-2995.1986.26386209381.x	ADP
ajlm-297	248	2	mohsin	mohsin	PROPN
ajlm-297	248	3	s	s	PROPN
ajlm-297	248	4	,	,	PUNCT
ajlm-297	248	5	amjad	amjad	PROPN
ajlm-297	248	6	s	s	PROPN
ajlm-297	248	7	,	,	PUNCT
ajlm-297	248	8	amin	amin	NOUN
ajlm-297	248	9	h	h	PROPN
ajlm-297	248	10	,	,	PUNCT
ajlm-297	248	11	et	et	PROPN
ajlm-297	248	12	al	al	PROPN
ajlm-297	248	13	.	.	PROPN
ajlm-297	248	14	red	red	ADJ
ajlm-297	248	15	cell	cell	NOUN
ajlm-297	248	16	alloimmunization	alloimmunization	NOUN
ajlm-297	248	17	in	in	ADP
ajlm-297	248	18	repeatedly	repeatedly	ADV
ajlm-297	248	19	transfused	transfuse	VERB
ajlm-297	248	20	cancer	cancer	NOUN
ajlm-297	248	21	patients	patient	NOUN
ajlm-297	248	22	.	.	PUNCT
ajlm-297	249	1	journal	journal	PROPN
ajlm-297	249	2	of	of	ADP
ajlm-297	249	3	rawalpindi	rawalpindi	PROPN
ajlm-297	249	4	medical	medical	PROPN
ajlm-297	249	5	college	college	PROPN
ajlm-297	249	6	(	(	PUNCT
ajlm-297	249	7	jrmc	jrmc	PROPN
ajlm-297	249	8	)	)	PUNCT
ajlm-297	249	9	.	.	PUNCT
ajlm-297	250	1	2013;17(2):219–222	2013;17(2):219–222	X
ajlm-297	250	2	.	.	NOUN
ajlm-297	250	3	sirchia	sirchia	VERB
ajlm-297	250	4	g	g	NOUN
ajlm-297	250	5	,	,	PUNCT
ajlm-297	250	6	zanella	zanella	PROPN
ajlm-297	250	7	a	a	PRON
ajlm-297	250	8	,	,	PUNCT
ajlm-297	250	9	parravicini	parravicini	VERB
ajlm-297	250	10	a	a	PRON
ajlm-297	250	11	,	,	PUNCT
ajlm-297	250	12	et	et	PROPN
ajlm-297	250	13	al	al	PROPN
ajlm-297	250	14	.	.	PROPN
ajlm-297	250	15	red	red	ADJ
ajlm-297	250	16	cell	cell	NOUN
ajlm-297	250	17	alloantibodies	alloantibody	NOUN
ajlm-297	250	18	in	in	ADP
ajlm-297	250	19	thalassemia	thalassemia	PROPN
ajlm-297	250	20	major	major	NOUN
ajlm-297	250	21	:	:	PUNCT
ajlm-297	250	22	results	result	NOUN
ajlm-297	250	23	of	of	ADP
ajlm-297	250	24	an	an	DET
ajlm-297	250	25	italian	italian	ADJ
ajlm-297	250	26	cooperative	cooperative	ADJ
ajlm-297	250	27	study	study	NOUN
ajlm-297	250	28	.	.	PUNCT
ajlm-297	251	1	transfusion	transfusion	NOUN
ajlm-297	251	2	.	.	PUNCT
ajlm-297	252	1	1985	1985	NUM
ajlm-297	252	2	;	;	PUNCT
ajlm-297	253	1	25(2):110–112	25(2):110–112	NUM
ajlm-297	253	2	.	.	PUNCT
ajlm-297	254	1	http://dx.doi.org/10.1046/j.1537-2995.1985.25285169198.x	http://dx.doi.org/10.1046/j.1537-2995.1985.25285169198.x	VERB
ajlm-297	254	2	murao	murao	NOUN
ajlm-297	254	3	m	m	PROPN
ajlm-297	254	4	,	,	PUNCT
ajlm-297	254	5	viana	viana	PROPN
ajlm-297	254	6	mb	mb	PROPN
ajlm-297	254	7	.	.	PROPN
ajlm-297	254	8	risk	risk	NOUN
ajlm-297	254	9	factors	factor	NOUN
ajlm-297	254	10	for	for	ADP
ajlm-297	254	11	alloimmunization	alloimmunization	NOUN
ajlm-297	254	12	by	by	ADP
ajlm-297	254	13	patients	patient	NOUN
ajlm-297	254	14	with	with	ADP
ajlm-297	254	15	sickle	sickle	NOUN
ajlm-297	254	16	cell	cell	NOUN
ajlm-297	254	17	disease	disease	NOUN
ajlm-297	254	18	.	.	PUNCT
ajlm-297	255	1	braz	braz	PROPN
ajlm-297	255	2	j	j	PROPN
ajlm-297	255	3	med	med	PROPN
ajlm-297	255	4	biol	biol	PROPN
ajlm-297	255	5	res	re	NOUN
ajlm-297	255	6	.	.	PUNCT
ajlm-297	256	1	2005;38(5):675–682	2005;38(5):675–682	X
ajlm-297	256	2	.	.	PUNCT
ajlm-297	257	1	http://dx.doi.org/10.1590/s0100-879x2005000500004	http://dx.doi.org/10.1590/s0100-879x2005000500004	PROPN
ajlm-297	257	2	aygun	aygun	VERB
ajlm-297	257	3	b	b	X
ajlm-297	257	4	,	,	PUNCT
ajlm-297	257	5	padmanabhan	padmanabhan	PROPN
ajlm-297	257	6	s	s	PROPN
ajlm-297	257	7	,	,	PUNCT
ajlm-297	257	8	paley	paley	PROPN
ajlm-297	257	9	c	c	PROPN
ajlm-297	257	10	,	,	PUNCT
ajlm-297	257	11	et	et	PROPN
ajlm-297	257	12	al	al	PROPN
ajlm-297	257	13	.	.	PROPN
ajlm-297	258	1	clinical	clinical	ADJ
ajlm-297	258	2	significance	significance	NOUN
ajlm-297	258	3	of	of	ADP
ajlm-297	258	4	rbc	rbc	PROPN
ajlm-297	258	5	alloantibodies	alloantibody	NOUN
ajlm-297	258	6	and	and	CCONJ
ajlm-297	258	7	autoantibodies	autoantibody	NOUN
ajlm-297	258	8	in	in	ADP
ajlm-297	258	9	sickle	sickle	NOUN
ajlm-297	258	10	cell	cell	NOUN
ajlm-297	258	11	patients	patient	NOUN
ajlm-297	258	12	who	who	PRON
ajlm-297	258	13	received	receive	VERB
ajlm-297	258	14	transfusions	transfusion	NOUN
ajlm-297	258	15	.	.	PUNCT
ajlm-297	259	1	transfusion	transfusion	NOUN
ajlm-297	259	2	.	.	PUNCT
ajlm-297	260	1	2002;42(1):37–43	2002;42(1):37–43	X
ajlm-297	260	2	.	.	PUNCT
ajlm-297	260	3	http://dx.doi.org/10.1046/j.1537-2995.2002.00007.x	http://dx.doi.org/10.1046/j.1537-2995.2002.00007.x	PROPN
ajlm-297	260	4	schonewille	schonewille	NOUN
ajlm-297	260	5	h	h	PROPN
ajlm-297	260	6	,	,	PUNCT
ajlm-297	260	7	haak	haak	NOUN
ajlm-297	260	8	hl	hl	NOUN
ajlm-297	260	9	,	,	PUNCT
ajlm-297	260	10	van	van	PROPN
ajlm-297	260	11	zijl	zijl	PROPN
ajlm-297	260	12	am	be	AUX
ajlm-297	260	13	.	.	PUNCT
ajlm-297	260	14	alloimmunization	alloimmunization	NOUN
ajlm-297	260	15	after	after	ADP
ajlm-297	260	16	blood	blood	NOUN
ajlm-297	260	17	transfusion	transfusion	NOUN
ajlm-297	260	18	in	in	ADP
ajlm-297	260	19	patients	patient	NOUN
ajlm-297	260	20	with	with	ADP
ajlm-297	260	21	hematologic	hematologic	NOUN
ajlm-297	260	22	and	and	CCONJ
ajlm-297	260	23	oncologic	oncologic	NOUN
ajlm-297	260	24	diseases	disease	NOUN
ajlm-297	260	25	.	.	PUNCT
ajlm-297	261	1	transfusion	transfusion	NOUN
ajlm-297	261	2	.	.	PUNCT
ajlm-297	262	1	1999;39(7	1999;39(7	NUM
ajlm-297	262	2	):	):	PUNCT
ajlm-297	262	3	763–771	763–771	NUM
ajlm-297	262	4	.	.	PUNCT
ajlm-297	263	1	http://dx.doi.org/10.1046/j.1537-2995.1999.39070763.x	http://dx.doi.org/10.1046/j.1537-2995.1999.39070763.x	NOUN
ajlm-297	263	2	lichtiger	lichtiger	PROPN
ajlm-297	263	3	b	b	PROPN
ajlm-297	263	4	,	,	PUNCT
ajlm-297	263	5	huh	huh	INTJ
ajlm-297	263	6	yo	yo	INTJ
ajlm-297	263	7	.	.	PUNCT
ajlm-297	264	1	autologous	autologous	ADJ
ajlm-297	264	2	blood	blood	NOUN
ajlm-297	264	3	deposit	deposit	NOUN
ajlm-297	264	4	and	and	CCONJ
ajlm-297	264	5	transfusion	transfusion	NOUN
ajlm-297	264	6	in	in	ADP
ajlm-297	264	7	cancer	cancer	NOUN
ajlm-297	264	8	patients	patient	NOUN
ajlm-297	264	9	.	.	PUNCT
ajlm-297	265	1	current	current	ADJ
ajlm-297	265	2	issues	issue	NOUN
ajlm-297	265	3	in	in	ADP
ajlm-297	265	4	transfusion	transfusion	NOUN
ajlm-297	265	5	medicine	medicine	NOUN
ajlm-297	265	6	.	.	PUNCT
ajlm-297	266	1	1992;1(1):10–14	1992;1(1):10–14	X
ajlm-297	266	2	.	.	PUNCT
ajlm-297	267	1	quijada	quijada	PROPN
ajlm-297	267	2	jg	jg	PROPN
ajlm-297	267	3	.	.	PUNCT
ajlm-297	268	1	post	post	ADJ
ajlm-297	268	2	-	-	ADJ
ajlm-297	268	3	transfusion	transfusion	ADJ
ajlm-297	268	4	alloimmunization	alloimmunization	NOUN
ajlm-297	268	5	(	(	PUNCT
ajlm-297	268	6	letter	letter	NOUN
ajlm-297	268	7	)	)	PUNCT
ajlm-297	268	8	.	.	PUNCT
ajlm-297	269	1	br	br	PROPN
ajlm-297	269	2	j	j	PROPN
ajlm-297	269	3	haematol	haematol	PROPN
ajlm-297	269	4	.	.	PUNCT
ajlm-297	270	1	1996	1996	NUM
ajlm-297	270	2	;	;	PUNCT
ajlm-297	271	1	95(3):573–574	95(3):573–574	NUM
ajlm-297	271	2	.	.	PUNCT
ajlm-297	272	1	badjie	badjie	PROPN
ajlm-297	272	2	ks	ks	PROPN
ajlm-297	272	3	,	,	PUNCT
ajlm-297	272	4	tauscher	tauscher	PROPN
ajlm-297	272	5	cd	cd	PROPN
ajlm-297	272	6	,	,	PUNCT
ajlm-297	272	7	van	van	PROPN
ajlm-297	272	8	buskirk	buskirk	PROPN
ajlm-297	272	9	cm	cm	PROPN
ajlm-297	272	10	,	,	PUNCT
ajlm-297	272	11	et	et	PROPN
ajlm-297	272	12	al	al	PROPN
ajlm-297	272	13	.	.	PROPN
ajlm-297	272	14	red	red	ADJ
ajlm-297	272	15	blood	blood	NOUN
ajlm-297	272	16	cell	cell	NOUN
ajlm-297	272	17	phenotype	phenotype	NOUN
ajlm-297	272	18	matching	match	VERB
ajlm-297	272	19	for	for	ADP
ajlm-297	272	20	various	various	ADJ
ajlm-297	272	21	ethnic	ethnic	ADJ
ajlm-297	272	22	groups	group	NOUN
ajlm-297	272	23	.	.	PUNCT
ajlm-297	273	1	immunohematology	immunohematology	NOUN
ajlm-297	273	2	.	.	PUNCT
ajlm-297	274	1	2011;27(1):12–19	2011;27(1):12–19	NUM
ajlm-297	274	2	.	.	PUNCT
ajlm-297	275	1	baby	baby	NOUN
ajlm-297	275	2	m	m	PROPN
ajlm-297	275	3	,	,	PUNCT
ajlm-297	275	4	fongoro	fongoro	PROPN
ajlm-297	275	5	s	s	PROPN
ajlm-297	275	6	,	,	PUNCT
ajlm-297	275	7	cissé	cissé	VERB
ajlm-297	275	8	m	m	PROPN
ajlm-297	275	9	,	,	PUNCT
ajlm-297	275	10	et	et	PROPN
ajlm-297	275	11	al	al	PROPN
ajlm-297	275	12	.	.	PUNCT
ajlm-297	276	1	[	[	X
ajlm-297	276	2	frequency	frequency	NOUN
ajlm-297	276	3	of	of	ADP
ajlm-297	276	4	red	red	ADJ
ajlm-297	276	5	blood	blood	NOUN
ajlm-297	276	6	cell	cell	NOUN
ajlm-297	276	7	alloimmunization	alloimmunization	NOUN
ajlm-297	276	8	in	in	ADP
ajlm-297	276	9	polytransfused	polytransfuse	VERB
ajlm-297	276	10	patients	patient	NOUN
ajlm-297	276	11	at	at	ADP
ajlm-297	276	12	the	the	DET
ajlm-297	276	13	university	university	NOUN
ajlm-297	276	14	teaching	teaching	NOUN
ajlm-297	276	15	hospital	hospital	NOUN
ajlm-297	276	16	of	of	ADP
ajlm-297	276	17	point	point	NOUN
ajlm-297	276	18	g	g	PROPN
ajlm-297	276	19	,	,	PUNCT
ajlm-297	276	20	bamako	bamako	PROPN
ajlm-297	276	21	,	,	PUNCT
ajlm-297	276	22	mali	mali	PROPN
ajlm-297	276	23	]	]	PUNCT
ajlm-297	276	24	article	article	NOUN
ajlm-297	276	25	in	in	ADP
ajlm-297	276	26	french	french	PROPN
ajlm-297	276	27	.	.	PUNCT
ajlm-297	277	1	transfus	transfus	PROPN
ajlm-297	277	2	clin	clin	PROPN
ajlm-297	277	3	biol	biol	PROPN
ajlm-297	277	4	.	.	PUNCT
ajlm-297	278	1	2010;17(4):218–222	2010;17(4):218–222	NUM
ajlm-297	278	2	.	.	PUNCT
ajlm-297	279	1	http://dx.doi.org/10.1016/j.tracli.2010.06.026	http://dx.doi.org/10.1016/j.tracli.2010.06.026	PROPN
ajlm-297	279	2	m’baya	m’baya	PROPN
ajlm-297	279	3	b	b	PROPN
ajlm-297	279	4	,	,	PUNCT
ajlm-297	279	5	mfune	mfune	PROPN
ajlm-297	279	6	t	t	PROPN
ajlm-297	279	7	,	,	PUNCT
ajlm-297	279	8	mogombo	mogombo	ADJ
ajlm-297	279	9	e	e	NOUN
ajlm-297	279	10	,	,	PUNCT
ajlm-297	279	11	et	et	PROPN
ajlm-297	279	12	al	al	PROPN
ajlm-297	279	13	.	.	PUNCT
ajlm-297	280	1	the	the	DET
ajlm-297	280	2	prevalence	prevalence	NOUN
ajlm-297	280	3	of	of	ADP
ajlm-297	280	4	red	red	ADJ
ajlm-297	280	5	-	-	PUNCT
ajlm-297	280	6	cell	cell	NOUN
ajlm-297	280	7	antigens	antigen	NOUN
ajlm-297	280	8	and	and	CCONJ
ajlm-297	280	9	antibodies	antibody	NOUN
ajlm-297	280	10	in	in	ADP
ajlm-297	280	11	malawi	malawi	PROPN
ajlm-297	280	12	.	.	PUNCT
ajlm-297	281	1	transfus	transfus	PROPN
ajlm-297	281	2	med	med	PROPN
ajlm-297	281	3	.	.	PUNCT
ajlm-297	282	1	2010;20(3):196–199	2010;20(3):196–199	X
ajlm-297	282	2	.	.	PUNCT
ajlm-297	283	1	http://dx.doi.org/10.1111/j.1365-3148.2009.00985.x	http://dx.doi.org/10.1111/j.1365-3148.2009.00985.x	ADJ
ajlm-297	283	2	schonewille	schonewille	NOUN
ajlm-297	283	3	h	h	NOUN
ajlm-297	283	4	,	,	PUNCT
ajlm-297	283	5	haak	haak	NOUN
ajlm-297	283	6	hl	hl	NOUN
ajlm-297	283	7	,	,	PUNCT
ajlm-297	283	8	van	van	PROPN
ajlm-297	283	9	zijl	zijl	PROPN
ajlm-297	283	10	am	be	AUX
ajlm-297	283	11	:	:	PUNCT
ajlm-297	283	12	rbc	rbc	PROPN
ajlm-297	283	13	antibody	antibody	NOUN
ajlm-297	283	14	persistence	persistence	NOUN
ajlm-297	283	15	.	.	PUNCT
ajlm-297	284	1	transfusion	transfusion	NOUN
ajlm-297	284	2	.	.	PUNCT
ajlm-297	285	1	2000;40(9):1127–1131	2000;40(9):1127–1131	NUM
ajlm-297	285	2	.	.	PUNCT
ajlm-297	286	1	http://dx.doi.org/10.1046/j.1537-2995.2000.40091127.x	http://dx.doi.org/10.1046/j.1537-2995.2000.40091127.x	PROPN
ajlm-297	286	2	natukunda	natukunda	PROPN
ajlm-297	286	3	b.	b.	PROPN
ajlm-297	286	4	red	red	PROPN
ajlm-297	286	5	blood	blood	NOUN
ajlm-297	286	6	cell	cell	NOUN
ajlm-297	286	7	alloimmunization	alloimmunization	NOUN
ajlm-297	286	8	and	and	CCONJ
ajlm-297	286	9	antigen	antigen	NOUN
ajlm-297	286	10	matching	match	VERB
ajlm-297	286	11	in	in	ADP
ajlm-297	286	12	sickle	sickle	NOUN
ajlm-297	286	13	cell	cell	NOUN
ajlm-297	286	14	disease	disease	NOUN
ajlm-297	286	15	–	–	PUNCT
ajlm-297	286	16	the	the	DET
ajlm-297	286	17	african	african	ADJ
ajlm-297	286	18	perspective	perspective	NOUN
ajlm-297	286	19	.	.	PUNCT
ajlm-297	287	1	isbt	isbt	NOUN
ajlm-297	287	2	science	science	PROPN
ajlm-297	287	3	series	series	NOUN
ajlm-297	287	4	.	.	PUNCT
ajlm-297	288	1	2012;7(1):129–133	2012;7(1):129–133	X
ajlm-297	288	2	.	.	PUNCT
ajlm-297	289	1	http://dx.doi.org/10.1111/j.1751-2824.2012.01572.x	http://dx.doi.org/10.1111/j.1751-2824.2012.01572.x	PROPN
ajlm-297	289	2	reverberi	reverberi	PROPN
ajlm-297	289	3	r.	r.	PROPN
ajlm-297	289	4	the	the	DET
ajlm-297	289	5	persistence	persistence	NOUN
ajlm-297	289	6	of	of	ADP
ajlm-297	289	7	red	red	ADJ
ajlm-297	289	8	cell	cell	NOUN
ajlm-297	289	9	alloantibodies	alloantibody	NOUN
ajlm-297	289	10	.	.	PUNCT
ajlm-297	290	1	blood	blood	NOUN
ajlm-297	290	2	transfus	transfus	PROPN
ajlm-297	290	3	.	.	PUNCT
ajlm-297	291	1	2008	2008	NUM
ajlm-297	291	2	;	;	PUNCT
ajlm-297	292	1	6(4):225–234	6(4):225–234	NUM
ajlm-297	292	2	.	.	PUNCT